The effects of some ligands on aspects of calcium and magnesium metabolism by Farningham, David A. H.
THE EFFECTS OF SOME LIGANDS ON
ASPECTS OF CALCIUM AND
MAGNESIUM METABOLISM
David A.H. Farningham
A thesis submitted to the
University of Edinburgh




To my wife Marian, and baby Roderick.
Declaration
In accordance with regulation 2.4.15 I declare that the work




I wish to thank the Horserace Betting Levy Board and the Animal
Health Trust for providing financial assistance enabling these
studies to be carried out. I must also thank Professor F. Alexander
for allowing me to study in his Department. I gratefully
acknowledge the advice and criticism given by my supervisor, Dr
S.S. Carlyle. In addition useful advice and criticism was given by
other members of the department. Thanks are due to Mr I.S. Warwick
and his technical staff for maintaining the animals and assisting
in a variety of ways. Finally I wish to express my thanks to
numerous people at Pfizer Central Research Ltd., especially Dr
J.R.C. Baird, for allowing the time and resources which enabled me





_I. Calcium and magnesium fractions in blood and plasma. . . .2
Ionized calcium and magnesium 3
Measurement of ionized calcium 4
Measurement of ionized magnesium 6
Complexed calcium and magnesium 7
Protein bound calcium and magnesium 8
Determination of diffusible calcium and magnesium . . .9
II. The renal handling of calcium and magnesium 11
Calcium 11
Magnesium 12
Some factors influencing the renal




The inverse relationship between the renal
tubular reabsorption of calcium and magnesium ... 17
III. Effects of ligands on calcium and magnesium metabolism . .18
Exogenous ligands:
1. Ethylene diamine tetraacetic acid (EDTA) 21
Exogenous ligands:
2. Calcium borogluconate 25
Exogenous ligands:
3. Ethane-l-hydroxy-1,1-diphosphonic acid (EHDP) 27
Condensed phosphates in vitro 27
Pyrophosphate and pyrophosphatase in vivo 28
Diphosphonates 30
Biological actions of diphosphonates 33
The renal effects of diphosphonates 34
The effects of diphosphonates on bone 34
Effects of diphosphonates on experimentally
induced calcification defects 36
CHAPTER II
MATERIALS AND METHODS
1. Preparation of sheep for infusion,
and urine and blood collection 39
2. Materials 41
3. Collection of blood for measurement of ionized
and ultrafiltrable calcium and magnesium 41
4. Total magnesium and calcium determination
by atomic absorption spectrophotometry (AAS) 42
5. Sample preparation for AAS 44
5.1 Plasma and ultrafiltrates 44
5.2 Urine preparation 44
5.3 Faecal preparation and analysis 45
5.3a Faecal dry matter and dry matter
calcium and magnesium content 45
5.3b Faecal fluid total and ultrafiltrable
calcium and magnesium content 46
5.4 Mouse femur preparation 46
5.5 Preparation of ultrafiltrates 47
6. Measurement of ionized calcium
using the Nova-2 Ca"*""*" Analyser 48
7. Measurement of ionized divalent cations
using the method of Heaton (1967) 49
7.1 Preparation of ion exchange strips 49
7.2 Estimation of ionized calcium and
magnesium in plasma 49
8. Estimation of ionized magnesium and calcium in vitro . 50
9. Sodium and potassium determination 52
10.Measurement of urinary pH, blood gases and pH 52
ll.l^Carbon scintillation counting 53
12.Creatinine estimation 55
13.1nulin Estimation 57
14.Calculation of renal clearances 58
15.Statistical analysis 59
CHAPTER III
EVALUATION OF METHODS FOR ESTIMATING FRACTIONS
OF PLASMA CALCIUM AND MAGNESIUM
Summary 60
MATERIALS AND METHODS 61
RESULTS AND DISCUSSION
I. Low capacity ion exchange strips for
measuring ionized calcium and magnesium 62
1. Calibration of the method 62
2. The effect of equilibration of ion
exchange strips on the composition of plasma 62
3. The effect of alterations in the composition
of the standard solution on calcium and
magnesium concentrations in the eluate 64
4. The effect of complexing agents on
eluted magnesium 68
Discussion 71
Low capacity ion exchange strips:
theoretical considerations 71
Comparison of the method used
with that of Heaton (1967) 73
Validation of the method 75
II.Evaluation of the Nova-2 analyser for
measuring calcium ions 79
1. Variability of the method 79
2. Linearity of the method 79
3. Recovery of added calcium chloride 81
4. Removal of calcium from plasma with EDTA 81
5. The effect of blood heparin concentration
on measurements of ionized calcium 83
Discussion 85
III.Evaluation of the method of preparing ultrafiltrates
1. Variability of the method 87
2. Protein permeability of the visking tubing 87
3. Changes in pH and pCC^ following ultrafiltration ... 88
4. The effect of temperature on
ultrafiltrable calcium and magnesium 89
5. The Donnan equilibrium: Measurement of
ultrafiltrate/plasma sodium, potassium
and EDTA concentration ratios 89
Discussion 91
CHAPTER IV
THE EFFECT OF ETHYLENE DIAMINE TETRAACETIC ACID (EDTA)
INFUSIONS ON THE PLASMA FRACTIONS AND URINARY







THE FORMATION OF CALCIUM COMPLEXES BY BOROGLUCONATE IN VITRO
AND DURING CALCIUM BOROGLUCONATE INFUSION IN SHEEP
Summary 110
Introduction 112
Methods and Results 113
1. The in vitro ionization of calcium
borogluconate and calcium chloride in blood 113
2. Ionized calcium in vitro after addition of sodium
gluconate and sodium borate to blood 115
3. The effect of calcium borogluconate infusion
on the plasma fractions and urinary excretion
of calcium and magnesium in sheep 117
4. The effect of calcium or sodium borogluconate on plasma
total calcium and magnesium concentrations 124
Discussion 126
CHAPTER VI
THE BINDING OF CALCIUM AND MAGNESIUM BY ETHANE-1-HYDR0XY-1,1-
DIPHOSPHONATE (EHDP) IN VITRO AND IN VIVO. ITS EFFECT ON
PLASMA AND URINARY CALCIUM AND MAGNESIUM IN THE SHEEP
Summary 131
Introduction 133
Methods and Results 134
1. The ionization of calcium and magnesium
in solutions containing EHDP 134
2. Ultrafiltrable calcium and magnesium
in solutions containing EHDP 138
3. Comparison of the ultrafiltrable calcium and magnesium
fractions in plasma and in solutions 140
4. The reduction in ionized and ultrafiltrable plasma
calcium concentrations after the addition of EHDP . . .142
5. The effect of EHDP, pyrophosphate and EDTA on
ionized calcium in plasma 144
6. The effect of EHDP infusions in sheep on





THE EFFECTS OF CHRONIC ETHANE-1-HYDR0XY-1,1-PIPHOSPHONATE
(EHDP) ADMINISTRATION ON THE EXCRETION OF CALCIUM AND
MAGNESIUM BY SHEEP AND HORSES
Summary 157
Introduction 159
Methods and Results 160
1. The effects of EHDP (4 mg kg--'-day--'- by subcutaneous
injection or 25 mg kg^day--'- per os) on plasma, urinary
and faecal calcium and magnesium in the horse 160
2. The effects of EHDP (4 mg kg-lday--'- by subcutaneous
injection) on urinary creatinine (cr) concentration,
[Ca]/[cr] and [Mg]/[cr], and plasma calcium and
magnesium in sheep 167
Discussion 170
CHAPTER VIII
EFFECT OF AMMONIUM CHLORIDE INDUCED ACIDOSIS AND
ETHANE-1-HYDROXY-1,1-PIPHOSPHONATE (EHDP)











A comparison between the renal clearance of endogenous








In biological solutions, such as plasma, a small proportion of the
calcium and magnesium present exists as free ions in equilibrium
with a larger inactive fraction which is bound to protein or small
diffusible ligands. The effects of ligands on the distribution of
calcium and magnesium between these physico-chemical states, and
their effects on the kinetics of these minerals in intact sheep and
horses form the major part of this study. Trisodium ethylene
diamine tetraacetate (EDTA), calcium and sodium borogluconate, and
disodium ethane-l-hydroxy-1,1-diphosphonate (EHDP), all exogenous
ligands of pharmacological and therapeutic interest were studied.
Estimation of total calcium and magnesium concentrations
presents few problems. However extensive investigations of possible
methods of estimating diffusible and ionic calcium and magnesium
were necessary, as was the validation of a method of estimating
glomerular filtration rate (GFR) in conscious intact sheep.
EDTA, largely in confirmation of published studies, caused an
almost stoichiometric shift of plasma calcium into the non-ionized
diffusible fraction, and resulted in stoichiometric increments in
urinary calcium and EDTA. The renal clearance of EDTA was similar
to GFR.
In vitro, calcium-borogluconate complex formation was
demonstrated and synergism observed between borate and gluconate.
During calcium borogluconate infusion a small increase in the
concentration of ionized plasma calcium was accompanied by a larger
increase in the non-ionized diffusible fraction. Administration of
sodium borogluconate resulted in decreased total plasma calcium
concentration, probably as a result of decreased renal tubular
reabsorption of calcium complexes. Calcium infusion was also
associated with reduced GFR, acidosis and slight hypomagnesaemia,
the implications of which were discussed.
EHDP was found to form large non-diffusible calcium and
magnesium complexes in vitro. This was due to aggregation of
complexes and not protein binding. Infusion of EHDP resulted in
increases in non-diffusible ultrafiltrable calcium in plasma and
urine. Evidence also indicated that the renal clearance of EHDP was
lower than GFR, presumably due to the low renal clearance of large
molecules. Additionally, chronic administration of low doses of
EHDP to horses caused a calciuresis too great to be attributable to
simple filtration of complexes, suggesting a second mode of action.
Limited evidence indicated a similar phenomenon in sheep.
Since ammonium chloride induced acidosis results in depletion of
bone mineral and EHDP reduces calcium turnover in bone, these drugs
were studied simultaneously in mice. Both substances caused
significant loss of bone potassium (per gm dry weight); acidosis
also reduced bone sodium and total bone fat. Since EHDP did not
alter the effects of acidosis it seemed unlikely to be of clinical




Calcium and magnesium are cations of particular interest in
veterinary medicine. Dryerre and Greig (1925) suggested that cows
suffering from milk fever had parathyroid deficiency. They went on to
demonstrate an association between milk fever and hypocalcaemia
(Dryerre and Greig 1928). Subsequently the presence of
hypomagnesaemia in calves with milk tetany was demonstrated by
Duncan, Huffman and Robinson (1935). Since these early studies
further work has confirmed the original observations and provided a
greater insight into calcium and magnesium homeostasis.
I. Calcium and magnesium fractions in blood and plasma
It has long been recognised that plasma calcium and magnesium exist
as diffusible and non-diffusible fractions (Rona and Takahashi,
1911; Tschimber and Tschimber, 1924). The presence of a non-
diffusible fraction was attributed to protein binding.
McLean and Hastings (1934a, 1934b) showed that calcium complexes
are formed by proteins and some diffusible anions normally present
in plasma. Plasma calcium and magnesium exists in three forms;
protein bound, complexed and ionized. In man, of the total plasma
calcium 54% is ultrafiltrable and 48% ionized (Walser, 1961a).
Plasma magnesium is 69% ultrafiltrable and 55% ionized (Walser,
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1961a).
Ionized calcium and magnesium
The biological significance of ionized calcium was not clearly
demonstrated until McLean and Hastings (1934a) produced a reliable
and accurate method of measuring the ionized component of plasma
calcium. They showed (McLean and Hastings, 1934b) that substances
which bind calcium reduce the contractility of the frog heart
preparation. The clear inference was that the inotropic response of
the myocardium was related to the calcium ion concentration. Other
workers have shown that perfusion of isolated parathyroid gland in
vitro and in vivo with blood containing ethylene diamine tetra-
acetic acid (EDTA) caused a rapid increase in parathyroid hormone
secretion, evidence that ionized and not EDTA bound calcium is the
important mediator of PTH secretion (Care, Sherwood, Potts, Mayer
and Aurbach, 1966; Sherwood, Potts, Care, Mayer and Aurbach, 1966).
The important implication of these studies was that the
biologically active component of plasma calcium was the ionized
fraction. It seems likely that ionized magnesium is also the
biologically active form. Direct evidence, of the type cited for
calcium, is difficult to produce since ionized magnesium is more
difficult to measure and substances which complex magnesium without
also complexing calcium are not yet available.
The biological or chemical response to an ion is related to its
activity in solution. The ionic activity divided by the
concentration of an ion is its activity coefficient. The activity
coefficient is also related to the radius of the hydrated ion and
the ionic strength of the solution (Kielland, 1937). Since in
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biological solutions ionic strength varies little, the activity
coefficient is fairly constant. Ionic activity is therefore
approximately proportional to ionized concentration. The activity
coefficient for calcium is about 0.36, for magnesium it is a little
greater as the hydrated magnesium ion is slightly larger (0.40;
Neuman and Neuman, 1958). Since methods of determining ionized
calcium and magnesium respond to the activity of the ions rather
than their concentrations, ionic strength will influence such
determinations. Usually this problem is overcome by measuring very
dilute calcium or magnesium standards and samples in which
concentration approximately equals activity; or by measuring
standards and samples of similar ionic strength, thus obtaining an
estimate of concentration.
Measurement of ionized calcium
In the past many methods have been used for measuring ionized
calcium. The frog heart method (McLean and Hastings, 1934a) was the
first and for many years the best method of measuring ionized
calcium. Other bioassays have also been used including a rachitic
cartilage calcification method (Yendt, Connor and Howard, 1955) and
the blood clotting method of Soulier and Crosnier (1958).
Aequorin is a jelly fish protein which fluoresces in the
presence of calcium ions. It has been used to measure ionized
calcium in plasma (Izutsu and Felton, 1972). Unfortunately the
method seems to be unsuitable for use in plasma as the amount of
aequorin required binds sufficient calcium to cause large
disturbances of the normal calcium binding equilibria in plasma.
The method seems to be more suitable for estimating calcium ion
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concentration in pure solutions containing strong calcium chelating
agents such as EDTA and EGTA (ethyleneglycol bis-(2 aminoethyl-
ether)tetra-acetic acid) (Izutsu, Felton, Siegel, Nicholls,
Crawford, McGough and Yoda, 1974).
Several workers have successfully used spectrophotometric
methods. The methods involve the formation of coloured calcium
complexes by dyes such as tetra methyl murexide. When the dye is
present in low concentrations, ionized calcium concentration is
related to the amount of coloured complex formed (Rose, 1957;
Walser, 1960; Pedersen 1970). The absorbancy change for changes in
ionized calcium is small, so it is difficult to obtain reliable
results. These methods require prior ultrafiltration of plasma and
so introduce two stages and subsequent compounding of errors.
The first attempt to measure ionized calcium using an ion
selective electrode was that of Neuhausen and Marshall (1922) who
made a calcium-mercury amalgam electrode. However it was not
specific enough for use in plasma. Commercial ion selective
electrodes are now available which can quickly, and with reasonable
accuracy, measure ionized calcium. Early versions suffered from
interference by sodium and were poisoned by contact with protein.
More recently these problems have been largely overcome. Flow
through electrodes are now available which are microproccessor
controlled and thermostatted, for example the Nova-2 (American
Hospital Supply UK Ltd) and SS-20 (Orion Research) which offer
simple methods of ionized calcium estimation. Several types of
electrode have been produced with liquid (Ross, 1967), solid state
(Schwartz, 1975) and PVC membrane (Pors Nielsen, Falch
Christiansen, Hartling and Trap-Jensen, 1977) ion exchangers.
5
Measurement of ionized magnesium
The first attempt to measure ionized magnesium was made by Nordbo
(1939) who used an indicator dye. Baum and Czok (1959) then
developed an enzymatic method but obtained very variable results.
Walser (1960) used the indicator eriochrome black-T in a
spectrophotometric method for estimating ionized magnesium. The
change in absorbancy due to change in the relative concentrations
of the two absorbing species magnesium-dye and H2~dye at 530 run,
was directly proportional to the ratio K/fMg"*-1"]11, where n is the
binding ratio of the magnesium-dye complex and K the equilibrium
constant. This method has not been used except by the original
author. To eliminate interference from plasma proteins
ultrafiltration is required. Relatively large volumes of tris
buffer have to be added to the ultrafiltrate to control pH, this
may alter equilibria present. The complications involved in this
method make it of questionable value for routine studies.
Low capacity ion exchange strips have been used for measuring
ionized calcium and magnesium (Frizel, Malleson and Marks, 1967;
Heaton, 1967). The principle of this type of method is the
adsorption of cations by ion exchange materials in proportion to
their relative concentrations and in proportion to their relative
affinities for the ion exchanger. The capacity of the ion exchanger
is 1-2% of the total plasma calcium, ensuring that minimal
derangement of existing equilibria is produced.
Frizel et al (1967) used an ion exchanger containing aryl
sulphonic acid groups. They showed that magnesium and calcium were
taken up by the ion exchange strip in proportion to their
concentrations. They also found that increasing the concentrations
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of sodium or potassium in the standard depressed the adsorption of
calcium, or magnesium, by the ion exchange strips. When citric
acid was added, the uptake of calcium and magnesium by the strips
was reduced. Heaton (1967) also used ion exchange strips and
showed that the uptake of magnesium was proportional to its
concentration in standard solutions and inversely proportional to
the concentration of interfering cations.
Ion exchange methods seem to offer a relatively simple approach
to the measurement of ionized magnesium which has the advantage of
minimal sample handling thus reducing the risk of pH changes. The
work of Heaton (1967) is widely quoted (for example: Achilles,
Scheidt, Hoppe and Cumme, 1977; May, Linder and Williams, 1977;
Bird and Maguire, 1978; Flatman and Lew, 1980; Speich, Bosquet and
Nicolas, 1981), possibly because of the low variation in his
results and the excellent agreement with the results of Walser
(1961).
Complexed calcium and magnesium
This is normally the smallest component of plasma calcium and
magnesium. It is usually determined as the difference between
ultrafiltrable and ionized calcium or magnesium; the compounding of
estimation errors and the small size of this fraction make it is
very difficult to study. The main complexes normally present in
plasma are those formed by citrate, phosphate (Walser, 1961a) and
bicarbonate (Greenwald, 1941; Neuman, Morrow, Toribara, Casarett,
Mulryan and Hodge, 1956). Whilst this fraction normally constitutes
only a small proportion of the total plasma calcium and magnesium
concentrations, during infusions of calcium and magnesium binding
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ligands the size of this fraction may become significant.
Speich, Bosquet and Nicolas (1981) described a method for
measuring complexed magnesium. The ionized and protein bound
magnesium were claimed to be adsorbed by a cation exchange resin.
The residual magnesium was assumed to be the complexed form which
was then measured by atomic absorption spectrophotometry. Since
this method involves the removal of all the ionized magnesium from
the sample, it would seem that in maintaining equilibrium complexed
magnesium would dissociate, so releasing magnesium to be adsorbed
by the resin. This would make measurement of the true
concentration of the complexed form in the original sample
unlikely.
Protein bound calcium and magnesium
McLean and Hastings (1934b) used their ionized calcium assay to
study calcium binding. They found that in protein containing fluids
such as ascitic, pleural or oedema fluids, serum or artificial
protein solutions, the ionization of calcium followed the law of
mass action. They were able to use their methods to determine
equilibrium constants for the calcium-protein reaction. No such
studies have been made in the case of magnesium, though attempts
were made to determine magnesium-protein equilibrium constants
using ultrafiltration (Copeland and Sunderman, 1952). Since ionized
magnesium was not measured, these constants are likely to be less
accurate.
In serum, albumin is responsible for binding 90% of the non-
diffusible calcium (Pedersen, 1972d; Tofaletti, Savory and
Gitelman, 1977) and all the protein bound magnesium (Cummings, Kuff
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and Sober, 1968). The nature of the bonds formed between calcium
and serum albumin has received detailed study (Pedersen, 1971b,
1972a,b,c&d). Calcium and magnesium have been shown to compete for
protein binding sites on the serum albumin molecule (Carr 1955;
Pedersen 1972b&d), the second author also demonstrating competition
between H+ and calcium ions. In vivo studies in rats have
demonstrated a strong negative correlation between ionized plasma
calcium and plasma pH. This was probably, at least in part, a
result of changes in protein binding (Girndt, Henning and Delling,
1979).
Determination of diffusible calcium and magnesium
Many techniques have been used for this determination, basically
they all involve either ultrafiltration through a semi-permeable
membrane (Rawson and Sunderman, 1948; Robertson and Peacock, 1968;
Pedersen, 1972b) or ultracentrifugation (Chanutin, Ludwig and
Masket, 1942; Ludwig, Chanutin, and Masket, 1942; Breen and
Freeman, 1961; Cummings et al, 1968). Most methods of
ultrafiltration use either positive pressure (Rose, 1957; Robertson
and Peacock, 1968) or centrifugation (Pedersen, 1971b) to induce
flow of ultrafiltrate through the semi-permeable membrane. Positive
pressure has the disadvantage of altering pCC>2 and thus piasma pd
and protein binding of calcium and magnesium.
Various types of membrane filters have been used including
collodion membranes (Tschimber and Tschimber, 1924; Greenberg and
Greenberg, 1931), visking tubing (Rawson and Sunderman, 1948;
Pedersen, 1971b), cuprophan membranes (Le Grimellec, Poujeol and de
Rouffignac, 1975) and Amicon "Centriflo" membranes (Holley and
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Evans, 1977). The type of filter used seems to be insignificant
providing the pores are small enough to prevent the passage of
protein molecules. Estimates of pore size in visking tubing may be
made by measuring the increased resistance to flow that occurs with
increased molecular weight of solutes. Studies suggest pore radii
of 1.3-2.3 nm (Renkin, 1954; Durbin, 1960) which is sufficiently
small to exclude all plasma proteins. Several factors require
consideration in the assessment of a method of determining
diffusible calcium and magnesium. These factors all seem to act
through Donnan (Greenberg and Greenberg, 1931) or pH effects
(Robertson et al, 1968).
Donnan (1924) demonstrated that when non-diffusible substances,
such as negatively charged protein molecules, are contained within
a semi-permeable sac, as a result of electrical and concentration
gradients diffusible cations move in whilst anions move out. When
these opposing forces equilibrate, a negative potential is present
within the sac whose magnitude is dependent on the Nernst equation.
When ultrafiltration of plasma takes place, the removal of protein
free filtrate increases the protein concentration and enhances the
Donnan effect. It is therefore important that excess ultrafiltrate
should not be removed from the sample.
Since calcium, magnesium and H+ compete for the same binding
sites on the albumin molecule (Carr, 1955; Pedersen, 1971a,1972a&d)
it is important that blood pH is carefully controlled during the
procedure. Temperature also effects blood gas equilibria and pH
and so is also likely to require careful control.
Ultracentrifugation can avoid the Donnan shifts associated with
the use of semipermeable membranes but requires the use of
sophisticated equipment and necessitates pH control during
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prolonged periods of centrifugation. Given careful control, it
would seem that ultrafiltration can provide a reasonable estimate
of diffusible calcium and magnesium in plasma.
The extent to which plasma ultrafiltrates resembles the
composition of glomerular filtrate is not absolutely clear. It is
likely that differences exist since the glomerulus is permeable to
some plasma proteins (Dirks, Clapp and Berliner, 1964) whilst the
pore size of most ultrafiltration systems is usually considerably
smaller and so prevents the passage of all proteins.
II. The renal handling of calcium and magnesium
Calcium
Clearance studies have shown that the renal handling of calcium
involves glomerular filtration with subsequent reabsorption of most
of the calcium by the renal tubule (Chen and Neuman, 1955a).
Micropuncture studies showed that the concentration of calcium in
the glomerular ultrafiltrate is approximately 60-70% of total
plasma calcium (Lassiter, Gottschalk and Mylle, 1963; LeGrimellec,
Poujeol and De Rouffignac, 1975). The second study did not find a
significant correlation between plasma ultrafiltrable and
glomerular filtrate calcium concentration. It was not certain
whether this merely reflected methodological variation, or whether
it was the result of genuine differences.
Lassiter et al (1963) were the first to use micropuncture to
study calcium transport in different segments of the nephron. Of
the filtered calcium, 60% was absorbed in the proximal tubule along
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with sodium and water. Murayama, Morel and Le Grimellec (1972)
found that the proximal tubule was highly permeable to calcium
since net reabsorption was only 1/3 of the unidirectional flux.
In the loop of Henle approximately 25% of filtered calcium is
reabsorbed (Lassiter et al, 1963). Rocha, Magaldi and Kokko (1977)
showed that the calcium permeability of all segments of the loop of
Henle was too low to allow calcium reabsorption by passive means.
Furthermore they demonstrated that in this segment, the thick
ascending limb was the primary reabsorptive site.
In the distal tubule approximately 10% of filtered calcium is
reabsorbed (Lassiter et al, 1963). Since reabsorption at this site
occurs against the trans-tubular potential (Clapp, Rector and
Seldin, 1962) and against a large concentration gradient (Lassiter
et al 1963), it is likely that reabsorption involves active
transport.
Magnesium
Magnesium, like calcium, is filtered by the glomerulus and then
undergoes reabsorption in the renal tubule. Approximately 70-80% of
total plasma magnesium is filtered by the glomerulus (Le Grimellec,
Poujeol, and De Rouffignac, 1975; Brunette and Crochet, 1975). The
concentration of magnesium in glomerular filtrate thus appears to
be similar to values determined in plasma ultrafiltrates (Walser,
1961a) .
Magnesium is partially reabsorbed in the proximal tubule.
Brunette, Wen, Evanson and Dirks (1969) found that in the dog,
proximal tubular magnesium absorption appeared to be isotonic and
followed sodium and water. Other studies have since shown that
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although magnesium reabsorption occurs, the proximal tubule is
relatively impermeable to magnesium and so the ratio of tubular
fluid to plasma ultrafiltrate magnesium concentration rises along
this segment. This was demonstrated by micropuncture studies in the
rat (Morel, Roinel and Le Grimellec, 1969) and by studies of
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magnesium permeability (Brunette and Aras, 1971). The distal
convoluted tubule is not a major site of magnesium transport.
Limited reabsorption occurs in this segment and is concentration
dependent (Quamme and Dirks, 1980).
The work of Morel et al (1969) indicated that 50-60% of filtered
magnesium was reabsorbed in the loop of Henle (De Rouffignac,
Morel, Moss and Roinel, 1973). Brunette, Vigneault and Carriere
(1978) found that at the tip of the loop of Henle magnesium
concentration was considerably higher than in the vasa recta. This
suggested that magnesium absorption was not occurring to any great
extent in the descending limb. During preliminary experiments in
which rabbit cortical thick ascending limbs were perfused in vitro,
Shareghi and Agus (1979) found that magnesium was absorbed from the
lumen suggesting that this portion of the ascending limb was the
important area of magnesium reabsorption.
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Some factors influencing the renal handling of calcium and
magnesium
Endocrine influences
The possible involvement of parathyroid hormone (PTH) in the
control of renal calcium excretion was first suggested by an acute
rise in urinary calcium following parathyroidectomy of rats
(Talmage and Kraintz, 1954). Since hypercalciuria occurred despite
decreased plasma calcium, it seemed likely that PTH had been
promoting tubular reabsorption of calcium. Kleeman, Rockney and
Maxwell (1958) subsequently demonstrated reduced calcium clearance
in man following administration of parathyroid extract. The
reduction was constant over the wide range of calcium clearances
induced by calcium chloride administration.
In the dog parathyroidectomy also induces hypercalciuria
(Kleeman, Bernstein, Dowling and Maxwell, 1960). Similarly, PTH
reduces calcium clearance in the dog (Widrow and Levinsky, 1962),
the rat (Maclntyre, Boss and Troughton, 1963) and in man (Edwards
and Hodgkinson, 1965). Clearance and stop-flow^ studies suggest
that PTH acts mainly at a distal site (Widrow and Levinsky, 1962;
Stop-flow studies are performed by inducing rapid diuresis,
usually using mannitol. Clamping the ureter stops or slows
glomerular filtration and urine flow through the nephron allowing
time for the nephron segments to alter solute concentrations. On
release of the clamp glomerular filtration rate and urine flow
rapidly rise to their former values and the altered urine is
rapidly flushed into the ureter with minimal alteration during its
passage through subseqent tubule segments. The urine is collected
in serial samples, early samples being from the distal tubular
segments and later samples from the proximal segments. Relating
the effects on solutes to the simultaneous measurements of sodium,
inulin and para-aminohippuric acid provides information regarding
the tubular transport of these solutes. Despite the assumptions
involved in the method, it has proved to be useful in the dog.
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Massry, Coburn, Chapman and Kleeman, 1967). Micropuncture studies
have confirmed that in the dog PTH has a selective action on
calcium reabsorption at or beyond the distal tubule (Sutton, Wong
and Dirks, 1976). Evidence for an action in the proximal tubule
and at a site between the proximal and distal tubule has also been
produced (Harris, Burnatowska, Seely, Sutton, Quamme and Dirks,
1979).
PTH seems to have an effect on renal magnesium handling similar
to that on calcium. Maclntyre et al (1963) showed that PTH
depressed magnesium excretion. Massry, Coburn and Kleeman (1969)
found that during magnesium infusion the fractional excretion of
magnesium was reduced by parathyroid extract. Unfortunately many
studies are difficult to interpret because of the close
relationship between the tubular reabsorption of calcium and
magnesium.
Although calcitonin seems to be less important in calcium
homeostasis, it has been found to enhance calcium excretion
(Ardaillou, Vuagnat, Milhaud and Richet, 1967; Singer, Woodhouse,
Parkinson and Joplin, 1969).
Anions
Anions present in plasma and renal tubular fluid significantly
affect the renal handling of calcium and other ions. The effects of
ligands on aspects of calcium and magnesium metabolism will be
considered in greater detail in a later section. Sodium citrate
increases the rate of excretion of calcium (Gomori and Gulyas,
1944) as does EDTA (Spencer, Vankinscott, Lewin and Lazlo, 1952).
Sulphate causes both calciuresis and magnesuresis (Wolf and Ball,
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1950). Gluconate increases the renal clearance of calcium
(Bernstein, Kleeman, Cutler, Dowling and Maxwell, 1962). The
calciuretic response to many anions is primarily a result of the
formation of complexes which are unavailable for renal tubular
reabsorption. Additionally, the formation of complexes may alter
plasma ultrafiltrable calcium and thus the rate of filtration of
calcium by the glomerulus. This latter effect has been demonstrated
with EDTA (Soffer and Toribara, 1961).
Anions with a valency greater than one probably also depress
tubular reabsorption by increasing the negative intratubular
potential and thus the opposing electrical gradient against which
cations must be absorbed (Clapp et al, 1962).
Hydrogen ion
Evidence suggesting that acidosis alters the renal handling of
calcium was first produced many years ago. Givens and Mendel (1917)
and Lamb and Evvard (1919) demonstrated that administration of
mineral acids augmented renal calcium excretion. The sheep was
found to develop a post prandial acidosis accompanied by
hypercalciuria and hypermagnesuria (Stacy, 1969). Stacy and Wilson
(1970) showed that hypercalciuria could be produced in the sheep by
respiratory or metabolic acidosis even when the filtered calcium
load was falling, this strongly implicates a direct inhibitory
action of acidosis on the renal tubular reabsorption of calcium.
Sutton Wong and Dirks (1979) performed micropuncture and
clearance studies in rats. Their studies suggested that H+ ions
depressed calcium reabsorption in the loop of Henle and in the
terminal nephron.
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The inverse relationship between the renal tubular reabsorptlon of
calcium and magnesium
The close relationship between calcium and magnesium excretion has
been recognised for many years. Mendel and Benedict (1909a&b)
showed that infusion of calcium or magnesium chloride caused an
increase in the excretion of both ions. Wolf and Ball (1949)
showed that calcium had a magnesuric effect. Massry, Coburn and
Kleeman (1969) performed renal clearance studies in dogs whilst
infusing calcium or magnesium chlorides. The tubular reabsorption
of magnesium increased in proportion to plasma magnesium and
reached a maximum at high plasma concentrations. Infusion of
calcium salts or saline diuresis depressed the magnesium tubular
maximum. Coburn, Massry and Kleeman (1970) confirmed the effect of
calcium chloride on magnesium excretion and also showed that the
effect occurred even when glomerular filtration rate (GFR) was
markedly reduced.
Evidence has been produced that this competition occurs in the
distal segment of the nephron. Samiy, Brown, Globus, Kessler and
Thompson (1960) performed stop flow studies in dogs (see footnote p
14). After release of the ureteral clamp, calcium and magnesium
were measured in sequentially collected urine samples. The
concentrations of both ions reached minima in the same samples,
suggesting that magnesium and calcium both underwent reabsorption
in the same portion of the renal tubule. Quamme and Dirks (1980)
carried out micropuncture and single nephron perfusion studies.
They showed that hypermagnesaemia caused a reduction in the
reabsorption of both calcium and magnesium from the loop of Henle.
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In view of the renal interaction between these two ions, it
might be expected that infusion of calcium would cause
hypomagnesaemia and vice versa. The hypocalcaemic effect of
magnesium infusions has been demonstrated in man, dogs and cats
(Kelly, Cross, Turton & Hatcher, 1960; Kemeny, Boldizar and Pethes
1961; Pors Nielsen, 1970). No evidence has been produced for a
hypomagnesaemic action due to calcium, possibly because the
relatively large variation normally occurring in plasma magnesium
concentrations would render this more difficult.
III. Effects of ligands on calcium and magnesium metabolism
Ligands are molecules or ions which form bonds with metallic ions
through their spare valency electrons. When such bonds form the
resulting complex has properties which differ from those of its
constituents. A chelate is a special case of a ligand which binds
the metal ion at two or more points thus forming a heterocyclic
ring. Depending on the number of bonds formed, chelates may be
bidentate, tridentate or polydentate. The metal ions bound to
chelates tend to be largely unavailable because of the extensive
shielding and the strong bonds which form. The extent to which the
complexed metal ions will be unavailable will depend on the degree
of covalency of the bonds formed and the degree of shielding
afforded by the ligand as compared to the hydrated cation. The
nature and stability of the chemical bonds formed has been reviewed
by Moeller and Horwitz, (1960).
Endogenous ligands and chelates are widespread in nature. Their
ability to bind cations is an important determinant of biological
18
function. Substances such as chlorophyll, haem and vitamin
depend on chelate formation for their desired properties. Many
enzymes require metal ions for their activity. In some enzymes the
metal is strongly bound by protein, but in others only very weak
bonds are formed. Magnesium is required by the important group of
enzymes involved in the transfer of phosphate groups, including
phosphatases and the enzymes involved in the reactions of ATP. It
is also involved in many decarboxylation reactions (Wacker and
Vallee, 1964).
The importance of exogenous ligands in pharmacology is widely
recognised. Various aspects of this subject have been extensively
reviewed (Chenoweth, 1956; Johnson and Seven, 1961; Pullman,
Lavender and Foreland, 1963; Levinson, 1980). For example, the
ability of EDTA, dimercaprol and penicillamine to form chelates is
central to their use in the treatment of heavy metal poisoning.
They act by making the metal ions unavailable to tissues and by
enhancing their renal excretion.
The calciuretic and magnesuretic effects of ligands, primarily
resulting from inhibition of renal tubular reabsorption, has
already been discussed. The formation of calcium complexes by
ligands often involves the displacement of H+ ions and so such
reactions are pH dependent. They are also dependent upon ionic
strength. It is to be expected therefore that the equilibrium
constants, and thus the degree of ligand binding, will vary along
the renal tubule as changes in pH and ionic strength occur. These
changes, occurring at the main sites of tubular reabsorption,
influence the degree to which the presence of ligand will alter the
tubular reabsorption of calcium and other cations and may well
result in non-stoichiometric binding of calcium and magnesium.
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As might therefore be expected, the increment in calcium
excretion associated with sulphate diuresis is invariably less than
predicted (Walser, 1961c). In the case of powerful calcium
complexing agents such as EDTA it might be expected that urinary
EDTA would be closely related to the increment in urinary calcium.
During EDTA infusion in man studies have indicated that the
increment in urinary calcium excretion is only 60-70% of that
predicted on the basis of stoichiometric binding (Spencer et al,
1952; Parfitt, 1969). Rubin and Lindenblad (1956-7) showed a
similar effect in the rat and produced evidence that this effect
might be dependent on urinary pH. In view of the massive changes in
EDTA-calcium binding accompanying pH changes, it is quite feasible
that the deficit in urinary calcium during EDTA infusion may be
due to pH changes along the renal tubule causing incomplete calcium
binding.
Since the binding constants of citrate for calcium and magnesium
are similar (Walser, 1961b; Meyer, 1974), large infusions of
citrate, by enhancing excretion, might be expected to lower the
plasma ionized concentrations of both calcium and magnesium. This
was demonstrated during infusions of acid citrate dextrose in dogs
(Killen, Grogan, Gower and Collins, 1971).
Two of the substances studied in this thesis, EDTA (ethylene
diamine tetraacetic acid) and EHDP (ethane-l-hydroxy-1,1-
diphosphonic acid) are known to have calcium binding properties.
The third, calcium borogluconate, was investigated as it was
considered likely to complex calcium.
20
Exogenous ligands: 1. Ethylene diamine tetraacetic acid (EDTA)
EDTA is a chelate which is widely used for complexometric
titrations since at high pH it chelates calcium and magnesium
stoichiometrically (Schwartzenbach, 1957). The great stability of
the chelates formed may be related to the number of bonds formed
with the metal ion (figure 1.1). EDTA binds the heavy metals most
strongly. However in the environment of blood, calcium is the
predominantly bound cation. Once virtually all the calcium is bound
then free EDTA will chelate magnesium (Shwartzenbach, 1957). As
with all ligands, competition between H+ and metal cations occurs.
The relationship shown in figure 1.2 indicates the massive changes
in binding following pH changes (after Martell and Calvin, 1952;
quoted by Rubin and Lindenblad, 1956-7).
The calcium-EDTA chelate is very useful for the treatment of
heavy metal poisoning. The copper chelate is used in treatment and
prophylaxis of copper deficiency in cattle and sheep.
EDTA is not metabolized by the rat (Foreman, Vier and Magee,
1953). Early reports, based on blood clearance calculations,
(Foreman et al, 1953) suggested EDTA was excreted by both
glomerular filtration and tubular secretion. Clearance studies in
dogs subsequently showed that it was excreted by glomerular
filtration alone (Forland, Pullman, Lavender and Aho, 1966) and may
be used to measure glomerular filtration rate. In the rat 95-98% of
EDTA is eliminated after six hours (Foreman et al, 1953).
Soffer and Toribara (1961) infused EDTA into human subjects and
measured total and ultrafiltrable calcium. EDTA had no effect on
total calcium but increased calcium chelate concentration in plasma
as measured by the increase in ultrafiltrable calcium and the
21
Figure 1.1 Spatial representation of the bonding of calcium by




Figure 1.2 The effect of pH on the -ve log [cation] (pM) in the
presence of EDTA (from: Martell and Calvin, 1952).
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decrease in calculated ionized calcium. This effect must have been
due to the presence of EDTA chelated calcium in plasma. Parfitt
(1969) infused Na2gDXA into man and found that ionized plasma
calcium fell during the infusion, then rapidly rose when infusion
ceased. Total plasma calcium, in contrast, was unchanged. Again
this indicates an increase in bound calcium in blood.
Many workers have demonstrated that EDTA infusion is accompanied
by hypercalciuria (Spencer, Vankinscott, Lewin and Lazlo, 1952;
Holland Danielson and Sahagian-Edwards, 1953; Chen and Neuman,
1955a; Rubin and Lindenblad, 1956-7; Levitt, Halpern, Polimero,
Sweet and Gribetz, 1958). Stop-flow studies have demonstrated a
distal minimum calcium concentration in samples corresponding to
the distal tubule (Howard, Wilde and Malvin, 1959). This distal
minimum is obliterated by EDTA (Grollman, Walker, Harrison and
Harrison, 1963) indicating depression of calcium reabsorption in
the distal tubule.
EDTA infusions seem to be associated with an increase in the
bound plasma calcium and a decrease in ionized plasma calcium.
Calciuresis results from the failure of the tubules to reabsorb
calcium-EDTA complexes. No effects on magnesium seem to have been
reported in the literature.
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Exogenous ligands: 2. Calcium borogluconate
Dryerre and Greig (1935) were the first to advocate the use of
calcium borogluconate solution for the treatment of post-parturient
hypocalcaemia in cattle. It was recommended for its great
solubility and non-irritant nature. They also showed that the
crystallised solid was a distinct chemical compound. Macpherson and
Stewart (1938) confirmed and extended these observations,
demonstrating that it contained 2 moles of borate per mole of
gluconate. However they also concluded that in aqueous solution the
boric acid seemed to exist as a free entity unassociated with
calcium gluconate.
Although there is no published evidence that borogluconate
complexes calcium, reports suggest that gluconate does. The
administration of calcium gluconate to patients undergoing cardiac
surgery was considerably less effective in raising blood ionized
calcium than was the administration of equivalent amount of calcium
chloride (White, Goldsmith, Rodriguez, Moffit and Pluth, 1976). It
was suggested that this effect was due to the formation of calcium-
gluconate complexes and that metabolism of the anion might be
required before release of free calcium ions.
Evidence that gluconate alters the renal handling of calcium was
produced by Howard Wilde and Malvin (1959) who performed stop-flow
studies in the dog (see footnote page 14). Calcium gluconate
infusion greatly increased the minimum calcium concentration in
early samples of urine collected after release of the ureteral
clamp, infusion of calcium chloride did not. It appeared that
calcium gluconate, but not calcium chloride, prevented the
reabsorption of calcium from within the distal segment of the renal
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tubule. Distal sodium and potassium reabsorption also seemed to be
depressed since the gluconate ion increased the free flow
concentrations of calcium, sodium and potassium. These results were
explained on the basis of a non-specific electrostatic attraction
produced by the large non-diffusible gluconate anions present in
the tubular fluid. Thus reabsorption of all cations was depressed.
However it seems likely that, as with other calcium complexing
agents such as EDTA, these renal effects were partially due to the
formation of calcium complexes.
Other workers demonstrated an increased clearance of calcium
during calcium gluconate infusion (Bernstein, Kleeman, Cutler,
Dowling and Maxwell, 1962). Dibona (1971) used micropuncture to
collect proximal tubular fluid from rats during intravenous
infusions of calcium chloride or calcium gluconate. Neither
solution affected proximal tubular calcium reabsorption whereas
only gluconate enhanced calcium excretion. This evidence supported
the stop-flow studies of Howard et al (1959) and was taken to
indicate inhibition of distal tubular reabsorption. Evidence
relating to the binding of magnesium by either gluconate or
borogluconate was not found in the literature.
26
Exogenous ligands: 3. Ethane-l-hydroxy-1,1-diphosphonic acid (EHDP)
Condensed phosphates are thought to play an Important role in
mineral metabolism. Since the P-O-P bonds of condensed phosphates
are rapidly hydrolysed in vivo, the diphosphonates (containing a
stable P-C-P group) were developed to assist investigations into
the role of condensed phosphates in mineral metabolism. EHDP
belongs to this group of compounds, it is known to complex calcium
(Carroll and Irani, 1968; Grabenstetter and Cilley, 1971). In order
to appreciate the significance of the diphosphonates it is
instructive first to consider evidence relating to condensed
phosphates.
Condensed phosphates in vitro
Condensed phosphates have an inhibitory action on the precipitation
of calcium carbonate (Buehrer and Reitmeier 1940), calcium sulphate
(Reitemeier and Ayers, 1947) and calcium oxalate (Fleisch and
Bisaz, 1964). Detailed investigations of this phenomenon have been
carried out with strontium sulphate (Miura, Otani, Kodama and
Shinagwa, 1962) and have shown the inhibitory action to be due to
coating of the crystal nuclei with a mono-molecular layer.
It is known that, with respect to calcium and phosphate, the
extracellular fluid is supersaturated. The concentrations of
calcium, phosphate and OH- are high enough to support the growth,
but not the initial formation, of bone hydroxyapatite crystals
(^a50H(P04)3). Fleisch and Neuman (1961) demonstrated that
collagen could act as a nucleus for the initiation of crystal
formation. Plasma ultrafiltrates were then shown to contain
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substances which inhibited the precipitation of hydroxyapatite, as
measured by the minimum [Ca] x [P] product initiating preciptation.
Several condensed phosphates, including pyrophosphate, also had
this inhibitory action. The inhibitory action of plasma
ultrafiltrates was destroyed by alkaline phosphatase, the
implication being that this might be due to destruction of
condensed phosphate (Fleisch et al, 1961).
Since collagen is not normally calcified this work raises the
interesting possibility that condensed phosphates may play an
important role in both the initiation and prevention of
calcification in normal tissues. If this is the case and if
pyrophosphate is the condensed phosphate in question, then the
control of the tissue concentration of these substances and thus
the control of calcification may be mediated by pyrophosphate and
pyrophosphatases.
Pyrophosphate and pyrophosphatase in vivo
Pyrophosphate has been detected in urine (Fleisch and Bisaz, 1962),
bone (Perkins and Walker, 1958) and teeth (Bisaz, Russell and
Fleisch, 1968). Russell, Bisaz, Donath, Morgan and Fleisch, (1971)
found that plasma pyrophosphate was raised in hypophosphatasia, a
hereditary condition characterised by bone abnormality and
deficiency of alkaline phosphatase. Alfrey and Ibels (1977) found
high levels of pyrophosphate in the visceral calcified deposits
occurring in some patients with chronic renal failure. Thus it may
be that although pyrophosphate prevents precipitation of calcium
phosphate from solution, once precipitation has occurred
dissolution is also inhibited.
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Several enzymes having pyrophosphatase activity have been found.
Cartier and Picard (1955) demonstrated the presence of an ATP-
pyrophosphatase present in sheep embryo cartilage. In the costal
cartilage of young rats Alcock and Shils (1969) found a neutral
pyrophosphatase, its concentration increased in proportion to the
rate of uptake of ^5ca suggesting a role in bone calcium uptake.
More recently, Morgan, Monod, Russell and Fleisch (1973)
demonstrated an acid phosphatase possessing pyrophosphatase
activity. Its production by bone was inhibited by dichloro-
methylene diphosphonate. Alkaline phosphatase also has
pyrophosphatase activity at neutral pH.
In vivo, pyrophosphate can prevent vitamin induced aortic
calcification (Schibler, Russell and Fleisch, 1968) and
experimentally induced skin calcinosis (Gabbiani, 1966). It has no
effect on bone in vivo, but prevents bone calcification in tissue
culture (Fleisch, Strauman, Schenk, Bisaz and Allgower, 1966). This
failure may be due to the high levels of pyrophosphatase activity
in bone.
The quoted literature suggests many relationships between pyro¬
phosphate and mineral metabolism. However the significance of these
findings is uncertain. Since pyrophosphate is rapidly inactivated
in vivo, compounds were developed which were resistant to
hydrolysis yet retained pyrophosphate-like activity. Imido-
phosphates are compounds containing P-N-P linkages, in contrast to
the P-O-P linkage of pyrophosphate. These substances have been
shown to have similar activity to pyrophosphate in vitro (Robertson
and Fleisch, 1970), but are claimed to have no activity in vivo
(Fleisch, 1975). Diphosphonates contain a P-C-P linkage, they are
active in vivo and have been extensively investigated.
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Diphosphonates
The two diphosphonates which have received the most detailed study,
EHDP (ethane-l-hydroxy-1,1-diphosphonate) and dichloro-methylene
diphosphonate, are compared with pyrophosphate in figure 1.3. This
group of compounds has been the subject of a number of reviews
(Fleisch, Bisaz, Care, Miillbauer and Russell, 1969; Russell and
Fleisch, 1975; Fleisch, 1975; Fleisch, 1980).
The absorption of EHDP from the gastro-intestinal tract is very
poor. Approximately 1-8 % is absorbed in man, rhesus monkeys, rats
and rabbits, and 10-12 % in the dog. Absorption is slightly higher
in puppies and weanling rats (Michael, King and Wakim, 1972; Recker
and Saville, 1973).
Michael et al (1972) found that in a number of different
species, 50% of an absorbed or injected dose of EHDP was rapidly
excreted in the urine. The remainder was taken up by bone and had
a half life of 12 days in the rat. The clearance of 99mxc-EHDP, as
a fraction of inulin clearance, was found to be 27.3% in the dog
(Hughes Davies, Bassingthwaighte, Knox and Kelly, 1977). Studies
using isotopically labelled EHDP indicate that it is not
metabolized (Michael et al, 1972).
In vitro, diphosphonates have a number of actions similar to the
effects of pyrophosphate. They probably inhibit the precipitation
of calcium phosphate from solution and the conversion of amorphous
calcium phosphate to crystalline hydroxyapatite by binding onto the
crystal surface (Francis, 1969; Fleisch, Russell and Francis,
1969). EHDP produces a calcium fraction in hydroxyapatite




















Figure 1.3 Comparison of the structure of two diphosphonates with
pyrophosphoric acid.
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does not exchange with ^Ca (Robertson, Morgan, Fleisch and
Francis, 1972). These effects may be the result of EHDP coating the
crystal nuclei in a manner analagous to that described by Miura £t_
al (1962). In addition to these properties, common to both
pyrophosphate and diphosphonates, diphosphonates also show some
properties which may be specific.
Several studies have been carried out which show that
diphosphonates complex calcium. Carroll and Irani (1968) performed
potentiometric studies and determined dissociation constants for
the formation of 1:1 calcium-EHDP complexes. Grabenstetter and
Cilley (1971) used both pH and complexometric titrations to
investigate calcium-EHDP binding. Large aggregates were produced
which they termed poly-nuclear complexes. The maximum EHDP:calcium
binding ratio was found to be 1.75:1. These workers used computer
curve fitting techniques to determine the calcium-EHDP ratios which
best fitted their data and found that a combination of the ratios
of 1:1, 3:2, 4:3, and 7:4 gave the best fit. Wiers (1971) also
demonstrated the formation of large complexes which were resistant
to precipitation. Their size was of the order of 10^ Daltons and
their approximate radius 2.6 nm. Bisaz et al (1978) showed that
the 99mtechnetium complex of EHDP, l^C-EHDP, l4c-dichloro-methylene
diphosphonate, and 32p_pyr0ph0sphate were partially
non-ultrafiltrable in plasma. They used ultrafilters with a
nominal cut off point of 50,000 Daltons which suggests either
protein binding or the formation of very large complexes.
Despite the detailed studies that have been made of the physico-
chemical interactions between EHDP, hydroxyapatite and calcium, the
complexation of calcium per se has received relatively little
study. The work of Grabenstetter and Cilley (1971) and Wiers
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(1971) has been mentioned, however it is difficult to extrapolate
from those results to the physiological situation since the studies
were made at pH 11 and many of the experiments were performed using
micro-molar concentrations of free calcium.
Biological actions of diphosphonates
Rats given large amounts of vitamin D developed aortic and renal
calcification which could be prevented by various diphosphonates
given per os or by subcutaneous injection (Fleisch, Russell, Bisaz,
Mullbauer and Williams, 1970). EHDP, dichloro-methylene
diphosphonate and methylene diphosphonate were the most effective
ones tested. In contrast pyrophosphate, which must administered
parenterally, only inhibited aortic calcification.
If Ringer solution is placed in the frog bladder, removal of
calcium with chelating agents greatly enhances water permeability
of the membrane. This effect has been used to study calcium binding
in vitro (Shakhmatova, Kabachnik, Medev' and Natochin, 1982). EHDP
was shown to have a large effect on water permeability. Though not
as effective as EDTA, it was more effective than the other
diphosphonates studied.
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The renal effects of diphosphonates
EHDP appears to prevent the renal hydroxylation of 25 hydroxychole-
calciferol (Hill, Lumb, Mawer and Stanbury, 1973). This conclusion
was reached following the demonstration that EHDP depressed calcium
absorption and that this effect was reversed by 1,25 dihydroxy-
cholecalciferol but not by huge doses of cholecalciferol or 25
hydroxycholecalciferol. The defect develops almost immediately and
so seems to be independent of the mineralisation defect which takes
several days to develop. EHDP is known to increase plasma phosphate
in man due to an increase in the maximal tubular reabsorption of
phosphate (Walton, Russell and Smith, 1975). This is not
accompanied by significant changes in GFR or plasma or urinary
calcium. Large doses of EHDP (20 mg kg~l s.c., Goulding and
Cameron, 1977; 40 mg kg~l s.c., Gasser et al, 1972) caused
increases in both urinary and plasma calcium whilst
dichloro-methylene diphosphonate had no effect.
The effects of diphosphonates on bone
Diphosphonates have a very strong affinity for bone (Michael et al,
1972). This property has enabled the use of 99mtechnetium labelled
EHDP for producing bone scans (Subramanian, McAfee, Blair, Mehter
and Connor, 1972). EHDP is now widely utilised for this purpose.
EHDP administered to young growing rats at 4 mg kg"l depressed
the rate of bone resorption whilst having little effect on
formation (Gasser, Morgan, Fleisch and Richelle, 1972). At 40 mg
kg~l the effect was greater and bone formation was also depressed.
Dichloro-methylene diphosphonate, by comparison, has a more
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specific effect on resorption. In isolated mice calvaria,
parathyroid extract induced bone resorption was prevented by
dichloro-methylene diphosphonate or methylene diphosphonate
(Fleisch, Russell and Francis, 1969). Furthermore, the
hypercalcaemic action of parathyroid extract in
parathyroidectomised rats was prevented by dichloro-methylene
diphosphonate or methylene diphosphonate.
During dichloro-methylene diphosphonate (4 mg kg~l)
administration to pre-parturient cattle, bone catabolism seemed to
be depressed as evidenced by reduced urinary hydroxyproline and
micro-radiography (Yarrington, Capen, Black, Re, Nagode and Geho,
1977a). The response of plasma calcium concentration to stress
induced by EDTA infusion can provide an index of an animal's
ability to mobilise bone calcium. In these experiments the animals
treated with dichloro-methylene diphosphonate showed a more
profound and prolonged hypocalcaemia than did controls. These
effects occurred despite adequate PTH levels, unimpaired uptake of
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Ca by duodenal mucosa and normal thyroid calcitonin content. They
were taken to imply a direct effect on bone rather than one
mediated by hormonal mechanisms. EHDP exacerbated the
periparturient decline in total serum calcium in cattle and
produced other effects very similar to those described for
dichloro-methylene diphosphonate (Yarrington, Capen, Black, Potts,
Re and Geho, 1977b).
Treschel, Schenk, Bonjour, Russell and Fleisch (1977) studied a
number of diphosphonates. The found that all diphosphonates which
inhibited skeletal mineralisation in vivo also inhibited the
precipitation of calcium phosphate in vitro. However some, which
were effective in vitro, had no effect on mineralisation. This
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suggested that not all dlphosphonates altered mineralisation merely
by their ability to bind hydroxyapatite.
Although EHDP prevents reabsorption of bone in the short term,
its long term effects, more likely to be of clinical relevance, ha
received little study. Rosenblum (1974) administered EHDP to
rabbits for 28 days and did not find any changes in bone mineral
content at doses as high as 10 mg kg-lday""l by subcutaneous
injection. Long term use of EHDP in man has been found to have
deleterious effects on bone, in particular an increase in the
amount of non-mineralised osteoid tissue (Jowsey, Riggs, Kelly,
Hoffman and Bordier, 1971). It has been suggested that this effect
is only seen with oral doses greater than 20 mg kg~l (Russell and
Fleisch, 1975). Experiments in animals have also demonstrated
increased non-mineralised osteoid tissue (King, Francis and
Michael, 1971; Rosenblum, 1974).
Effects of diphosphonates on experimentally induced calcification
defects
Since diphosphonates inhibit bone turnover they are likely to alter
the development of pathological defects of calcification.
Osteoporosis of rat tibiae and femora can be readily induced by
resection of the sciatic nerve or the 2nd-4th lumbar nerve trunks.
EHDP or dichloro-methylene diphosphonate reduced the loss of bone
ash from immobilised limbs compared with saline controls (Michael,
King and Francis 1971; Mulbauer, Russell, Williams and Fleisch,
1971).
Experimentally induced chronic renal failure results in loss of
bone mineral and an increase in the number of bone resorptive
36
sites. EHDP (0.7 mg kg~l) did not prevent these changes (Kaye,
1973). However dichloro-methylene diphosphonate (2 mg kg~l)
inhibited bone resorption in renal osteodystrophy (Russell, Termine
and Avioli, 1975).
Corticosteroids are known to cause a loss of bone substance.
Lindenhayn, Trzenschik, Buhler and Wegner (1982) found that EHDP
prevented the bone changes induced by prednisolone treatment in
rabbits.
There is good evidence that the neutralisation of excess acid
also results in demineralisation. Hydrochloric acid administered to
rats and guinea pigs consistently reduced bone carbonate (Irving
and Chute, 1932). Administration of ammonium chloride to dogs
induced loss of cortical and trabecular bone. The effect was
greatest in young dogs and was similar to the effect of a low
calcium diet (Jaffe, Bodansky and Chandler, 1932). This work
suggested that bone buffers part of an acid load and provided an
explanation for an earlier observation; that only 66-86% of an
ingested acid load could be accounted for in the urine either as
titrable acid or ammonium (Lamb and Evvard, 1919).
Relman, Lennon and Lemann (1961) developed a method for
measuring net acid balance in man. It was used to study patients
suffering from renal tubular acidosis. These patients excreted
significantly less acid in the urine than was produced endogenously
(Goodman, Lemann, Lennon and Relman, 1965). It was suggested that
the deficit had previously been neutralised by bone resorption. The
same effect was observed in normal subjects with ammonium chloride
induced acidosis (Lemann, Lennon, Goodman, Litzow and Relman,
1965). This also resulted in negative calcium and phosphorous
balances (Lemann, Litzow and Lennon, 1966).
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In view of the relation between acidosis, bone and EHDP,
Goulding and Broom (1979) studied the effect of EHDP on acid base
status in rats. They found, in nephrectomised animals only, that
EHDP caused extracellular and intracellular acidosis, and decreased
plasma bicarbonate. This is the only study relating to the effect
of EHDP on acidosis. However since the studies of Irving et al
(1932) and Jaffe et al (1932) several studies of the effect of
acidosis on bone mineral have been carried out.
Burnell (1971) used dogs to show that acidosis induced for 5-10
days caused significant reductions in the CO^/Ca and Na/Ca ratios
in bone. During alkalosis these effects were reversed. Studies of
the effects of acidosis induced for several months in rodents have
also been carried out. Newell and Beauchene (1975) found no change
in bone after administration of ammonium chloride to rats. However
Barzel and Jowsey (1969), in a similar type of study, observed
significant reductions in organic matrix, bone ash, calcium and
phosphorous. These changes were independent of dietary calcium, but
were reversed by administration of bicarbonate. Dekanic (1979) also
found loss of bone ash in rats following induction of acidosis by
calcium chloride administration. The effect of EHDP on such changes




I. Preparation of sheep for infusion, and urine and blood
collection
Many of the experiments reported in this thesis involved
intravenous infusions and the subsequent collection of blood and
urine. The day before such procedures female sheep, 20-45 kg, were
fitted with catheters under halothane anaesthesia.
For the collection of urine, "Folatex" (Eschmann) balloon
catheters (14 to 18 gauge, usually 18 gauge) were used. The 30 ml
cuff was only inflated to 10 ml as this was found to be completely
effective in retaining the catheter, yet was less likely to induce
tenesmus predisposing to leakage of urine. Increased abdominal
pressure caused leakage by preventing urine from flowing through
the catheter. During the experiment the urine drained via silicone
rubber tubing into a plastic measuring cylinder containing
approximately 50 mm depth of paraffin oil.
Two venous catheters were fitted in one jugular vein through a
small incision. One catheter, a 14 gauge, 120 mm polythene
over-the-needle type (Intranule, Vygon), was used for collection of
blood. For the intravenous infusion of substances a 2 metre length
of PVC tubing (V-3, 2 mm, Bolab Inc) was used. This was inserted
through a 14 g needle, in the same vein as the first catheter. The
tips of the catheters were approximately 50 mm apart, the infusion
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catheter being nearest to the heart. The small incision was closed
and the catheters were held in place with monofilament nylon
sutures. They were strapped to the sheep's neck with adhesive
tape, flushed with 500 i.u. ml~l sodium heparin in saline and
sealed until the experiment was to be performed. During an
experiment the catheter was flushed with 100 i.u.ml-! sodium
heparin after each sample.
For the duration of an experiment the sheep was restrained in a
plastic coated steel mesh crate. A mesh partition prevented the
sheep from turning and so tangling the catheters. The sheep was
prevented from lying down, and thus impeding urine flow, by a
surcingle attached to the crate and fitted loosely around the
sheep's abdomen. The animal was allowed water ad libitum
throughout an experiment, but food was with-held.
Infusions were usually made using a Harvard Apparatus
infusion/withdrawal pump. When a higher infusion rate was required,
in order to avoid frequent syringe changing, an Ismatec MP-13
peristaltic pump was used.
The experiment was never started until an un-impeded flow of
urine, without leakage, was apparent. Sometimes urine failed to
flow due to an air lock in the tubing, in that case the injection
of 10 ml of sterile water along the catheter usually started urine
flow. It was found that at a diuresis greater than 1 ml min~l
urine flow was less likely to be troublesome. It was therefore
attempted to increase the rate of urine flow. This was done in
some experiments by infusing saline solutions at 2.75 ml min~l,
with variable results. In other experiments 4 1 of water was given
by stomach tube 90 minutes before the start of the experiment, This
was found to be considerably more effective, but despite these
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measures in a number of cases urine flow was still less than 0.5 ml
min~l.
Despite the low level of diuresis in many experiments, higher
rates of fluid administration were not used since greater levels of
saline diuresis increases calcium excretion, decreases proximal
tubule reabsorption of both calcium and sodium (Agus, Chiu and
Goldberg, 1977 ), and can slightly reduce plasma calcium (Lins,
1979). Saline infusion always started at least one hour before the
start of the experiment and continued until after the post-infusion
sampling periods, it is therefore unlikely that any small effects
would significantly influence changes produced by the the drug
under examination.
2. Materials
All chemicals, unless otherwise stated, were Analytical Reagent
grade, and obtained from British Drug Houses Ltd.
3. Collection of blood for measurement of ionized and
ultrafiltrable calcium and magnesium
In order to maintain anaerobic conditions prior to preparation of
ultrafiltrates, blood was collected in a 10 ml B-D disposable
syringe in which the dead space had been filled with lithium
heparin (1000 i.u. ml-!). The final blood heparin concentration was
10 i.u. ml~l. When blood was withdrawn from heparinised catheters
the first 5 ml was discarded. Blood was drawn into the syringe
until the the rear end of the rubber plunger was level with the end
of the syringe barrel, the hub was sealed with a plastic cap and
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the plastic plunger removed carefully so as not to admit air. Any
small bubbles were immediately expelled. The syringe was
centrifuged for 20 minutes at 1000 g, the hub being protected by a
plastic sleeve in the bottom of a centrifuge bucket of the
appropriate diameter. After centrifugation the plasma was
withdrawn using a 5ml syringe and 20g needle inserted through the
rubber plunger. When determining ionized calcium, blood containing
10 i.u. ml~l lithium heparin was assayed directly. All
determinations of ionized calcium and preparation of plasma
ultrafiltrates were made within 30 minutes of blood collection.
Prior to long term storage, additional heparin was added to prevent
clotting of plasma proteins.
4. Total magnesium and calcium determination by atomic absorption
spectrophotometry (AAS)
The Perkin Elmer model 103 atomic absorption spectrophotometer was
used in conjunction with a Servoscribe IS potentiometric chart
recorder. The absorption of samples was measured at a wavelength
of 285.2 nm for calcium, and 422.7 nm for magnesium. Analysis was
carried out using a nitrous oxide-acetylene flame. This has a
higher flame temperature than the air-acetylene normally used and
so eliminates chemical interferences due to phosphate (Carlyle,
1975). The use of a high flame temperature tends to cause
ionization of magnesium and calcium in the flame and thus reduces
spectral absorption due to atomic calcium and magnesium. This
source of error is readily eliminated by adding a relatively high
concentration of an easily ionized alkali metal, such as sodium or
potassium. Thus potassium chloride (0.2% w/v) (BDH Laboratory
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Reagent for AAS) was used for diluting all standards and samples.
Samples were diluted to provide 25-50 micro-mol 1"^ calcium, and
10-20 micro-mol l--*- magnesium. The standards used (BDH Laboratory
Reagent, 1 mg ml-1 MgNO^j BDH Clinical Reagent 10 mM Ca standard)
were diluted to 16.4 micro-mol l-^ magnesium and 50 micro-mol l-^
calcium. Analyses were performed soon after dilution so as to
avoid errors due to absorption of calcium and magnesium by the
glass tubes .
To allow time for stabilisation of the burner temperature, at
least five minutes elapsed after igniting the flame before
measurements were made. It was found that the measured absorbancy
was directly proportional to the magnesium concentration over the
full range of the machine, extending to 150 micro-mol 1~1. For
calcium, the relationship between concentration and absorbancy was
non-linear above 150 micro-mol 1~1. This extent of linearity is
significantly greater than the figures quoted by Perkin Elmer for
the air-acetylene flame and may reflect superiority of the nitrous
oxide-acetylene flame for these determinations. During analysis
the machine was zeroed whilst aspirating distilled water, a
standard followed by two samples was then aspirated. This procedure
was repeated until all the samples had been dealt with.
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5. Sample preparation for AAS
5.1 Plasma and ultrafiltrates
Plasma and ultrafiltrates required minimal preparation, all that
was normally required was a 1:50 dilution with potassium chloride.
5.2 Urine preparation
Urine required care in handling as some of the urine magnesium and
calcium, was in the form of insoluble salts. These were mainly
carbonates and bicarbonates and readily dissolved on acidification.
Horse urine contained large amounts of acid soluble sediment which




Urine (mM) Ca Mg Ca Mg
Mean (n=15) 1.36 9.60 19.5 11.9
Urine was always thoroughly mixed by shaking before removing a
sample for analysis. Initially acidification was carried out using
hydrochloric acid, later nitric acid was used. There was no
difference in results obtained using either acid. Acidification of
sheep urine was carried out by adding nitric acid to give 1% v/v.
Horse urine was acidified by adding 5 M nitric acid until
liberation of CO2 ceased. The volume of acid added was corrected
for in subsequent calculations. Some non acidified urine was always
retained for biochemical assays such as creatinine estimation.
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5.3 Faecal preparation and analysis
After weighing the 24 hour collection, the faeces were thoroughly
mixed in a large plastic container for five minutes. Portions were
then removed for subsequent analysis.
5.3a Faecal dry matter and dry matter calcium and magnesium content
Faecal dry matter was determined by drying a weighed amount of
faeces (approximately 200 gm) in an oven at 95°C, until no weight
change occurred over a 24 hour period. Portions of faeces (500 gm)
were thoroughly mixed and smaller portions of approximately 2 gm
were weighed into two pre-weighed porcelain crucibles. These
samples were dried for 48 hours at 95°C and their weights recorded.
They were ashed in a muffle furnace at 300°C for 12 hours followed
by 500°C for a further 24 hours. The crucible was then placed on a
gauze several inches above a low bunsen flame. Aliquots (1.5 ml)
of 0.5 M hydrochloric (BDH, Aristar Reagent) acid were added and
transferred, when hot, to a 10 ml volumetric flask. This process
was continued until the flask was almost full. Care was taken to
ensure that all solid matter was transferred, thoroughly washing
down the sides of the crucible. When cool, the flasks were topped
up with hydrochloric acid and sealed. Over the next two to three
days they were periodically mixed by inversion, the supernatants
were then saved for analysis by AAS. Faecal calcium and magnesium
were calculated on the basis of the dry weight of faeces in the
crucibles.
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5.3b Faecal fluid total and ultrafiltrable calcium and magnesium
content
Faecal fluid was extracted by compressing the faeces in a thick
walled plastic cylinder with a piston driven by a screw jack. The
resultant fluid percolated out through holes in the base of the
cylinder and was collected in a plastic beaker below. The extract
was centrifuged for 1 hour at 1000 g to remove coarse debris and
was then assayed directly by AAS after appropriate dilution.
Ultrafiltrates of the faecal fluid were also prepared, as described
over the page, and analysed by AAS. The 24 hour excretions of
calcium and magnesium in faecal water fractions were calculated,
for example for calcium:
Ca24hours = faecal weight x (1 - (dry matter % r 100)) x [Ca]
5.4 Mouse femur preparation
Within one hour of death the left femur of each mouse was carefully
dissected out. The bones were then dried at 105°C for six hours,
allowing easier removal of excess soft tissue, before drying for a
further 18 hours. They were allowed to cool in a desiccator and
weighed. Each set of dried bones was defatted by refluxing, for 12
hours, in 100 ml methanol/trichloro-ethylene (50% v/v of each)
which was replaced with fresh solvent at four hourly intervals.
After draining, the excess solvent was allowed a few minutes to
evaporate before the bones were dried in an oven at 105°C for six
hours. They were then cooled in a desiccator, weighed in tared and
labelled porcelain crucibles, and the fat-free weights recorded.
Ashing was carried out in a muffle furnace at 300°C for 3 hours
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followed by 600°C for 24 hours. This temperature, higher than that
used in 5.3b , was not associated with losses of sodium, potassium,
calcium or magnesium from samples of the chloride salts. The ash
was allowed to cool and was then extracted hydrochloric acid as
described in 5.3a.
5.5 Preparation of ultrafiltrates
Visking tubing 5.2 cm circumference (Scientific Instrument Centre
Ltd) was cut into lengths 3 metres long which were then connected
to a mains cold water supply and rinsed through with soft tap water
for about three hours. This process served to remove gross
contamination. The excess water was then squeezed out and the
tubing was placed in a beaker of distilled water which was changed
every day for approximately fourteen days. Both ends of the tubing
were connected to a manifold to dry the tubing by inflating with
O2/CO2 from a gas cylinder. After two hours the tubing could be
cut into lengths 10 cm long and stored ready for use.
Prepared visking tubing was folded longitudinally and then bent
double and put in a polystyrene tube (1.5 by 9.0 cm ) with both
open ends protruding. The polystyrene tube was gassed with 95% 0^
5% CO2 delivered to the bottom of the container via fine tubing.
The sac was then filled with 1.5-2.0 ml of plasma from a 5 ml
syringe. The sac was protected from perforation by a small piece of
PVC tubing slipped over the end of the needle. The tube was
briefly gassed again before sealing with a plastic cap, so that the
ends of the visking tubing were trapped outside the polystyrene
tube. Parafilm (Gallenkamp) was then wound in a narrow strip
around the end of the tube to assist in forming a gas tight seal.
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All samples were ultrafiltered in duplicate.
The tubes were placed in a MSE Mistral 2L centrifuge whose
temperature had been raised to 37°C by running it at 2300 rpm for
approximately one hour. A swing out rotor was used since the angle
rotor drastically reduced the yield of ultrafiltrate. The tubes
were then spun at 900 g for two hours, yielding 0.3-0.4 ml of
ultrafiltrate. The visking tubing and its contents were then
removed and calcium and magnesium assayed in the ultrafiltrate.
6. Measurement of ionized calcium using the Nova-2 Ca"^" Analyser
The Nova-2 calcium analyser (American Hospital Supply UK Ltd),
consists of a microprocessor controlled flow-through electrode
system thermostatted at 37°C. The machine is highly automated:
standardisation, checks for drift, instability of electrode emf,
reduction in electrode response and the presence of air bubbles are
automatically made and indicated as detected. The machine performs
a two point calibration using 1.0 and 2.0 mM calcium standards
(containing sodium chloride to provide an approximately
physiological ionic strength) every two hours, or as required. It
also analyses a 1.0 mM standard after each sample.
During in vivo experiments calcium concentration was always
measured on freshly drawn whole blood. The presence of blood cells
does not affect the electrode response to calcium ions. Blood or
plasma was aspirated directly from the syringe. The system was
checked by analysing 0.5 and 1.5 mM standards (American Hospital
Supply UK Ltd) daily. Blockage of the reference electrode was a
recurring problem, this was usually readily overcome by flushing
the electrode with distilled water.
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7. Measurement of ionized divalent cations using the method of
Heaton (1967)
7.1 Preparation of ion exchange strips
The cation exchange strips used in the original study were no
longer available so a simple method for producing them in the
laboratory was developed. Visking tubing, 5.2 cms circumference
was split longitudinally along its flattened edges. These lengths
were then carefully cut into 4 cms strips (the coefficient of
variation of the weight of 50 strips was 1.4%). Batches of strips
were soaked in five changes of distilled water, changed at 24 hour
intervals. Excess water was then drained and the strips transferred
to a magnetically stirred solution of congo red (May and Baker Ltd,
0.5% w/v, in 20% v/v industrial alcohol) at 60°C. After four hours
the strips were removed and rinsed in distilled water which was
changed daily until only a faint tinge of pink remained in the
discarded washings. The final rinses were made in 150 mM NaCl, 4
mM KCl, 1 mM CaC^ (diluted from 1 M CaCl2, BDH Ltd Volumetric
solution) and 0.5 mM MgC^ (diluted from BDH Ltd, Clinical Reagent
1 M Mg).
7.2 Estimation of ionized calcium and magnesium in plasma
Samples were handled anaerobically (as previously described).
Plasma (3 ml) was then transferred to a polystyrene tube which had
been gassed with 95% 002^ 5% 02. Using forceps, an ion exchange
strip was vigorously shaken to remove excess moisture and placed in
the plasma. The tube was then briefly gassed again, sealed with a
plastic cap and placed in a Gallenkamp shaking water bath at 37°C.
After 10 minutes the strip was removed from the sample. It was
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briefly rinsed in a jet of double distilled water and shaken in
order to remove excess plasma. Elution was carried out by placing
the strip in a 6 ml glass test tube containing 5 ml of potassium
chloride (0.2% w/v, Aristar grade, BDH Ltd) for 30 minutes.
Adequate mixing was achieved by attaching the tubes to a metal disc
which rotated at 8 rpm in a vertical plane, the tubes long axis was
aligned on the disc radially, as a spoke of a wheel, so that with
each revolution it was inverted once.
After elution the solution was analysed, without further
dilution, by AAS. The measured eluate calcium and magnesium
concentrations were then compared with calibration curves prepared
using 5 ml samples of standard solutions. These solutions were of
the basic composition: 150 mM NaCl, 4 mM KC1 and 6 mM tris-HCl
buffer (pH 7.40); the concentration of magnesium was varied in six
equal steps, from 0.2 to 1.2 mM; calcium was similarly varied, from
0.2 to 2.2 mM.
8. Estimation of ionized magnesium and calcium in vitro
Studies of the effects of complexing agents on ionized magnesium or
calcium in aqueous solutions were performed using either the Orion
Research 93-20-01 calcium ion electrode or the 93-32-01 divalent
cation electrode in conjunction with the 90-01 single junction
reference electrode. The divalent cation electrode suffered severe
interference in the presence of 0.16 M sodium and lesser
interference from potassium. When using this electrode experiments
were therefore carried out in solutions containing low sodium and
potassium concentrations.
The same concentration of tris-HCl buffer was used in standard
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and test solutions, this was necessary since the divalent electrode
is sensitive to tris. Over the concentration range 10~2 to 10-^ M,
tris buffer (pH 7.34) was found to produce an electrode response of
15 mV per 10 fold change in concentration (Kent, Bunce, Bailey and
Aikens, 1974).
It was always attempted to bracket each sample with standards of
higher and lower magnesium or calcium concentration. At very low
concentrations this was not possible. In the EHDP binding studies
(Chapter VI) standards of 0.04, 0.07, 0.10, and 0.70 mM were used.
The electrode emf was measured using either an EIL 33B-2 vibron
electrometer, or a Fluke digital mV meter (input impedances of 1015
ohms and 10^ ohms respectively). At a given calcium concentration
the emf recorded by the Fluke mV meter was slightly lower than that
of the electrometer presumably due to its relatively low
resistance, however this did not affect the measured ionic
activities. All readings were taken at room temperature.
The electrodes displayed a variable degree of drift during use.
After placing the electrode in a solution the electrode emf
stabilised in approximately 60 seconds, thereafter the emf
continued to change at a slower rate. The emf was not recorded
until reasonably steady values had been reached.
9. Sodium and potassium determination
These ions were determined by means of a Corning EEL Clinical Flame
Photometer. Plasma was diluted 1:200 with distilled water, urine
was diluted as necessary. Standards containing 200 mM sodium and 10
or 100 mM potassium were prepared and diluted 1:200 for use. The
propane/air mixture was adjusted for maximum light emission from an
aspirated standard solution and ten minutes allowed for
stabilisation before any samples were analysed.
10. Measurement of urinary pH, blood gases and pH
Heparinised blood was collected anaerobically and analyses made as
soon as possible. Blood PCO2 ancj pH were measured using the
Corning model 165 pH/blood-gas analyser. This machine uses the
Henderson-Hasselbalch equation to calculate values for bicarbonate.
The values for base excess and total CO2 are calculated from
constants used in man, which are probably not accurate in the sheep
due to the low 2,3 diphosphoglyceric acid concentration in sheep
blood. It was therefore considered preferable to use the nomogram
of Gattinoni and Samaja (1979).
Urine was collected under oil to prevent loss of CC^. When
urine pH was required the measurement was made as soon as possible
after collection of the sample, with a Pye Unicam model 290 pH
meter and a Russell glass pH electrode.
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11. ^Carbon scintillation counting
C-EDTA was measured in plasma and urine collected from sheep
during intravenous infusions of EDTA. Counting was carried out in
a Corumatic-200 liquid scintillation spectrometer (ICN Tracerlab)
after mixing with Aquasol 2 (New England Nuclear) in glass
scintillation vials. Counting was performed for 500,000 counts, or
for at least fifty minutes. The method posed few problems. The
main one was the reduction in counting efficiency, or quenching
effect, due to the aqueous nature of samples such as plasma and
urine (figure 2.1).
To minimise quenching errors standardisation was carried out,
for each experiment, by counting four or five plasma samples before
and after the addition of aliquots of the infusion solutions
containing approximately 20 nano-Ci of the tracer l^C-EDTA. The
same procedure was also used in urine when the level of diuresis
changed little. In some experiments the diuresis was very low,
with a resultant increase in the concentration of the urochrome
pigments present. This caused a significant increase in the
quenching produced by urine in addition to the quenching effect due
to the aqueous phase. This, in itself, was not a problem since the
concentration of EDTA in antidiuretic urine was also high, so
allowing the use of higher dilutions. However when the diuresis
varied greatly during any one experiment it was necessary to use
internal standards for every urine sample in order to overcome this
variability.
When EDTA infusions into sheep were to be made, 8 micro-Ci of
14 _ i
C-EDTA (specific activity 108 Ci mol-i; Radiochemical Centre,
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Figure 2.1 The quenching effect of plasma on the efficiency of
scintillation counting of l4C-glucose counting in Aquasol-2.
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then used for infusion after retaining some for internal
standardisation of urine and plasma. For measurement of in
plasma, 3 ml was mixed with 10 ml of aquasol. With urine this was
reduced, sometimes only 0.05 ml was required, depending on the
level of diuresis and the resultant EDTA concentration. However the
dilution was kept constant for any single infusion.
12. Creatinine estimation
Measurement of creatinine in urine and plasma was based on the
method of Owen, Iggo, Scandrett and Stewart (1954), as described by
Varley (1980). The method described below incorporates a number of
minor modifications.
12.1 Reagents:
(1) 0.15 M sodium tungstate.
(2) 0.33 M sulphuric acid.
(3) 10% suspension of Lloyd's reagent (BDH Fullers earth for
adsorption purposes).
(4) Saturated oxalic acid solution.
(5) 2.5 M sodium hydroxide.
(6) Saturated picric acid.
(7) Stock creatinine zinc chloride 10 mM (BDH Laboratory Reagent)
was stored at 4°C and prepared fresh every 4 weeks.
Prepared fresh for use:
(1) Standard creatinine ( stock was diluted 1:250 or 1:500).
(2) Alkaline picrate (27.5 ml saturated picric acid plus 5.5 ml
sodium hydroxide, diluted to 100 ml with distilled water).
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12.2 Method:
Plasma was deproteinated by mixing 0.75 ml each of plasma,
distilled water, tungstate and sulphuric acid reagents followed by
shaking and centrifugation.
Two ml of deproteintSax! supernatant, 0.2 ml of oxalic acid and
0.4 ml of Lloyds reagent (re-suspended immediately before
withdrawing an aliquot), were placed in a round bottomed test tube
which was then stoppered and shaken to suspend the solid. The
tubes were mixed continuously by attaching the tubes to a metal
disc which rotated in a vertical plane at 8 rpm, the long axis of a
tube was aligned radially as the spoke of a wheel, so that with
each revolution it was inverted once.
At1 the end of this period the tubes were centrifuged. The
supernatants were then decanted and the tubes inverted onto filter
paper to drain.
After five minutes 2 ml of alkaline picrate was added and the
Lloyds reagent resuspended by mixing on a vortex mixer (round
bottomed tubes were preferable to conical centrifuge tubes as the
Lloyds reagent re-suspended more readily). They were then
restoppered and mixed for a further 10 minutes on the rotating
disc.
Finally the tubes were centrifuged at 1000 g at room
temperature. The absorbance of the supernatant was then measured
at 520 nm in a glass micro-cell with a 1 cm light path, using a
Cecil Instruments CE 303 grating spectrophotometer.
Standards and distilled water blanks were also analysed in an
identical way. Urine did not require deproteinisation, it was
usually diluted 1:400 before analysis.
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Duplicate estimations of urinary creatinine gave a mean
coefficient of variation of 2.16% (n=ll). In plasma, probably as a
result of the very low creatinine concentration, the coefficient of
variation was 3.78% (n=30). Recovery of creatinine added to urine
was 98.3 + 1.2% (n=5). The accuracy of the method was more than
adequate for the determination of clearances and was greater than
that of the inulin assay which is usually considered to be the more
accurate measurement.
13. Inulin estimation
Inulin was measured by the method of Davidson and Sackner (1963).
The method is a modification of the anthrone method (Young and
Raisz, 1952), in which the anthrone concentration is reduced to
0.08% and the incubation temperature reduced to 38°C. These
modifications were shown by Davidson and Sackner (1963) greatly to
reduce the interference produced by glucose.
13.1 Reagents:
(1) 1.0 M trichloroacetic acid.
(2) Anthrone reagent; 100 ml sulphuric acid was slowly added to 26
ml distilled water and allowed to cool, in this was then dissolved
0.1 gm anthrone (BDH Ltd Laboratory Reagent; recrystallised twice
from hot glacial acetic acid). This solution was prepared fresh
every 48 hours, and stored at 4°C in a dark bottle.
(3) Stock inulin standard 1 mg ml-^ (Koch-Light Laboratories Ltd,




Plasma (0.2 ml), 1.0 ml water and 0.8 ml 1.0 M trichloroacetic acid
were placed in a test tube, shaken thoroughly and centrifuged at
1000 g for 20 minutes. The supernatant was saved for analysis.
Aliquots (3 ml) of the anthrone reagent were cooled in test
tubes in iced water. Then 0.5 ml of each supernatant was added to
the tubes which were stoppered, thoroughly mixed and returned to
the iced water.
The tubes were incubated in a water bath at 38°C for 50 minutes,
then rapidly cooled in iced water. The absorbance of samples,
appropriately diluted standards and blanks were read at 620 nm in
glass cells with a 1 cm light path using a Cecil Instruments CE 303
grating spectrophotometer.
Urine was analysed after appropriate dilution, without
deproteinisation. Urine and plasma blanks were made from the urine
and plasma collected before the start of the inulin infusion.
The coefficient of variation of the method was 3.19% (n=29) in
plasma and 4.37% (n=21) in urine. The plasma inulin concentration,
when infusions were made as described in the Appendix, was 20-30 mg
100ml~l. The absorbance of the blanks was negligible.
14. Calculation of renal clearances 1
The renal clearance of a substance, for example creatinine, (where
V0lurine is in ml hour"1)* was calculated as follows:
Volurine x [Creatinine]urine
Creatinineclearance ml min
[Creatinine] , x 601 plasma A
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For the calculation of inulin clearance, plasma inulin
concentration was determined in blood samples collected at the
beginning and end of each hourly period of urine collection and the
mean calculated. Since plasma creatinine concentration varied very
little during the four to eight hours of an infusion, creatinine
clearance was calculated from the mean value of plasma creatinine
determined during the whole period of the infusion. During the
experiments in the horse, in which 24 hour values for creatinine
clearance were determined, clearance was calculated from the daily
plasma creatinine concentration.
15. Statistical analysis
Results were compared with control values using a paired t-test for
paired data. The t-test for the un-paired case was used to compare
un-paired groups of data. In the experiments described in Chapter
VIII a large number of t-tests would have been required to
evaluate the data. In order to reduce the risk of producing false
significance associated with such multiple comparisons the data was
first analysed using analysis of variance. Where this revealed
significant differences, the individual groups were then compared
with the unpaired t-test to reveal where such differences lay.
Correlation coefficients, regression lines and their confidence
limits were calculated by the method of least squares. All data in




EVALUATION OF METHODS FOR ESTIMATING FRACTIONS OF PLASMA
CALCIUM AND MAGNESIUM
Summary
1. Low capacity ion exchange strips were examined as a potential
method of measuring ionized calcium and magnesium. Ion exchange
strips were equilibrated with test solutions and the adsorbed
cations eluted into potassium chloride solution. The concentration
of calcium and magnesium in eluates was proportional to their
concentrations in standard solutions and inversely proportional to
the concentration of interfering cations, though the latter effect
was small. Unfortunately complexed magnesium was as readily
adsorbed by the ion exchange strips as the ionized fraction. It was
concluded that the method did not specifically measure ionized
magnesium.
2. The Nova-2 calcium ion analyser was examined. The linearity of
the response of electrode emf to changes in log calcium
concentration, reproducibility and response to added calcium, EDTA
or heparin in blood was studied. Provided heparin concentration was
low and carefully controlled it was found to be a satisfactory
method of measuring ionized calcium.
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3. The suitability of a method using visking tubing for the
preparation of plasma ultrafiltrates was investigated. The method
was influenced by Donnan shifts and temperature. Small increases in
pH occurred during ultrafiltration which would be expected to
slightly depress ultrafiltrable calcium and magnesium
concentrations. This effect was less than the inherent variability
of the method.
MATERIALS AND METHODS




Low capacity ion exchange strips for measuring Ionized calcium and
magnesium
1. Calibration of the method
Calibration curves were prepared as described in Chapter II,
section 7.2. As expected, the magnesium concentration in the eluate
was directly proportional to the magnesium concentration in the
standard solution (figure 3.1). The correlation coefficient was
highly significant (r=0.999, P<0.001). Calcium also showed the
same relationship (r=0.996, P<0.001).
2. The effect of equilibration of ion exchange strips on the
composition of plasma
Total calcium and magnesium concentrations were measured by AAS in
10 plasma samples before and after ion exchange strips were
equilibrated in them. Ion exchange strips did not cause measurable
changes in either calcium or magnesium concentration: the calcium
concentration was 2.40 + 0.05 mM pre-equilibration and 2.41 + 0.05
mM post-equilibration; the magnesium concentration was 0.801 + 0.03
mM pre-equilibration and 0.798 + 0.04 mM post-equilibration.
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Figure 3.1 The effect of changes in the concentration of calcium or
magnesium in standard solutions on the concentration of calcium or
magnesium in eluates from ion exchange strips. Each point is a mean
and standard error of four observations.
63
3. The effect of alterations in the composition of the standard
solution on calcium and magnesium concentrations in the eluate
The interference produced by alterations in the constituents of the
standard was investigated by independently varying the constituents
over a range of concentrations. The concentration ranges used are
shown in table 3.1. The basic composition of the standard was: 150
mM NaCl, 4 mM KCl, 6 mM tris-HCl (pH 7.40), 1.0 mM CaCl2 and 0>6 mM
MgCl2>
The concentration of magnesium in the eluate decreased as the
concentration of tris (P<0.02), calcium (P<0.02) or sodium
(P<0.001) in the standard solution increased (figure 3.2). Figure
3.3 shows that eluted calcium was similarly affected by sodium
(P<0.001) and magnesium (P<0.05), though the effect of tris was not
significant. Potassium had no significant effect on either ion. The
calculated gradients of the regressions in figures 3.2 and 3.3 are
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Figure 3.2 The effect of changes in the concentration of the
constituents of the standard solution on the concentration of
magnesium in eluates from ion exchange strips. Each point is a mean
and standard error of four observations.
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constituents (mmol I in standard solution
Figure 3.3 The effect of changes in the concentration of the
constituents of the standard solution on the concentration of
calcium in eluates from ion exchange strips. Each point is a mean
and standard error of four observations.
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4. The effect of complexing agents on eluted magnesium
Standard solutions contained: 150 mM NaCl, 4 mM KC1, 6 mM tris-HCl
(pH 7.40), 0.6 mM MgC^ and either: EDTA (0 to 6.0 mM); trisodium
citrate (0 to 3.0 mM); or EHDP (0 to 6.0 mM). These solutions were
equilibrated with ion exchange strips and the adsorbed cations
eluted into potassium chloride solution. Eluate magnesium
concentrations were assayed by AAS. Standard solutions containing
varying magnesium concentrations were also assayed enabling values
for ionized magnesium to be obtained.
The correlation between measured ionized magnesium and the
concentration of complexing agent was not significant for either
citrate (r=0.69, n=5), or EDTA (r=0.27, n=7). Figure 3.4 shows
very clearly the deviation of measured ionized magnesium
concentration from calculated values in the presence of citrate or
EDTA.
In saline solution the correlation between EHDP concentration
and measured ionized magnesium was significant (r=0.92, n=5,
P<0.05; table 3.2), however the reduction in measured ionized
magnesium was extremely small (2.4% per mM change in EHDP).
Finally, ion exchange strips were equilibrated with 5 ml samples of
plasma containing 0.6 ml aliquots of saline or EHDP solutions (0 to
60 mM). Plasma ionized magnesium was not significantly altered by
EHDP (r-0.37, table 3.2).
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Figure 3.4 A comparison of measured and theoretically derived
values for ionized magnesium concentration in aqueous solutions
containing EDTA or citrate. Theoretical values (heavy lines) were
calculated from the binding constants at pH 7.40: Magnesium
citrate, 10-^ M; Magnesium EDTA, 10 ^ M. Each point is a mean and
standard error of four observations.
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Table 3.2
Measurement of Ionized magnesium, using the method of Heaton




0.0 0.60 + 0.02 (4)
1.0 0.59 + 0.03 (4)
2.0 0.57 + 0.04 (4)
4.0 0.54 + 0.04 (4)




0.0 0.60 + 0.03 (4)
0.6 0.56 + 0.02 (4)
2.3 0.57 + 0.03 (4)
4.4 0.60 + 0.04 (4)
6.4 0.58 + 0.03 (4)
Figures are means + standard errors (number of observations). The
correlation between EHDP and ionized magnesium was calculated for




Low capacity ion exchange strips: theoretical considerations
In order to appreciate the implications of some of the findings
reported in this work it is first necessary to discuss some of the
theory and assumptions involved in the method. Low capacity ion
exchange strips are assumed to have a fixed number of cationic
receptor sites. In a solution containing a vast excess of a cation
such as sodium, all receptors will be occupied by that ion. If a
low concentration of a second ion having a similar affinity for the
receptors is added to the solution it will displace some of the
sodium. As the concentration of the second ion increases, the
amount adsorbed by the ion exchange strips will also increase. Not
until its concentration is many times that of sodium will
effectively all the cationic receptors be occupied by the second
ion. If that second ion is magnesium then the relationship between
the ionized concentration of magnesium at equilibrium and the total
bound magnesium can be described graphically. For an ion exchange






Reducing sodium concentration will increase bound magnesium and so
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shift the curve to the left. Increasing sodium concentration will
decrease bound magnesium and so shift the curve to the right.
Similarly, an increase in the affinity of the receptors for
magnesium or a decrease in the affinity for sodium will shift the
curve to the left, the converse is also true. As the affinity for
magnesium increases the curve will approach closer and closer to
the x axis. At infinitely high magnesium affinity bound magnesium
will no longer be related to magnesium concentration at equilibrium
but to the total magnesium present in the solution or the total
number of receptor sites, which ever is the smaller.
In plasma, because of the relative affinities of ion exchange
strips for sodium and magnesium and because the concentration of
sodium is much higher than magnesium, bound magnesium constitutes
only a very small fraction of the total bound cations. The result
is that the portion of the bound versus ionized magnesium curve
very close to the origin is the only part of the curve which is of
relevance. Experiment has shown that over this portion of the curve
the relationship is, to all intents and purposes, linear (Heaton,
1967).
In order to accurately measure ionized magnesium it is also
important that the total capacity of the ion exchange strips is low
so that the concentration of the various ions in the sample is not
substantially altered. This would affect ionic strength and
magnesium-ligand equilibria, both changes which would affect
ionized magnesium.
It seems that several criteria might be suggested which may
indicate the suitabilty of any low capacity ion exchange method for
measuring ionized cations.
(1) It is axiomatic that the cation exchange strips must only
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adsorb ionized species and that the the adsorbed cations must be
available for elution.
(2) The ratio of measured to interfering cation (eg.
magnesium/sodium) in the sample must be small.
(3) The affinity of the cation exchange strips for the measured
cations must fall within limits.
(4) The total capacity of the ion exchange strips must be low,
so that in plasma samples, when all the cationic sites are
occupied, minimal changes in composition occurs.
Criteria 2 and 3 are difficult to quantify, suffice it to say
that if experiment demonstrates a linear relationship between bound
and ionized magnesium over an appropriate concentration range, it
is reasonable to assume that these criteria are being
satisfactorily met. Although magnesium was the cation considered in
this discussion, the method should be equally applicable to any
cation which fits these criteria. In the studies described some of
these criteria were investigated.
Comparison of the method used with that of Heaton (1967)
Since the procedure used by Heaton (1967) was slightly modified for
use in this study it is pertinent consider methodological
differences that might invalidate the proposed method. These
modifications were introduced to improve the method. The main
modifications were: the use of magnesium and calcium containing
solutions for storing ion exchange strips prior to use; the use of
37°C instead of room temperature for equilibration of the ion
exchange strips; the use of tris instead of bicarbonate buffer in
standard solutions; elution in 0.2% potassium chloride instead of
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5% sodium chloride; the source of the ion exchange material.
By equilibrating ion exchange strips with 0.6 mM magnesium and
1.0 mM calcium prior to use, the subsequent change in ionized
calcium and magnesium in the sample under investigation was
minimised since the ion exchange strips already contained
approximately the amount of calcium and magnesium that would be
adsorbed from the solution.
The use of 37°C can only improve the method since gas partial
pressures and thus plasma pH will be maintained at physiological
levels. As described in the introduction these factors are
important in determining ionized calcium and magnesium.
Tris was the preferred buffer since bicarbonate is known to
complex magnesium and requires gassing with 00^/02 during use.
Calibration curves prepared using bicarbonate and tris buffers
revealed no differences.
Heaton (1967) used 5% sodium chloride for elution, presumably in
the hope that a relatively high concentration of sodium would
displace the adsorbed cations most effectively. However the calcium
and magnesium concentration in eluates was not significantly
different after elution into either 0.2% potassium chloride or 5%
sodium chloride. Potassium chloride (0.2%) was preferred as it is a
more suitable ionization buffer for AAS, and as high concentrations
of salts can cause inaccuracy during analysis due to solids
accumulating on the burner.
The modifications described so far did not adversely affect the
method. The properties of the ion exchange strips are probably the
most likely source of discrepancies between the published results
of Heaton (1967) and those of the present study. The magnesium
adsorbing capacity of the strips calculated from calibration curves
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was greater in the present study than in the original work
(P<0.05). The difference was not observed in batches of ion
exchange strips prepared using a lower concentration of congo red;
it thus seemed to be due to a higher content of the adsorbing dye
and of no significance.
In the original work it was shown that a 37 mM decrease in the
sodium concentration of the standard solution increased the
magnesium concentration in the eluate by 120%. In the present
study calculation from the data in figure 3.2 gives the same
result: 120 + 1.6% (mean + SEM) . However there appear to be
quantitative differences in the relative susceptibility to
interference from potassium and calcium of the original method and
that described here, since Heaton's data fall outside 95%
confidence limits calculated from the data presented in table 3.1.
Since Heaton made few observations, the apparent differences may
merely be a result of experimental variation.
Validation of the method
It was not possible to detect any alteration in plasma total
calcium or magnesium before or after equilibration of ion exchange
strips. This is not surprising since the capacity of the strips was
very low and prior to use they were equilibrated with solutions
containing 1.0 mM calcium and 0.6 mM magnesium. The method clearly
does not alter plasma calcium or magnesium concentrations
sufficiently to have a significant effect on protein and ligand
binding equilibria.
In this study the concentration of magnesium in the eluate was
directly proportional to the concentration of magnesium in the
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standard, calcium showed the same relationship. This confirmed the
expected linear relationship between eluted cations and cation
concentration. Since the amount of magnesium or calcium adsorbed by
the ion exchange strips was also inversely proportional to the
concentrations of interfering cations present in the standard
solution, competition for the binding sites must have occurred.
The change in eluate calcium and magnesium induced by alterations
in interfering cations was less than 1% of that resulting from
equimolar alterations in measured cations. Clearly the method is
very sensitive to changes in the measured cation and relatively
insensitive to changes in interfering ions.
Ions which have a large effect on eluted calcium or magnesium
must displace divalent cations from the cationic binding sites and
so be bound more strongly by these sites than ions which have
little effect. Thus the gradients of the interference regressions
shown in table 3.1 indicate the relative affinities of the ion
exchange strips for different cations. The gradients of the
regressions were similar for all monovalent cations which seem,
therefore, to have similar affinities for the cationic receptor
sites. Changes in calcium concentration in the standard had a
ten-fold greater effect on eluted magnesium concentration than did
equimolar changes in monovalent cations. Similarly, the effect of
magnesium on eluted calcium was ten times that of the monovalent
cations. Thus it seems that the ion exchange strips have a ten-fold
greater affinity for divalent than for monovalent ions.
The evidence discussed so far suggests that the method might be
suitable for the measurement of ionized calcium and magnesium. When
complexing agents were added to solutions calcium was excluded so
enabling the investigation of magnesium complex formation in the
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absence of competing ions. EHDP added to magnesium containing
solutions had a very small but significant effect on eluted
magnesium, in plasma it had no effect. Binding constants for
EHDP-magnesium have not been determined; however in Chapter VI
evidence will be presented that EHDP, added to plasma at lower
concentrations than those used here, caused a significant fall in
ultrafiltrable magnesium. It seems, therefore, that at the EHDP
concentrations used in this study, large decreases in ionized
magnesium went undetected by the method.
EDTA and citrate added to magnesium containing solutions also had
no effect on measured ionized magnesium. In these cases binding
constants are known, allowing calculation of expected ionized
concentrations. The amount of magnesium bound by EDTA is
approximately equal to the EDTA concentration. Citrate binds
magnesium much less strongly. It is apparent from figure 3.4 that
the method does not distinguish between magnesium ions and
magnesium bound by EDTA or citrate. One must conclude that in the
presence of EDTA, citrate or EHDP the method did not measure true
ionized magnesium. Though the effect of complexing agents on
measured ionized calcium was not studied, it seems likely that
complexed calcium would also be adsorbed by ion exchange strips.
Frizel et al (1967) also used a low capacity ion exchange strip
to measure ionized calcium and magnesium, and investigated the
effect of ligands on measured free ionic concentrations. When
citrate was added to a standard, a significant reduction in
adsorbed calcium and magnesium was observed. However free citrate
calculated from their data was 400% greater than a value predicted
from published binding constants. It appears, therefore, that their
method does not accurately measure ionized magnesium either. It
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may be that the problem encountered with Heaton's (1967) method may
be of more general application to methods involving low capacity
ion exchange strips.
In addition to the adsorption of cations by the dye, relatively
large amounts of the solution under investigation may be trapped
within the pores of the visking tubing. Typically, wet visking
tubing contains 50% by weight of trapped solution. This might
explain why the measured "ionized" magnesium and calcium in plasma
is invariably less than the total, since protein would not
penetrate the visking tubing pores and so protein bound cations
would remain free in the sample. This mechanism would not explain
the interference effects seen which are probably due, as expected,
to cationic binding sites.
In conclusion, it is likely that measurement of ionized
magnesium as a routine experimental procedure will have to await
the production of a suitable ion specific electrode or the
production of more suitable ion exchange materials.
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II
Evaluation of the Nova-2 analyser for measuring calcium ions
1. Variability of the method
Within-run variability was assessed by collecting heparinised
plasma and analysing it repeatedly. The coefficient of variation
was 0.9% (n=ll).
Day to day variability was assessed by analysing the 1.5 mM
calcium standard (American Hospital Supply UK Ltd) over a period of
one month, at no less than daily intervals. The coefficient of
variation was 1.8% (n=23).
2. Linearity of the method
Standards containing 0.5-2.5 mM calcium were analysed and the
electrode emf recorded. 0.5, 1.5 and 2.5 mM were American Hospital
Supply external standards; 1.0 and 2.0 mM were American Hospital
Supply internal standards; 0.75 mM calcium was obtained by mixing
0.5 and 1.0 mM standards.
Figure 3.5 shows that electrode emf was linearly related to log
calcium concentration over the studied range.
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log [C a] mM
Figure 3.5 The electrode emf produced by the Nova-2 calcium ion
analyser in response to changes in log [calcium ion] of aqueous
solutions.
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3. Recovery of added calcium chloride
Aliquots (0.05 ml) of calcium chloride solutions (0.18, 0.36 or
0.54 M) were placed in 5 ml syringes which were then filled with 5
ml of heparinised blood. Ionized calcium was measured, and plasma
separated for calcium assay by AAS.
Addition of calcium chloride raised total plasma calcium
concentration by 2.95, 6.01 or 9.03 mM. The increments in ionized
calcium, expressed as a % of the increase in total calcium, were,
respectively: 51.5 + 3.93%, 48.8 + 3.01% and 49.9 + 3.65%(n= **)•
4. Removal of calcium from plasma with EDTA
In an experiment to be described on page 144, EDTA was added to
heparinised plasma to give concentrations of 0.3-3.0 mM EDTA.
Ionized calcium in untreated plasma was 1.21 mM. Ionized calcium
was reduced after addition of EDTA. On a molar basis the reduction




The decrease on Ionized calcium, as measured by the Nova-2 calcium
ion analyser, following addition of EDTA to sheep plasma
Plasma mM change in
[EDTA] ionized calcium
mM
0.3 0.18 + 0.03
0.6 0.31 + 0.01
0.9 0.45 + 0.02
1.2 0.59 + 0.03
1.8 0.85 + 0.03
2.4 1.09 + 0.04
3.0 1.18 + 0.04
Values are means + standard errors for 5 observations. Control
blood contained 1.21 mM ionized calcium.
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5• The effect of blood heparin concentration on measurements of
ionized calcium
Aliquots (0.049 ml) of lithium heparin solutions containing 625,
1250, 2500 or 5000 i.u. ml~l added to 2 ml blood samples gave final
heparin concentrations of 15-123 i.u. ml~l. Ionized calcium was
measured in serum and in the heparinised blood. The small dilution
error was accounted for by multiplying the value for serum calcium
by 0.975.
Heparin reduced ionized calcium (figure 3.6). Up to 30 i.u. ml--*-
heparin, the rate of fall of ionized calcium was approximately
linear. Calculation of the gradient of this portion of the line
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Figure 3.6 The effect of blood heparin concentration on ionized
calcium as a % of serum controls. Each point is a mean and standard




The variability of this method was excellent and unlikely to be a
significant source of error. The day to day analysis of 1.5 mM
calcium standards gave a mean value of 1.55 mM, not significantly
greater than 1.5. However Larsson and Ohman (1980) noted that
calcium ion concentration measured with the Nova-2 analyser was
consistently higher than simultaneous analyses made with an Orion
SS-20 calcium electrode system. This may result from the different
type of electrodes used in the two systems. Which of the two
systems provides the more accurate estimate of ionized calcium
remains uncertain.
Electrode emf was linearly related to log calcium ion
concentration, as would be expected on theoretical grounds. Only
50% of calcium chloride added to plasma was recovered as ionized
calcium. This was probably because of uptake of calcium by
endogenous ligand binding sites. Similarly, when EDTA was added to
blood, only 50% of the removed calcium came from the ionized
fraction. These findings are as would be expected since normally
approximately 50% of plasma calcium is ionized, plasma proteins
serving to buffer most of the remainder of the removed or added
calcium.
Heparin complexes calcium and so interferes with estimations of
ionized calcium (Moore, 1970; Ladensen and Bowers, 1973; Boyd and
Williamson, 1980) The use of serum would have avoided this
problem, but was impracticable because of the low yield.
Consequently, it was necessary to use heparinised blood so as to
provide sufficient material for the number of analytical procedures
required. It was therefore necessary to quantify the potential
85
error due to heparin.
For measurement of ionized calcium, a blood heparin
concentration of 10 i.u. ml~l was used. The gradient of the linear
portion of figure 3.6 indicates that this would reduce ionized
calcium by approximately 1.5%; less than the day to day variability
of the method. However the error is large enough to be detected
within a run of analyses, so heparin concentration should be
closely controlled.
The only way this source of error could be eliminated is by
using serum. However the delay incurred by the preparation of serum
would be such that even greater errors would be likely to occur as
a result of pH changes (Siggaard-Andersen, 1961; Pedersen, 1971a).
Alternatively the blood heparin concentration could be further
reduced. However the risk of blood clotting and so damaging the
electrodes would be increased. In view of the ease with which the
electrode seemed to block, this risk was unacceptable.
The Nova-2 calcium ion analyser seems to provide an acceptable
method of measuring ionized calcium providing that the required
care in handling blood samples is exercised.
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Evaluation of the method of preparing ultrafiltrates
1. Variability of the method
Thirty seven samples of plasma were ultrafiltered in duplicate and
calcium and magnesium determined by AAS in the ultrafiltrates. The
average coefficient of variation between duplicates was 3.55% for
calcium and 3.34% for magnesium.
2. Protein permeability of the visking tubing
The presence of protein in the ultrafiltrate was tested for by
adding a few drops of trichloro-acetic acid (10% w/v) to the
ultrafiltrate. The formation of a faint opalescence was taken as a
positive result. This method was found to be extremely sensitive,
slight wetting of the outside of the sac was sufficient to give a
positive reaction.
Initially a large number of samples were shown to be
contaminated with protein. Great care was required during filling
of the visking tubing sacs, ensuring that the outside of the sac
was not wetted. Filling too quickly could easily cause the sac to
overflow, the plasma being drawn up between the closely apposed
surfaces by capillarity. When the required care was appreciated,
it was found that the problem was readily eliminated. Out of 146
samples of ultrafiltrate tested, only 3 were positive.
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3. Changes in pH and pC02 following ultrafiltration
Blood was collected from sheep and pH and pCC^ measured
immediately. Plasma was then separated, some was ultrafiltered and
some stored at 4°C. After ultrafiltration pH and pCO^ were measured
in retentate and in stored (control) plasma.
Ultrafiltration caused a rise in pH, and a fall in pCC^ (table
3.4). Similar changes also occurred during the time taken to
separate plasma from blood.
Table 3.4
The changes, induced by ultrafiltration, in pH
and pC02 in sheep plasma
pH pco2
mmHg
Blood, immediately after collection
7.42 44.7
Plasma, before and after ultrafiltration




Standard error 0.0028 0.68
P (cf. 0.0) <0.001 <0.001
Values are means + standard errors for 5 observations.
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4. The effect of temperature on ultrafiltrable calcium and
magnesium
Plasma was ultrafiltered at 37°C or 20°C and calcium and magnesium
determined in both ultrafiltrate and plasma. Ultrafiltrable
calcium, as a % of total, was significantly higher at 20°C than at
37t>c (P<0.001). Magnesium was similarly affected (P<0.0001; table
3.5).
5. The Donnan equilibrium: Measurement of ultrafiltrate/plasma
sodium, potassium and EDTA concentration ratios
Plasma was ultrafiltered and then sodium and potassium
concentration determined in both ultrafiltrate and plasma. EDTA
partition was measured in plasma and ultrafiltrates collected
during intravenous infusion of ^C-EDTA (see Chapter IV for
experimental details).
The ultrafiltrate/plasma ratios were: for sodium, 0.992 +0.005
(n = 5); for potassium, 1.004 + 0.005 (n = 5); and for EDTA, 1.089
+ 0.025 (n = 16). The ratios differed significantly from 1.000 for
both sodium (P<0.05) and EDTA (P<0.01).
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Table 3.5
Ultrafiltrable calcium and magnesium, as % of total, measured after




Calcium 50.1% +1.2 (11) 58.9% +2.0 (10) P<0.001
Magnesium 72.3% + 1.7 (11) 77.7% + 0.7 (10) P<0.0001
Values are expressed as % of the total calcium and magnesium
concentrations in the samples, they are shown as means + standard
errors (number of observations).
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Discussion
When the method was first used, the visking tubing was washed, then
stored in a solution containing 150 mM NaCl, 4 mM KC1, 1.4 mM
^a^"2> and 0*6 MgCl2, ultrafiltrates were then prepared using
moist tubing. This appeared to work perfectly well when measuring
"normal" values of ultrafiltrable calcium and magnesium. However
the wet visking tubing held approximately its dry weight of
solution. Since only 0.2-0.3 ml of ultrafiltrate was produced, and
the visking tubing contained 0.2 ml of solution, it was probable
that the ultrafiltrate was seriously contaminated.
This problem was overcome by adopting the procedure of Pedersen
(1971b) for producing dry visking tubing. In addition, the use of
dry tubing facilitated filling of the membrane sacs. Pinholing of
the tubing was not found to be a problem as analysis of
ultrafiltrates for protein showed. However very intensive washing
was required, otherwise traces of magnesium and calcium were
concentrated in the tubing during drying causing a significant rise
in ultrafiltrate calcium and magnesium.
In addition to the investigations described, the effect of
prolonged ultrafiltration was briefly examined. Over several hours
of centrifugation time did not significantly change ultrafiltrable
calcium and magnesium.
The pH change which occurred during ultrafiltration is likely to
have some effect on measured ultrafiltrable calcium and magnesium.
Pedersen (1971a) found that serum pH decreased by 0.06-0.08 pH
units during ultrafiltration. Detailed study of the effects of
bicarbonate, pCO and pH on serum calcium fractions showed that
increasing pH from 7.0 to 8.0 decreased the ultrafiltrable calcium
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by 40% (Pedersen, 1971a). Over this range the increase in protein
binding was linearly related to pH. In the present investigation
the increase in pH from the time of collection of blood to
completion of ultrafiltration was 0.12. The expected decrease in
ultrafiltrable calcium was therefore 5%. On the assumption of
linearity (Pedersen, 1971a), the data of Robertson and Peacock
(1968) would suggest an effect of similar magnitude.
Siggaard-Andersen (1961) showed that at 38°C, under anaerobic
conditions, blood pH fell linearly by 0.066 pH units per hour for
four hours after collection. This effect was a function of time
and could only be substantially reduced by storing at 4°C. The pH
change shown in table 3.4 was in the opposite direction and was
probably the result of C02 loggj but gince approximately 3 hours
elapses between blood collection and completion of ultrafiltration,
the observed change was apparently smaller than that described by
Siggaard-Andersen (1961). It therefore seems unlikely that the pH
change in the present method could be substantially reduced.
Pedersen (1971a) found that cooling serum from 37°C, to 22°C
caused pH to increase from 7.40 to 7.57. From his data he
calculated that protein binding of calcium should decrease by 7%.
In this study the effect of temperature was very similar (8.8%).
The data of Robertson et al (1968) are also in good agreement.
The Donnan ratio is approximately 0.90 for divalent cations in
plasma. Thus ultrafiltrable calcium and magnesium might be expected
to be only 90% of their total plasma levels even in the absence of
protein binding. In addition, ultrafiltrate/plasma ratios are also
influenced by the plasma water factor. Plasma proteins effectively
dilute the plasma water and so reduce the concentration of
substances in plasma compared to ultrafiltrates. Although the
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Donaan equilibrium may influence the formation of ultrafiltrate,
the extent to which it does so is not clear. Walser (1969) did not
consider that equilibrium conditions would be reached. Pedersen
(1972b) could not detect such shifts in his method, contrary to the
results presented here. However it seems unlikely that the
electrical and concentration gradients across the membrane have
absolutely no influence on the composition of ultrafiltrates.
In the present investigation, ultrafiltrate/plasma ratios for
sodium and potassium were very close to 1.00. This suggested that
for monovalent cations Donnan and plasma water factors were acting
equally but in opposite directions. In the case of anions the
Donnan effect and the plasma water factor will be additive since
they both act to increase the measured concentration in the
ultraf iltrate. In blood, EDTA is largely in the form of the
calcium chelate which exists as a divalent anion (Schwartzenbach,
1957). The Donnan ratio for a divalent anion is 1.10, the plasma
water factor is approximately 5%. The concentration of divalent
anions would thus be expected to be 15% higher in the ultrafiltrate
than in plasma; greater than the observed gradient. Thus it seems
that although the plasma water factor and the Donnan effect
appreciably altered the partition of anions across the
semipermeable membrane, equilibrium was not reached. Similarly, it
seems likely that divalent cation concentrations will be
appreciably lower in ultraf iltrates than in plasma even in the
absence of protein binding, although probably somewhat less than
the 5% expected at equilibrium.
In studies of the chemistry of calcium and magnesium binding it
would be necessary to take account of Donnan shifts, but since they
are equally likely to occur in vivo as in vitro, the presence of
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such shifts does not necessarily constitute a disadvantage when
attempting to determine glomerular filtrable calcium and magnesium.
Since this was the primary area of interest in the studies
described in this thesis, no correction factors were necessary.
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CHAPTER IV
THE EFFECT OF ETHYLENE DIAMINE TETRAACETIC ACID (EDTA)
INFUSIONS ON THE PLASMA FRACTIONS AND URINARY
EXCRETION OF CALCIUM AND MAGNESIUM IN SHEEP
Summary
1. EDTA containing tracer ^C-EDTA was infused intravenously into
sheep. Blood was collected every half hour and urine every hour,
before, during and after the infusion. Total, ultrafTitrable and
ionized calcium concentrations, and total and ultrafTitrable
magnesium were determined in plasma. Plasma EDTA concentration,
blood pH, endogenous creatinine clearance and the urinary excretion
of calcium, magnesium and EDTA were also measured.
2. Following EDTA administration, ultrafiltrable plasma calcium
concentration increased and ionized calcium decreased whilst the
total was unchanged. The net increase in plasma complexed calcium
was approximately equimolar with the EDTA concentration.
3. Calcium excretion also increased despite unchanged creatinine
clearance. The increments in urinary EDTA and calcium were
approximately equimolar.
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4. The effect of EDTA on the measured plasma fractions of magnesium
and calcium were similar; ultrafiltrable plasma magnesium
increased, whilst the total remained unchanged. Unlike calcium,
urinary magnesium excretion did not increase significantly.
5. The renal clearance of EDTA and endogenous creatinine were
similar.
6. The effects of EDTA on plasma and urinary calcium are consistent
with the formation in plasma of Ca-EDTA complexes which are then
eliminated by glomerular filtration without tubular secretion or
reabsorption. These findings are largely in agreement with previous
studies, however the stoichiometric relationship between urinary
calcium and EDTA has not been seen previously. The high urinary pH
of herbivores probably accounts for this difference, since it
results in enhancement of EDTA-calcium binding.
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Introduction
The metabolism of EDTA has been studied in a number of species
including human, dog and rat, but has not, so far, been studied in
sheep. Soffer et al (1961) infused EDTA into human subjects and
measured the concentrations of plasma calcium fractions. Total
plasma calcium did not change but complexed calcium increased
considerably. This effect was attributed to the presence of EDTA
chelated calcium in plasma. Parfitt (1969) also obtained similar
results in man.
EDTA is excreted by glomerular filtration in the dog (Forland et
al, 1966). In the rat 95-98% of an administered dose of EDTA is
eliminated within six hours (Foreman et al, 1953). Studies have
demonstrated that EDTA infusion induces hypercalciuria in man
(Spencer et al, 1952; Holland et al, 1953; Levitt et al, 1958), dog
(Chen et al, 1955a) and rat (Rubin et al, 1956-7). However the
increment in urinary calcium excretion seems to be considerably
less than that predicted on the basis of stoichiometric binding
(Spencer et al, 1952; Rubin et al, 1956-7; Parfitt, 1969). Stop-
flow studies in dogs have demonstrated that the calcium
concentration in samples corresponding to the distal tubule is
greatly increased by EDTA (Grollman et al, 1963) indicating
depression of calcium reabsorption in the distal tubule.
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Methods
The pH of Na2EDTA solution was adjusted to 7.40 with sodium
hydroxide and a 3.76% solution, approximately isotonic with plasma,
was made. Sheep were equipped with Foley urinary and PVC jugular
catheters. They were then infused with a priming dose of 2.5
micro-mol min-^kg~-'- EDTA for half an hour followed by a maintenance
dose of 0.7 micro-mol min-lkg~l for two hours. The Harvard
infusion pump was set to infuse at 0.6 ml min--*-. EDTA solution was
diluted with saline to provide the appropriate dose. Two
preliminary infusions of unlabelled EDTA were made using this
dosage regime; having established that a measurable effect occurred
four further infusions of EDTA, containing 8 micro-Ci of l^C-EDTA
(108 Ci mol~l; Radiochemical Centre, Amersham) were made. Blood
samples were collected every 30 minutes and urine for periods of
one hour except for the half hour period during administration of
the priming dose.
In these experiments it was attempted to induce a mild diuresis
by the administration of four litres of water by naso-pharyngeal
tube 90 minutes before the start of urine collection. EDTA was
administered after a two hour control period of urine and blood
collection. When the infusion was complete, blood and urine
collection continued for a further four hours. Plasma and blood
fractions of calcium and magnesium were measured. Creatinine and
EDTA were also determined.
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Results
Only the data from the four sheep. Infused with l^C-EDTA are
reported. The other two animals showed similar responses, but were
excluded to allow comparisons between EDTA and calcium
concentrations in blood and urine.
During EDTA infusion, plasma ionized calcium concentration fell
(P<0.001) whilst the ultrafiltrable calcium fraction increased
(P<0.01) and the total did not change significantly (figure 4.1).
The increase in complexed calcium during the period of EDTA
infusion was 0.49 + 0.06 mM (n = 8) and was not significantly
different from the EDTA concentration observed in the same samples
(0.47 + 0.04, n = 8).
The urinary excretion of calcium increased 100 fold (P<0.001;
figure 4.2). The increment in the urinary excretion of calcium was
very similar to that of EDTA and the correlation highly significant
(r = 0.94, PC0.001).
The ultrafiltrable fraction of plasma magnesium also increased
(P<0.05; figure 4.3) but total plasma magnesium did not change.
Total plasma calcium and magnesium were correlated during the
control period (r = 0.59, P<0.01) and during the infusion period (r
= 0.86, PC0.001).
The urinary excretion of magnesium did not change significantly
(table 4.1). No significant changes in blood pH (figure 4.4) or H+
excretion (table 4.1) were seen. Endogenous creatinine clearance
did not change significantly (table 4.2). It was similar to the
simultaneous EDTA clearance but the SEM of EDTA clearance during










Figure 4.1 The effect of EDTA infusion in four sheep on the
concentration of total (closed circles), ultrafiltrable (squares)
and ionized (open circles) plasma calcium, and plasma EDTA
concentration (triangles). EDTA was infused at 7 micro-mol
min-l-lcg-l for 120 minutes (shown hatched), following a 30 minute
priming dose at 25 micro-mol rain^k.g--'-. Values of calcium
concentrations were compared with their pre-infusion controls: ***,





















2 2 5 3-5 4-5 5 5 6 5 7-5 8-5
hours
Figure 4.2 The effect of EDTA infusion in four sheep on the urinary
excretion of EDTA and calcium. EDTA was infused at 7 micro-mol
min-lkg-l for 120 minutes (shown hatched), following a priming dose
of 25 micro-mol min-lkg--'- for 30 minutes. Values of calcium
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Figure 4.3 The effect of EDTA infusion in four sheep on the
concentration of total (closed circles) and ultrafiltrable (open
circles) plasma magnesium. EDTA was infused at 7 micro-mol
min~lkg~^ for 120 minutes (shown hatched), following a 30 minute
priming dose at 25 micro-mol min~lkg~^. Values were compared with




Figure 4.4 The effect of EDTA infusion in four sheep on blood pH.
EDTA was infused at 7 micro-mol min-1Kg-1 for 120 minutes (shown
hatched), following a 30 minute priming dose at 25 micro-mol
min ^Kg ^. Values were compared with their pre-infusion controls.
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Table 4.1
The effect of EDTA infusion on the excretion of H~^" and












EDTA infusion rate: 25 micro-mol kg~^-min~-*-
2-2.5 0.17 + 0.12 12.9 + 10.2
EDTA infusion rate: 7 micro-mol kg~^min~^
2.5-3.5 0.17 + 0.06 11.7 + 10.4
3.5-4.5 0.11 + 0.05 11.6 + 10.4
Post-infusion period
4.5-5.5 0.11 + 0.04
5.5-6.5 0.18 + 0.10
10.7 + 8.9
17.1 + 10.8
Each value is a mean + standard error of four observations.
Magnesium and IT1" excretion did not differ significantly in the
control, infusion, or post-infusion periods.
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Table 4.2
A comparison of the renal clearances of endogenous












0-1 41.8 + 8.1
1-2 42.5 + 7.0
EDTA infusion rate: 25 micro-mol kg~^min~^-
2-2.5 46.6 + 11.1
EDTA infusion rate: 7 micro-mol kg~-'-min~^
2.5-3.5 29.6+4.6 38.6+7.0
3.5-4.5 27.3 + 4.3 34.8 + 6.5
Post-infusion period
4.5-5.5 40.9 + 16.0 38.5 + 6.2
5.5-6.5 32.4 + 11.7 29.8 + 3.5
7.5-8.5 44.6+17.8 43.1+8.3
8.5-9.5 40.7 + 12.1 40.3 + 6.9
Each value is a mean + standard error of four observations. The
clearances of EDTA and endogenous creatinine were not significantly
different during each period. Endogenous creatinine clearance did




The effects of EDTA on plasma and urinary calcium were as expected.
The complexed calcium fraction in blood increased, the increase was
equimolar with the EDTA concentration in the same samples.
Similarly, the excretion of EDTA was accompanied by a large
increment in urinary calcium. In the first two experiments urinary
ultrafiltrable calcium was determined. This confirmed that the
increment in urinary calcium was indeed ultrafiltrable. It seemed
that the increase in complexed calcium in blood was due to the
formation of EDTA-calcium complexes which were then eliminated by
the kidney. The effect on complexed calcium seemed to involve an
increase in ultrafiltrable plasma calcium and a decrease in the
ionized fraction.
These changes are as expected on the basis of previous studies
(Spencer et al, 1952; Soffer et al, 1961). The effect of EDTA on
the excretion and plasma fractions of calcium was due to the
formation in blood of EDTA-calcium complexes which were then
eliminated by glomerular filtration without further reabsorption or
secretion. The increase in calcium excretion was primarily due to
the non-availability of complexed calcium for tubular reabsorption.
However, in addition, since GFR was unchanged and ultrafiltrable
calcium increased, the filtered load of calcium entering the
nephron also increased. This would also exacerbate renal calcium
loss.
Unlike previous studies in which the increment in urinary
calcium was considerably less than the increment in EDTA, this
study obtained similar increments in both substances. This may have
resulted from the relatively alkaline urine produced by ruminants
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which would enhance calcium binding.
The clearance of endogenous creatinine and EDTA were similar.
This suggests that in the sheep EDTA was primarily excreted by
glomerular filtration, as it is in the dog (Forland et al, 1966).
However, since the clearance of EDTA was very variable, the
evidence is not completely conclusive.
The increase in ultrafiltrable magnesium (approximately 0.05 mM)
during EDTA infusion was unexpected. It is unlikely to have been
due to a reduction in plasma magnesium protein binding since blood
pH, the main determinant of protein binding, did not change. It
may be that the increase in plasma ultrafiltrable magnesium was a
result of the formation of EDTA-magnesium complexes. From published
EDTA binding constants, the maximum concentration of magnesium
likely to be bound is 0.005 mM, only 10% of the observed effect.
However the value of such constants is uncertain since it has been
found that under physiological conditions the EDTA-calcium constant
is an order of magnitude less than published values (Kim and
Padilla, 1978); it would not be surprising if EDTA-magnesium
constants err similarly. Clearly, corroborative evidence is
required to justify the conclusion that EDTA complexes magnesium in
vivo.
Since calcium and magnesium compete for renal tubular
reabsorption, by complexing calcium EDTA might be expected to
enhance magnesium reabsorption as a result of reduced ionized
calcium in the renal tubule. However, since EDTA infusion did not
decrease magnesium excretion, the experiments do not indicate that
competition occurred. Previous studies have demonstrated
competition during periods of raised plasma calcium and magnesium
(Samiy et al, 1960; Massry et al, 1969). It may be that in normal
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circumstances competition between calcium and magnesium for tubular
reabsorption is not of physiological importance in the homeostasis
of these ions. Such conjectures are clearly not justified if in
fact EDTA complexes significant amounts of magnesium, since this,
in itself, would cause hypermagnesuria. The use of a ligand such as
EGTA, which shows considerably greater selectivity for calcium than
does EDTA might clarify this point.
Despite the hypercalciuria observed during EDTA infusion, in
this and other studies total plasma calcium often remained constant
(Spencer et al, 1952; Soffer et al, 1961). It seems, therefore,
that the plasma calcium pool is being replenished from some
external store. The most likely source is bone. Ramberg, Mayer,
Kronfeld, Aurbach, Sherwood and Potts (1967) showed that
parathyroid hormone (PTH) secretion was active within 15 minutes of
commencing EDTA infusions in cattle. However it is unlikely that
PTH is involved in the maintenance of plasma calcium during the
preliminary stages of EDTA infusion since PTH mediated bone
resorption is not active until 70-80 minutes following
administration (Parfitt, 1969). In addition PTH may cause a
transient hypocalcaemia during the first 20 minutes post-
administration (Parsons and Robinson, 1971), this was certainly not
observed during EDTA infusion.
Rodan, Lieberman, Paran and Anbar, (1967) found that when EDTA
was administered to the dog hind limb in which the blood supply was
isolated from the rest of the animal, plasma calcium concentration
in the isolated limb rose. They calculated that the available
calcium was approximately 1/1000 of total bone calcium. This
mechanism may be responsible for the maintenance of plasma calcium
during the early stages of EDTA infusion.
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In conclusion, in the sheep EDTA acts as a classical chelating
agent, as previously described in other species. The effect of EDTA
on plasma calcium fractions resulted in enhanced renal excretion of
calcium. The failure significantly to alter total plasma calcium




THE FORMATION OF CALCIUM COMPLEXES BY BOROGLUCONATE IN VITRO AND
DURING CALCIUM BOROGLUCONATE INFUSION IN SHEEP
Summary
1. The calcium binding ability of calcium borogluconate, a drug
widely used for the treatment of hypocalcaemia, does not seem to
have been investigated. The effect of sodium and calcium
borogluconate on ionized calcium was studied in vitro. Calcium
borogluconate was then infused into sheep. Blood was collected
every fifteen minutes and urine for periods of one hour. Total,
ultrafiltrable and ionized calcium, and total and ultrafiltrable
magnesium concentrations were determined in plasma. Plasma pH and
endogenous creatinine clearance and the urinary excretion of
calcium, magnesium and hydrogen ion were determined.
Finally, the effect of subcutaneous administration of calcium and
sodium borogluconates on total plasma calcium and magnesium
concentrations was examined in sheep.
2. When equimolar amounts of calcium as the borogluconate or
chloride were added to blood in vitro, the chloride salt caused the
greater increase in ionized calcium.
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3. Addition to blood, in vitro, of either sodium borate (5 mM) or
sodium gluconate (5 mM), caused small decreases (0.08 mM) in plasma
ionized calcium. The two substances together had a synergistic
action, causing a large decrease in ionized calcium (0.53 mM).
4. The effects of intravenous infusion of calcium borogluconate
were:
(i) a large increase in both total and ultrafiltrable plasma
calcium concentration;
(ii) a relatively small increase in plasma ionized calcium;
(iii) an increase in calcium excretion, accompanied by a fall in
endogenous creatinine clearance post-infusion;
(iv) respiratory acidosis, developing during the infusion, and a
fall in urinary pH post-infusion;
(v) a slight fall in total plasma magnesium concentration which
may have resulted from competition between calcium and
magnesium for renal tubular reabsorption (although magnesium
excretion did not increase significantly).
5. Following subcutaneous administration of sodium borogluconate to
sheep, total plasma calcium concentration decreased.
6. It is suggested that the effect of calcium borogluconate on
urinary and plasma calcium fractions was due to the formation of
calcium-borogluconate complexes. The hypocalcaemic effect of sodium
borogluconate was probably due to decreased renal tubular
reabsorption of complexed calcium. The in vitro studies showed that




Crystallised calcium borogluconate solid appears to exist as a
distinct chemical substance (Dryerre and Greig, 1935; Macpherson
and Stewart, 1938). However the physico-chemical nature of calcium
in an aqueous solution of the salt does not seem to have been
investigated. Its beneficial attributes, as compared with the
gluconate and chloride salts are its stability and non-irritant
nature (Dryerre and Greig, 1935).
Gluconate causes hypercalciuria by depressing the renal tubular
reabsorption of calcium (Howard et al, 1959; Bernstein et al, 1962;
Dibona, 1971). Additionally, calcium gluconate Is less effective
than calcium chloride in raising plasma ionized calcium
concentration (White et al, 1976). These effects are probably the
result of formation of calcium complexes with reduced bio¬
availability.
In view of the widespread use of calcium borogluconate in
veterinary practice and its chemical relationship to gluconate,
which is believed to complex calcium, it was proposed to
investigate the possible formation of calcium complexes in vitro.
These experiments were followed by studies in vivo.
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Methods and Results
1. The in vitro ionization of calcium borogluconate and calcium
chloride in blood
Methods
Solutions of the calcium salts, borogluconate (Astra Chemicals Ltd)
and chloride (BDH Analar Reagent) were prepared containing slightly
in excess of 90 mM calcium. These two solutions were then analysed
by AAS and slight volume adjustments made to provide two solutions
containing 90 mM calcium.
Portions (0.1, 0.2 or 0.3 ml) of the calcium solutions were
placed in 5 ml syringes which were then filled with 5 ml of
heparinised sheep blood and thoroughly mixed. Ionized calcium was
measured in these samples and in control blood containing no
additional calcium. The procedure was carried out with blood from
four animals. The pH of control blood and blood containing the
largest amount of the two calcium solutions was also measured.
Results
Table 5.1 compares ionized calcium in blood after the addition of
three concentrations of calcium as the borogluconate or as the
chloride. At every concentration of calcium, ionized calcium was
considerably lower in the presence of calcium borogluconate than it
was in the presence of the chloride salt (P<0.02).
The pH of blood containing calcium chloride (7.33 + 0.04) or
calcium borogluconate (7.22 + 0.03) was less (P<0.002) than the pH
of control blood (7.40 + 0.04). This is to be expected since
calcium chloride is an acidic salt and calcium borogluconate
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contains boric acid. The acidifying effect of calcium
borogluconate was greater than that of calcium chloride (P<0.007).
Table 5.1
A comparison of ionized calcium concentrations after the addition
of equimolar amounts of calcium borogluconate or
calcium chloride to blood
Volume (ml)
90 mM calcium













0.1 2.78 + 0.18 2.32 + 0.06 P<0.02
0.2 4.19 + 0.14 2.76 + 0.06 P<0.0001
0.3 5.77 + 0.25 2.95 + 0.06 P<0.0001
Values are means + standard error of four observations. The
ionized calcium in untreated blood was 1.26 + 0.06 mM.
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2. Ionized calcium in vitro after addition of sodium gluconate
and sodium borate to blood
Methods
The following solutions were prepared: (1) 0.2 M sodium chloride
(control); (2) 0.2 M sodium gluconate (Sigma); (3) 0.2 M boric
acid; (4) 0.2 M sodium gluconate and 0.2 M boric acid. The
solutions were adjusted to pH 7.40 with sodium hydroxide. Aliquots
(0.05 ml) of each solution were placed in 2 ml syringes which were
then filled to the 2 ml mark with heparinised sheep blood. Ionized
calcium was then measured. The procedure was carried out five times
with blood from different animals.
Results
Table 5.2 shows that sodium gluconate caused a 0.08 mM decrease in
ionized calcium compared with saline controls (P<0.02), the effect
of boric acid was similar although less significant (P<0.06).
Together, sodium gluconate and boric acid had a large synergistic
effect on ionized calcium, which fell by 0.53 mM (P<0.0005).
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Table 5.2
The effect on Ionized calcium concentration of the addition to













saline 5 mM 1.27+0.03
Sodium gluconate 5 mM 1.19 + 0.03 PC0.02
Sodium borate 5 mM 1.19 + 0.05 PC0.06
Sodium gluconate 5 mM 0 74 + 0 04
and sodium borate 5 mM
PC0.0005
Values are means + standard errors of five observations.
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3. The effect of calcium borogluconate infusion on the plasma
fractions and urinary excretion of calcium and magnesium in
sheep
Methods
Calcium borogluconate (60 ml, 40% w/v, Astra Chemicals Ltd) was
diluted with 90 ml of saline (0.9% w/v sodium chloride). This
prevented precipitation during the subsequent adjustment of pH to
7.40 with sodium hydroxide. Finally the solution was diluted to 170
ml with saline. Sheep were catheterised for infusion purposes and
for urine and blood sampling as described in Chapter II. Blood was
collected every 15 minutes, and urine for periods of one hour. The
animals were infused intravenously at 2.75 ml min-^- with the
calcium borogluconate solution. This provided a dose of 0.53 mmol
min~l calcium and thus a total dose of 31.7 mmol calcium;
approximately a normal clinical dose for a sheep. Saline was
infused at the same rate before and after the period of calcium
administration.
Results
Figure 5.1 shows that during and after the infusion of calcium
borogluconate large increases in both total and ultrafiltrable
calcium occurred accompanied by a smaller increase in ionized
calcium.
When total plasma calcium concentration was plotted against
ultrafiltrable and ionized calcium, as in figure 5.2, it became
much more apparent that the increment in total calcium was largely
due to an increase in the non-ionized, ultrafiltrable component of
plasma calcium. The gradient of the calculated regression of
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ionized on total plasma calcium was less than the gradient of the
regression of ultrafiltrable on total calcium (P<0.01).
Total plasma magnesium fell gradually almost from the start of
the calcium infusion (figure 5.3) but was not significantly lower
than the control value until 45 minutes after the calcium infusion
had ceased (P<0.02). The gradient of the regression of plasma
magnesium on time, calculated from the time the infusion started,
was significantly different from zero (t-test, P<0.001).
Ultrafiltrable plasma magnesium, as a total or as a percentage of
total, was not significantly altered by calcium infusion.
Infusion of calcium borogluconate (pH 7.40) was associated with
respiratory acidosis (figure 5.4); blood pH decreased and pC^
increased. This resulted in an increase in bicarbonate
concentration. Urinary pH was not significantly different during
the period of infusion (7.10 + 0.51) than during the control period
(8.13 + 0.17), however by the post infusion period it was
significantly lower (P<0.02, 6.18 + 0.56) than control. When
calculated in terms of H+ excretion the change, although large, was
not significant (figure 5.5). Calcium borogluconate infusion was
followed by a reduction in GFR, as measured by endogenous
creatinine clearance (figure 5.5). The urinary excretion of
calcium increased during the post infusion period but no
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Figure 5.1 The effect of infusion of calcium borogluconate (pH
7.40, 14% w/v; shown at the bottom of the figure) in five sheep on
the concentration of total (closed circles), ultrafiltrable
(squares) and ionized (open circles) plasma calcium. Values were




Figure 5.2 Calculated regression lines for plasma ultrafiltrable
calcium (dotted line) and ionized calcium (dashed line) on total
calcium during infusions of calcium borogluconate into five sheep.
The ionized calcium regression line falls outside the 99%
confidence intervals (curved lines) for the ultrafiltrable calcium
regression (P<0.01).
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Figure 5.3 The effect of infusion of calcium borogluconate (pH
7.40, 14% w/v; shown at the bottom of the figure) in five sheep on
total (closed circles) and ultrafiltrable (open circles) plasma
magnesium. Values were compared with their pre-infusion control
concentrations: *, P<0.05; **, P<0.02.
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Figure 5.4 The effect of infusion of calcium borogluconate (pH
7.40, 14% w/v; shown at the bottom of the figure) in five sheep on
some indices of blood acid-base status. Values were compared with



































Figure 5.5 The effect of infusion of calcium borogluconate (pH
7.40, 14% w/v; shown at the bottom of the figure) in five sheep on
the urinary excretion of calcium, magnesium and H+, and the
endogenous creatinine clearance. Values were compared with their
control values: *, PC0.05; **, P<0.02.
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4. The effect of calcium or sodium borogluconate on plasma total
calcium and magnesium concentrations
Methods
Sodium borogluconate solution (20% w/v) was prepared by dissolving
16.6 g of sodium gluconate (Sigma) and 3.4 g of boric acid in water
to make 100 ml. Four sheep received one of two treatments: 100 ml
of sodium borogluconate (20% w/v), or 100 ml of calcium
borogluconate (20% w/v) administered by subcutaneous injection,
alternatively the animals were treated as controls which received
no treatment. The animals were randomly assigned to these three
groups, and were subjected to all three procedures at 48 hour
intervals. Two hours following an injection blood sampling
commenced. Four venous blood samples were taken at 90 minute
intervals. Total plasma calcium and magnesium concentrations were
measured.
Results
Little change in plasma calcium and magnesium occurred after the
first two hours following calcium administration and so the mean
for each treatment in each animal was calculated to improve the
precision of the estimation. As expected, calcium borogluconate
injection increased total plasma calcium concentration compared
with the control period (P<0.0005; table 5.3). Sodium
borogluconate caused plasma calcium to decrease (P<0.015). Neither
solution had significant effects on plasma magnesium concentration,
although a small decrease in plasma magnesium was seen in each case
after calcium borogluconate (P<0.1).
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Table 5.3
The effect of subcutaneous calcium or sodium borogluconates
on plasma calcium and magnesium concentration in sheep
Treatment Mg mM Ca mM
Control 0.798 + 0.053 2.28 + 0.051
Sodium
borogluconate 0.840 + 0.067 *2.02 + 0.056
(100 ml 20% w/v)
Calcium
borogluconate 0.621 + 0.080 **3.59 + 0.018
(100 ml 20% w/v)
Values are means + standard errors for four sheep. The treatments
produced significant changes in calcium concentrations compared
with controls; *, P<0.015; **, P<0.0005.
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Discussion
In experiment 1, changes in ionized calcium were measured after the
addition of either calcium borogluconate or calcium chloride to
blood. In order to make such measurements valid, pH changes induced
by these solutions must be considered. In this experiment the
dilution effect was minimised by the use of concentrated calcium
solutions. However these solutions were, of necessity, acidic since
they precipitated at pH 7.40. Calcium borogluconate was associated
with lower pH and lower ionized calcium than was calcium chloride.
Since calcium complexes are more dissociated at low pH this
difference would have the opposite effect on ionized plasma calcium
to that observed. Thus it cannot account for the different
ionization of the two solutions. The observed differences are most
readily accounted for by the formation of calcium borogluconate
complexes.
In experiment 2, the effects on ionized calcium of gluconate
and/or borate were compared. The small decrease in ionized calcium
produced by addition of either sodium gluconate or sodium borate
was negligible compared with the effect of the two ions together.
Careful pH control was instituted during this experiment so pH has
no bearing on the result. The observed synergism between borate and
gluconate was probably due to the formation of complexes which
involve calcium, gluconate and borate.
During the intravenous infusion of calcium borogluconate the
increase in total plasma calcium was primarily due to a massive
increase in the non-ionized ultrafiltrable fraction of plasma
calcium. It is very unlikely that an effect of this magnitude would
be due to an increase in the normal calcium complexing substances
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present in plasma. The effect is almost certainly due to the
presence of calcium-borate-gluconate complexes.
During the infusions several effects occurred which are likely
to affect calcium excretion: hypercalcaemia, an increase in plasma
calcium-chelate concentration, acidosis and a reduction in GFR. In
this experiment plasma ultrafiltrable calcium concentration was
raised 2-3 fold and so the filtered load of calcium was greatly
increased. This would cause hypercalciuria. Since a large part of
the increased filtered calcium load was in the form of non-ionized
complexes, tubular reabsorption of filtered calcium would have been
greatly depressed, so enhancing calcium excretion. These two
effects almost certainly account for the bulk of the observed
increase in calcium excretion.
Additionally, acidosis promotes the excretion of calcium in the
sheep (Stacy, 1969; Stacy et al, 1970) although any effect produced
in this way was probably relatively insignificant. During the post
infusion period GFR, as measured by the endogenous creatinine
clearance, was significantly reduced. This effect has been clearly
demonstrated in the dog (Edwards, Sutton and Dirks, 1974; Lins,
1979) and may result from increased renal vascular resistance
(Frohlich, Scott and Haddy, 1962). Though decreased GFR might be
expected to decrease calcium excretion, it seems to have been of
little significance during this experiment.
Since borogluconate complexes calcium so strongly, by promoting
the renal excretion of calcium it might cause hypocalcaemia. In
accordance with this expectation, sheep given sodium borogluconate
by subcutaneous injection showed significant reductions in total
plasma calcium.
Following the intravenous infusion of calcium borogluconate in
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sheep, alterations in urinary pH, calcium excretion and GFR did not
reach significance until the post infusion period. This was
probably a result of dead space in the urinary bladder and
collection apparatus, since the extremely variable urine flow rate
and the volume of the catheter and tubing would account for delays
in collection of approximately 5-40 minutes.
Intravenous infusion of calcium borogluconate in sheep was
followed by a decrease in plasma magnesium. Though the increase in
magnesium excretion observed during these infusions was not
significant (P<0.09), hypermagnesuria and hypomagnesaemia may
result from an increase in filtered calcium load causing
competitive depression of the renal tubular reabsorption of
magnesium (Samiy et al, 1960; Massry et al, 1969; Quamme et al,
1980). However since complexing agents which complex calcium
almost invariably also complex magnesium, hypomagnesaemia may also
result from the formation and elimination of
magnesium-borogluconate complexes. Although clear evidence
supporting this suggestion is lacking, the possibility merits
further investigation.
If the hypomagnesaemia associated with calcium borogluconate
infusion was the result of calcium and magnesium competing for
renal tubular reabsorption, it seems likely that the administration
of magnesium salts might be followed by hypocalcaemia. Various
studies have demonstrated this effect (Kelly et al, 1960; Kemeny et_
al, 1961; Pors Nielsen, 1970). The possibility that sheep might
also show this effect was briefly investigated. Four animals were
used in a cross over experiment, the experimental protocol and
results are shown in figure 5.6. Administration of magnesium
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Figure 5.6 The effect of administering magnesium chloride on total
plasma calcium and magnesium concentrations in four sheep. At time
0.0 hrs. 150 ml of solution (pH 7.40, 10% w/v) was administered by
subcutaneous injection. Plasma concentrations were compared with
their pre-administration levels: *, P,0.02; **, P<0.01, ***,
P<0.005.
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associated with hypocalcaemia (P<0.01). Clearly the result
supports this hypothesis.
In this chapter evidence is presented showing that borogluconate
is a powerful calcium complexing agent in vitro and in vivo.
Though the scope of this work does not extend to a clinical
appraisal of calcium borogluconate, these findings suggest that the
clinical efficacy of calcium borogluconate is likely to differ from
that of more completely ionized calcium salts. This study suggests
that clinical comparisons of calcium borogluconate with more




THE BINDING OF CALCIUM AND MAGNESIUM BY ETHANE-1-HYDROXY-l,1-
DIPHOSPHONATE (EHDP) IN VITRO AND IN VIVO. ITS EFFECT ON
PLASMA AND URINARY CALCIUM AND MAGNESIUM IN THE SHEEP
Summary
1. Calcium and magnesium binding by EHDP was studied in vitro using
divalent cation selective electrodes and ultrafiltration. EHDP was
then infused intravenously into sheep. Blood was collected every
half hour and urine for periods of one hour, before, during and
after the infusion. Total, ultrafiltrable and ionized calcium, and
total and ultrafiltrable magnesium concentrations were determined
in plasma. Endogenous creatinine clearance and the urinary
excretion of calcium, magnesium, sodium, potassium and hydrogen ion
were measured.
2. In vitro EHDP added to calcium or magnesium containing solutions
caused a decrease in ultrafiltrable and ionized calcium and
magnesium concentrations. The decrement in the ultrafiltrable
fraction was very similar in both plasma and saline of similar
ionic composition.
3. Addition of EHDP to blood in vitro also depressed ionized
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calcium concentration, the effect was similar to the effect of
pyrophosphate but greater than the effect of EDTA.
4. These studies showed that in vitro EHDP complexed both calcium
and magnesium. The decrease in plasma ultrafiltrable calcium and
magnesium seemed to be the result of agregation of complexes and
not the result of protein binding of EHDP-divalent cation
complexes.
5. Intravenous infusions of EHDP into sheep resulted in:
(i) increased total plasma calcium concentrations;
(ii) decreased ultrafiltrable plasma calcium and magnesium
concentrations;
(iii) decreased ionized plasma calcium concentration;
(iv) increased urinary calcium excretion which was primarily due
to an increase in the non-ultrafiltrable fraction and was not
associated with a change in endogenous creatinine clearance;
(v) increased urinary non-ultrafiltrable magnesium excretion
whilst total excretion did not change significantly;
(vi) increased renal excretion of hydrogen ions.
6. These observations indicate calcium and magnesium complex
formation in vitro and in vivo. Since the complexes formed were
only partially ultrafiltrable, and since EHDP infusion resulted in
hypercalcaemia, it seems likely that the clearance of EHDP is less
than other ligands, such as EDTA, whose clearance is equal to GFR.
132
Introduction
Several studies have been carried out which show that
diphosphonates complex calcium (Carroll and Irani, 1968;
Grabenstetter and Cilley, 1971). Large aggregates were produced,
the maximum overall EHDP:calcium binding ratio was found to be
1:1**75 . Wiers (1971) demonstrated the formation of large complexes
of the order of 10^ Daltons and with approximate radii of 2.6 nm.
However these studies were carried out at pH 11 and at non
physiological calcium concentrations. The extent to which these
results can be extrapolated to studies in vivo is not clear.
Bisaz et al (1978) showed that 32p-pyr0ph0Sphate an(i various
diphosphonates, including l^C-EHDP, were partly non-ultrafiltrable
in plasma. It was not clear whether this effect was due to protein
binding, or the formation of large complexes.
Complex formation by EHDP was examined in plasma and in
artificial solutions. EHDP infusions were then made in sheep to
examine binding in vivo.
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Methods and Results
1. The ionization of calcium and magnesium in solutions
containing EHDP
Methods
Aqueous solutions containing 15 mM tris-HCl (pH 7.40), and 21.2 or
39.6 micro-mol EHDP (donated by Proctor and Gamble Ltd) in 40 ml
were titrated with 0.80 M MgCl2 or o.80 M CaCl2 in 15 mM tris.
This was carried out in a 50 ml beaker on a magnetic stirrer. Ionic
divalent cation activities were measured using the Orion divalent
ion electrode.
Intersections of the asymptotes of titration curves (such as
those in figures 6.1 and 6.2) with the abscissa indicates the
theoretical maximum amount of cation bound by each amount of EHDP.
Since in the present investigation EHDP was never saturated by
divalent cation, rather than attempting to extrapolate the data to
indicate theoretical maxima, lines of gradient 1.0 were drawn to
indicate the maximum cation bound during each titrations. Thus the
values indicated by such a manouvre in fact represent binding
ratios which are likely to be less than the theoretical maxima.
Results
The maximum volume of calcium or magnesium added to the initial
volume (40 ml) was 0.12 ml. Figure 6.1 shows that at the start of
the titration nearly all added calcium was not ionized whereas at
the end, increments in total and ionized calcium were almost equal.
Doubling the concentration of EHDP had the effect of shifting the
inflexion of the curve to the right, thus the maximum amount of
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calcium bound was increased. Magnesium showed very similar effects
(figure 6.2). At the maximum titres of magnesium or calcium, 44.3
micro-mol calcium or 36.9 micro-mol of magnesium were non-ionized
in the presence of 21.2 micro-mol EHDP. With 39.6 micro-mol EHDP,
72.5 micro-mol calcium, or 65.7 micro-mol of magnesium were non-
ionized. These figures represent binding ratios of 1.7—2.1.
The Scatchard Plot can be used to obtain values for
binding ratios.When the data are plotted in this way the
points fall on a straight line.The binding ratios were
2.26 for calcium and 1.83 for magnesium.
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Figure 6.1 Active calcium, measured by the divalent cation
electrode, during titration of 21.2 micro-mol (closed circles) or
39.6 micro-mol (triangles) EHDP in 40 ml of tris buffer, with 0.80
M calcium chloride. The intersection of the dashed lines (of
gradient 1.0) and the x-axis indicates the maximum calcium bound by
each amount of EHDP. Each point is a mean and standard error of
four observations.
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Figure 6.2 Active magnesium, measured by the divalent cation
electrode, during titration of 21.2 micro-mol (closed circles) or
39.6 micro-mol (open circles) EHDP in 40 ml of tris buffer, with
0.80 M magnesium chloride. The intersection of the dashed lines (of
gradient 1.0) and the x-axis indicates the maximum amount of
magnesium bound by each amount of EHDP. Each point is a mean and
standard error of four observations.
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2. Ultraftitrable calcium and magnesium in solutions containing
EHDP
Methods
Solutions were prepared containing 150 mM NaCl, 0.53 mM EHDP, 4.0
mM KC1, 15 mM tris-HCl (pH 7.40) and either MgC^ Qr CaCl2 at 0-2
mM. These solutions were ultrafiltered and total magnesium or
calcium concentrations measured in ultrafiltrates.
Results
Figure 6.3 shows that only part of the calcium and magnesium in the
solutions was ultrafiltrable (P<0.001). Over the studied EHDP
concentration ranges, the proportion of the total calcium and
magnesium which was ultrafiltrable was remarkably constant (47.3 +
2.3% n = 7) and (81.7 + 0.9% n = 7) respectively.
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total mM
Figure 6.3 Ultrafiltrable calcium (closed circles) or magnesium
(open circles) in solutions containing 0.53 mM EHDP and varying
concentrations of either calcium or magnesium. The expected line,
if ultrafiltrable and tot^l concentrations were equal, is shown
dashed. Each point is a mean and standard error of four
observations.
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3. Comparison of the ultrafiltrable calcium and magnesium
fractions in plasma and in soiutions
Methods
Portions (12, 24 or 36 micro-1) of 160 mM EHDP solutions were put
in 5 ml syringes which were then filled to the mark with
heparinised sheep plasma. The final EHDP concentrations were 0.38,
0.77 and 1.15 mM. The plasma was ultrafiltered and calcium and
magnesium concentrations in ultrafiltrates measured as described in
Chapter II. Solutions were then made up containing 150 mM NaCl, 4.0
mM KC1, 15 mM tris-HCl (pH 7.40) and calcium and magnesium at
concentrations equal to those previously determined in plasma
ultrafiltrates. These solutions were ultrafiltered in triplicate.
Results
In this experiment the maximum dilution produced by the addition of
EHDP to plasma was 0.7%. The solutions for comparison with plasma
contained 1.53 mM CaCl^ ancj 0.690 mM MgCl£. Figure 6.4 shows that
at every EHDP concentration, ultrafiltrable calcium concentration
and was the same in plasma as in artificial solutions; similarly
for magnesium.
The ultrafiltrable magnesium concentration in plasma containing
EHDP, at 0.77 and 1.15 mM, was lower than in plasma containing no
EHDP (P<0.01). The effect of EHDP on ultrafiltrable calcium was
larger, significant decreases were observed at all three




Figure 6.4 The effect of EHDP concentration on plasma
ultrafiltrable calcium and magnesium (open circles) compared with
the effect of EHDP concentration on ultrafiltrable calcium and
magnesium in saline solutions of similar ionic composition (closed
circles). Each point is a mean and standard error of four
observations.
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4. The reduction in ionized and ultrafiltrable plasma calcium
concentrations after the addition of EHDP
Methods
Portions (12, 24 or 36 micro-1) of 160 mM EHDP solutions were put
in 5ml syringes, which were then filled to the mark with
heparinised sheep plasma. Ionized calcium was determined with the
Nova-2 analyser and the remaining plasma ultrafiltered in
duplicate. Calcium and magnesium were measured in the
ultrafiltrates.
Results
Addition of EHDP to plasma (table 6.1) caused a reduction in
ultrafiltrable and ionized calcium at all three EHDP
concentrations. Approximately 70-80% of the non-ionized calcium
was also non-ultrafiltrable. The decrements in ionized and
ultrafiltrable calcium only differed significantly at the highest
EHDP concentration (1.15 mM) (P<0.05).
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Table 6.1
Comparison of the reduction in ultrafiltrable and ionized
calcium produced by the addition of EHDP to plasma
Final Reduction in Reduction
[EHDP] ultrafiltrable in ionized
calcium calcium
mM mM mM
0.38 0.27 + 0.03 (3) 0.40 + 0.08 (3) ns
0.77 0.46 + 0.08 (3) 0.58 + 0.01 (3) ns
1.15 0.66 + 0.05 (3) 0.80 + 0.02 (3) P<0.05
The figures are mean + standard error (number of observations).
Comparisons were made between the ultrafiltrable and ionized
fractions at each EHDP concentration. The ultrafiltrable and
ionized calcium concentrations in untreated plasma were 1.53 mM and
1.19 mM respectively.
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5. The effect of EHDP, pyrophosphate and EDTA on ionized calcium
in plasma
Methods
Syringes (2 ml) containing aliquots of 0, 0.01, 0.02, to 0.1 ml of
60 mM EHDP were filled to the 2 ml mark with heparinised sheep
plasma, ionized calcium was then measured. On separate occasions
the experiment was repeated using either 60 mM tetrasodium
pyrophosphate, or 60 mM EDTA.
Results
The effects of EHDP and pyrophosphate on ionized calcium (figure
6.5) were similar. EDTA complexes calcium in the ratio 1:1 and had
a significantly smaller effect on ionized calcium at the lower
concentrations, but a greater effect at the highest concentrations.
Increasing EDTA concentration was associated with an almost linear
fall in ionized calcium, whereas EHDP and pyrophosphate showed
distinctly non-linear relationships with ionized calcium.
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complexing agent mM
Figure 6.5 The effect of some ligands on ionized calcium in plasma.
Each point is a mean and standard error of four observations.
Untreated plasma contained 1.20-1.22 mM calcium.
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6. The effect of EHDP infusions in sheep on urinary and plasma
calcium and magnesium fractions
Methods
Four sheep were equipped with urinary and jugular venous catheters.
The pH of EHDP (4% w/v) was adjusted to 7.40 with sodium hydroxide,
this gave an approximately isotonic solution. Intravenous infusion
of sodium chloride solution (0.9% w/v) was made during two hour
control periods before and after EHDP infusion. EHDP was infused at
a priming dose of 2.5 micro-mol min-^kg-^ for half an hour followed
by a maintenance dose of 0.7 micro-mol min~lkg~l for two hours.
EHDP solution was diluted as required with saline so as to maintain
a constant infusion rate of 1.2 ml min~l. Blood samples were
collected every 30 minutes, urine was collected for 60 minute
periods except for the 30 minute period during administration of
the priming EHDP dose.
Results
During EHDP infusion, total plasma calcium concentration increased
(figure 6.6; P<0.01) whilst ionized calcium decreased (P<0.02). As
a % of the total, plasma ultrafiltrable calcium decreased (P<0.05).
Total plasma magnesium concentration did not change significantly
(figure 6.7), but was significantly correlated with total calcium
(r=0.667, P<0.001). Ultrafiltrable magnesium concentration (as % of
total) decreased (P<0.05).
Total urinary calcium excretion increased (P<0.01; figure 6.8).
The increment was entirely due to the non-ultrafiltrable fraction
(P<0.01), since the ultraf'iltrable fraction did not change
significantly. The excretion of non-ultrafiltrable urinary
146
magnesium also increased (P<0.001). In this case the increment was
a result of a combination of a non-significant increase in total,
and a non-significant decrease in ultrafiltrable magnesium
excretion. GFR, as measured by endogenous creatinine clearance did
not change, and neither did sodium or potassium excretion (table
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Figure 6.6 The effect of EHDP infusions in four sheep on the
concentration of total (closed circles), ultrafiltrable (triangles)
and ionized (open circles) plasma calcium. EHDP was infused at 7
micro-mol rain-■'•kg--'- for 120 minutes (shown dotted), following a 30
minute priming infusion of 25 micro-mol min^kg-^. Values were
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Figure 6.7 The effect of EHDP infusions in four sheep on the
concentration of total (closed circles) and ultrafiltrable
(triangles) plasma magnesium. EHDP was infused at 7 micro-mol
min ^Kg ^ for 120 minutes (shown dotted), following a 30 minute
priming infusion of 25 micro-mol min ^"Kg Values were compared
with their pre-infusion controls: *,P<0.05.
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Figure 6.8 The effect of EHDP infusions in four sheep on the hourly
excretion of total and ultrafiltrable calcium and magnesium. EHDP
was infused at 7 micro-mol min ^"Kg ^ for 120 minutes (shown
dotted), following a 30 minute priming infusion of 25 micro-mol
min ^Kg Total and non-ultrafiltrable values were compared with




The effect of EHDP infusion in the sheep on the excretion
of sodium, potassium and H"^, and GFR
Collection
period
Sodium Potassium -1+ GFR
hours mmol hr -1 mmol hr" nmol hr-1 ml min'-1
Control
5.6 + 1.9 12.2 + 5.7 0.93 + 0.41 93 + 12
5.2 + 1.6 8.0 + 3.5 0.74 + 0.29 86 + 26
0-1
1-2
EHDP infusion rate: 25 micro-mol kg ^min \
2-2.5 9.7 + 3.4 9.4 + 5.1 1.05 + 0.33 80 + 10
EHDP infusion rate: 7 micro-mol kg~^-min~^
2.5-3.5 10.7+3.1 10.2+3.2 *5.08+1.48 74+6
3.5-4.5 6.0 + 2.0 9.5 + 1.4 3.96 + 1.95 72 + 15
Post-infusion period
2.9+1.1 8.7+1.9 1.81+0.44 82+8
3.7 + 0.5 8.4 + 1.9 1.86 + 0.57 75 + 11
4.5-5.5
5.5-6.5
Each figure is a mean + standard error of four observations. The





Evidence presented by Bisaz et al (1978) showed that EHDP in plasma
was partly non-ultrafiltrable through filters with a cut off point
of 50,000 Dal tons. They did not show whether this was due to
protein binding or the formation of large complexes.
In the present study EHDP was found to form non-ultrafiltrable
non-ionized complexes with calcium and magnesium in vitro. EHDP
reduced ultrafiltrable calcium and magnesium to the same extent in
plasma as in protein free artificial solutions. It seemed,
therefore, that the effect of EHDP on calcium and magnesium binding
was the result of the formation of large non-ultrafiltrable
aggregates and not protein binding of EHDP-divalent cation
complexes.
The non-ultrafiltrable nature of calcium and magnesium in the
presence of EHDP might have been due to adsorption of EHDP-divalent
cation complexes by visking tubing. This hypothesis was rejected
following hot ashing of strips of visking tubing which had been
soaked in EHDP-Ca-Mg solutions. The ash calcium and magnesium
content was no greater than would be expected as a result of the
water content of the visking tubing.
In this study EHDP seemed to complex calcium more strongly than
magnesium. This was suggested by ionic determinations in
solutions; for a given titre of calcium or magnesium the former ion
was more completely bound (comparison of figures 6.1 and 6.2). In
ultrafiltrates prepared from aqueous solutions, or from plasma,
considerably more of the calcium was non-ultrafiltrable than was
152
magnesium. However despite the apparently greater affinity of EHDP
for calcium, magnesium binding occurred to a significant extent
both in vitro and during EHDP infusions.
Since EDTA complexes calcium stoichiometrically it was used in
experiment 5 to sequester specific amounts of plasma calcium.
This indicated the reduction in plasma calcium associated with
chelation of specific amounts of plasma calcium,in the presence
of the buffering ability of plasma proteins, xhus figure 6.5
shows that the calcium binding ratios of EHDP and pyrophosphate
were both greater than 1:1 (the ratio for EDTA). Figures 6.1 and
6.2 also indicate that in buffered solutions the amount of non-
ionized calcium or magnesium reached maxima approaching twice the
amount of EHDP present. This suggested maximum binding ratios
similar to the ratio of 1.75 proposed by Grabenstetter and Cilley
(1971).
The similarity between calcium binding by pyrophosphate and EHDP
in whole blood suggests that pyrophosphate, like EHDP, forms large
aggregates. Little evidence on this point exists in the literature
although Bisaz et al (1978) showed that calcium-^^mTc-pyrophosphate
was not completely ultrafiltrable. This might have been due to the
formation of large aggregates.
Although EHDP clearly formed large, non-ultrafiltrable calcium
and magnesium complexes in plasma, it was not certain whether or
not these complexes would be filtered by the glomerulus. The pore
radius of visking tubing is 1.3-1.9 nm (Renkin, 1954; Durbin, 1960),
slightly smaller than the estimated radius of the calcium-EHDP
aggregates (2.6 nm; Wiers, 1971). The glomerular pore size has not
been estimated in the sheep', however in most species molecules
larger than about 70,000 Daltons are not filtered. Thus although
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the complexes may be too large to be readily ultrafiltered by
visking tubing, their molecular weight (of the order of 10,000
Daltons) would suggest that they probably pass through the
glomerulus.
Such large particles almost certainly flow less readily through
the glomerular membrane than smaller ones. This phenomenon is well
recognised, and has been used to estimate the pore size of
artificial membranes. Particles undergoing ultrafiltration are
subject to resistance in proportion to their size. Dextran
infusions in dogs have been used to demonstrate the relationship
between filtered fraction and molecular weight over the range
10,000-70,000 Daltons (Giebisch, Lauson and Pitts 1954). In a
similar way large EHDP aggregates are probably subject to
considerable resistance as they pass through the glomerular filter.
If large partially filtrable complexes are formed in blood then
this would explain why the EHDP clearance was only 27% of the
simultaneous creatinine clearance (Hughes et al, 1977).
In vivo
EHDP has been found to cause acidosis in nephrectomised rats, but
not in intact animals (Goulding and Broom, 1979). It was suggested
that the effect was related to inhibition of bone resorption. The
increased H"1" excretion observed during EHDP infusions in sheep may
have resulted from similar mechanisms, however since the present
observations were made in intact animals a different mechanism may
be involved.
The changes observed in plasma calcium and magnesium fractions
during EHDP infusion suggest the formation of large non-
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ultrafiltrable complexes which are not available for renal tubular
reabsorption. Thus, hypercalciuria may have been due to glomerular
filtration of some of these aggregates. The fact that EHDP infusion
also brought about a large increase in the non-ultrafiltrable
fractions of urinary calcium and magnesium is consistent with
glomerular filtration of calcium and magnesium complexes.
Comparison of the data collected during intravenous EDTA
(Chapter IV) and EHDP infusions shows differences which can be
explained on the basis of the formation of poorly filtered EHDP
aggregates. Though such uncontrolled comparisons must be treated
cautiously, they certainly suggest a low renal clearance of EHDP.
The experiments were carried out using identical protocols and
doses of EDTA and EHDP (mol kg-!). Hypercalcaemia was observed with
EHDP and not with EDTA. This is likely to be due to an accumulation
of calcium-EHDP complexes in blood resulting from a relatively low
renal clearance of EHDP. Additionally, EDTA caused a larger
increment in urinary calcium excretion (3.05 + 0.39 mmol hour-!)
than did EHDP (1.72 + 0.48 mmol hour-!) though the difference was
not significant (P<0.09). However if EHDP was excreted by
glomerular filtration, as EDTA is known to be (Forland et al 1966),
it would be expected that EHDP would cause the greater increase in
calcium excretion since it binds almost twice as much calcium per
mole as does EDTA. Furthermore, the animals infused with EDTA had
considerably lower GFRs than those treated with EHDP. Again, this
would result in lower calcium excretion following EDTA
administration. Thus it seems likely that EHDP-calcium complexes
are only partially filtered by the glomerulus.
Equally, the discrepancies between these two sets of data could
be explained by tubular reabsorption of EHDP. This seems less
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likely in view of the large size of the EHDP aggregates and their
large electrical charge (Wiers, 1971).
In order to further verify that EHDP complexes are partially
non-filtrable, it is clearly essential to estimate EHDP in plasma
and urine. Unfortunately the only method available (Bisaz, Felix
and Fleisch, 1975) requires the use of l^C-EHDP to correct for the
large losses inherent in the method. The labelled EHDP was not
available and cannot be readily synthesised. It was attempted to
determine EHDP in urine as the difference between the inorganic
phosphate as measured before and after ashing urine samples in the
presence of sodium hydroxide. This method gave excellent recovery
of orthophosphate or EHDP added to urine, however the agreement
between unadulterated urine with and without ashing was
unsatisfactory.
To summarise: EHDP has been shown to form large calcium and
magnesium complexes in vitro and in vivo. These complexes are
eliminated by the kidney so producing hypercalciuria and
hypermagnesuria. The presence of non-ultrafiltrable calcium and
magnesium in plasma and urine indicates that the complexes formed
probably pass through the glomerulus. However the extent of the
hypercalciuria (compared to that induced by EDTA), and the
concomittant hypercalcaemia would support the contention that the
clearance of these complexes is less than the GFR.
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CHAPTER VII
THE EFFECTS OF CHRONIC ETHANE-I-HYDROXY-1,1-DIPHOSPHONATE (EHDP)
ADMINISTRATION ON THE EXCRETION OF CALCIUM AND
MAGNESIUM BY SHEEP AND HORSES
Summary
1. EHDP was administered to horses (4 mg kg-lday~l by subcutaneous
injection, or 25 mg kg-lday~l per os) for four days. Blood was
collected daily, and 24 hour collections of urine and faeces made.
Total and ultrafiltrable calcium and magnesium concentrations were
determined in plasma. Endogenous creatinine clearance was also
measured. 24 hour faecal calcium and magnesium excretions were
measured as total after ashing, and total and ultrafiltrable
fractions of faecal water calcium.
2. The two dosage regimes had similar effects on measured
variables, allowing the data to be pooled. EHDP did not
significantly affect plasma calcium or magnesium plasma fractions,
or urinary or faecal magnesium excretion. However the urinary
excretion of calcium was increased.
3. EHDP produced significant reductions in 24 hour faecal water.
The total and ultrafiltrable faecal water calcium fractions were
also reduced, whilst total faecal calcium remained unchanged.
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4. Since endogenous creatinine clearance was reduced and
ultrafiltrable plasma calcium unchanged, the increment in calcium
excretion was thought to be due to decreased renal tubular
reabsorption. The effect was too great to be merely due to
filtration of calcium-EHDP complexes, possible mechanisms were
discussed.
5. Preliminary studies in the sheep, in which measurement of
urinary [Ca]/[cr] and [Mg]/[cr] ratios were made, suggested that
EHDP (4 mg kg-lday"! by subcutaneous injection) had a similar
effect on urinary calcium to that observed in the horse.
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Introduction
In Chapter VI evidence was presented which demonstrated that EHDP
complexes calcium and magnesium. It was suggested that the
hypercalciuria observed following intravenous EHDP was the result
of filtration of calcium complexes. In those experiments a large
dose of EHDP (40 mg kg~l) was administered over two and a half
hours. This dose is much in excess of that at which EHDP has
pharmacological actions (Gasser et al, 1972). In man EHDP has
beneficial effects in Pagets disease at doses as low as 5 mg kg""-'-
orally (Altman, Johnstone, Khairi, Wellman, Serafini, and Sankey,
1973). Thus, in this chapter the effect of lower doses of the drug
was studied.
The dose rates chosen were 4 mg kg~lday~l by subcutaneous
injection, or 25 mg kg~lday~l per os. The 4 mg kg-lday~l dose of
EHDP was selected on the basis of its known pharmacological action
in cattle (Yarrington et al, 1977b). The extent to which EHDP is
absorbed by the gastro-intestinal tract in sheep and horses is not
known. Michael et al (1971) estimated that in other species
absorption lay in the range 1-15%, higher estimates being obtained
from young animals. This range is clearly too large to enable a
directly comparable dose to be given per os. Based on these figures
a dose of 25 mg kg~l was chosen as being unlikely to result in an
absorbed dose greater than 4 mg kg-l.
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Methods and Results
1. The effects of EHDP (4 mg kg~lday~l by subcutaneous injection
or 25 mg kg~lday~l per os) on plasma, urinary and faecal
calcium and magnesium in the horse
Methods
The pH of EHDP solution for subcutaneous injection was adjusted to
7.40 with sodium hydroxide, it was then made approximately isotonic
by dilution to give a 4% (w/v) solution. Orally administered EHDP
was mixed with sucrose syrup (20 ml, 40% w/v) into which was
stirred bran and rolled oats (50 gms, 50/50 w/w).
Orally administered EHDP was fed at 9.00 am each day before the
morning hay ration. Parenterally administered drug was divided, 2
mg kg-l was given at 9.00 am and again at 5.00 pm. Initially
inflammation frequently followed injection of the drug. In an
attempt to aid absorption and so minimise this effect,
hyaluronidase (750 i.u., Hyalase, Fisons Ltd) was added and each
dose was further divided and given at two sites. Despite these
precautions subcutaneous administration of diphosphonate was still
occasionally accompanied by an inflammatory reaction. For this
reason in subsequent experiments the drug was administered orally.
Seven experiments were carried out in five male ponies. Control
experiments consisted of three 24 hour collections of urine and
faeces, and twice daily jugular venous blood samples (9.30 am and
4.30 pm). Two weeks later EHDP administration started, after 24
hours a second three day period of collection commenced. EHDP was
administered until the end of the experiment. The two ponies which
were used twice were allowed 19 weeks between the two experiments.
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Ponies were restrained in stalls in which 24 hour faecal and
urine collections were made by methods routinely used in this
laboratory. Faeces were collected by means of an apron held closely
under the pony's tail which directed the faeces into a plastic bin
at the rear of the stall. Urine was collected via a large rubber
funnel suspended below the pony's abdomen. This delivered urine
along a large bore plastic tube into a polythene water carrier
situated in a sump below ground level. These devices were attached
to the pony by means of a webbing harness and surcingle (Warwick,
1966).
Results
During each 3 day collection period in each animal, since measured
variables did not change significantly, means for each variable
were calculated so improving precision. Data from the two dosage
regimes were then pooled since there were no significant
differences between results obtained with either method of
administration.
No significant changes in the concentrations of the plasma
fractions of calcium or magnesium occurred during the experiment
(table 7.1). The 24 hour urinary excretion of calcium increased
following EHDP administration (P<0.01; figure 7.1) but magnesium
excretion did not change significantly. Compared with control,
urine volume did not change significantly (control, 2.16 + 0.18 1
24~1 hours; EHDP, 2.44 + 0.13 1 24 hours-!) whilst GFR decreased
(P<0.05: control, 247 + 26 ml min-!; EHDP, 192 + 19 ml min-!).
Total 24 hour faecal calcium was unaffected by EHDP, but small
reductions occurred in both the 24 hour total faecal water calcium
(P<0.01) and ultrafiltrable faecal water calcium (P<0.02; figure
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7.2). Total 24 hour faecal water was also reduced (P<0.05; figure
7.3) and was reflected in similar changes in faecal weight. The %
decrease in faecal water was significantly correlated with both
faecal water calcium (P<0.05) and with ultraftitrable faecal water
calcium (P<0.05; figure 7.4).
Table 7.1
The effect of EHDP (4 mg kg~J-day~^- by subcutaneous injection,
or 25 mg kg~lday~l per os) on plasma calcium and
magnesium in the horse
mM Control
[CaJ total 2.69 + 0.08
^Ca^ultrafiltrate 1»51 + 0.05
[Mg]total 0.62+0.03
ultrafiltrate 0.46 + 0.03
EHDP
(7) 2.75 + 0.06 (7) ns
(6) 1.58 + 0.03 (7) ns
(7) 0.65 + 0.02 (7) ns
(6) 0.50 + 0.02 (7) ns
The results are expressed as mean + standard error (number of
observations). Values were compared with their respective controls.
The data for the two dosage regimes were pooled since there were no












F igure 7.1 The effect of four days administration of EHDP (4 mg
k.g~tday~l by subcutaneous injection, or 25 mg kg-lday-l per os) on
the 24 hour urinary excretion of calcium and magnesium in the


































Figure 7.2 The effect of four days administration of EHDP (4 mg
kg~lday~l by subcutaneous injection, or 25 mg kg-^day-^ per os) on
24 hour total, liquid phase and ultrafTitrable liquid phase faecal
calcium and magnesium in the horse. Each bar is a mean and standard









Figure 7.3 The effect of four days administration of EHDP (4 mg
kg^day"! by subcutaneous injection, or 25 mg kg~^day~f per os) on
24 hour faecal wet weight and faecal water in the horse. Each bar
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Figure 7.4 The relationship between % change in faecal water and %
change in both 24 hour faecal water calcium (open circles), and
faecal water ultrafiltrable calcium (closed circles), resulting
from EHDP administration (4 mg kg-^day-^ by subcutaneous injection,
or 25 mg kg-lday~l per os) for four days.
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2. The effects of EHDP (4 mg kg~J-day~J- by subcutaneous injection)
on urinary creatinine (cr) concentration, [Ca]/[cr] and
[Mg]/[cr], and plasma calcium and magnesium in sheep
Methods
Four sheep were equipped with indwelling fbley urinary catheters
then restrained in crates. Blood samples were drawn into
heparinised syringes via jugular puncture at 2.00 pm each day.
Urine was collected in plastic urine collection bags via indwelling
balloon catheters. Control collections were made for three days,
then administration of EHDP (4% w/v pH 7.40; 4 mg kg-lday~l by
subcutaneous injection) commenced and continued for a further three
days. The experiment was designed to detect sustained rather than
transient effects on plasma calcium and magnesium and so EHDP was
administered immediately after blood sampling. Thus it was hoped to
avoid the acute hypercalcaemia that might result from high EHDP
blood concentrations, as described in Chapter VI.
Results
No changes in total plasma calcium or magnesium concentration were
observed (table 7.2). Urinary creatinine concentration did not
change, but [Ca]/[cr] increased (P<0.03); likewise [Mg]/[cr]
increased (P<0.01). For comparative purposes table 7.3 also
includes creatinine concentrations and ratios calculated from the
data obtained in the horse.
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Table 7.2
The effect of EHDP (4 mg kg~^day"^- by subcutaneous Injection)
dally for three days on total plasma calcium and
magnesium concentrations In sheep
Control EHDP
[Ca] mM 2.29 + 0.03 (4) 2.39 + 0.07 (4) ns
[Mg] mM 0.729 + 0.035 (4) 0.700 + 0.055 (4) ns
Each value is a mean + standard error (number of animals).
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Table 7.3
Comparison of the effect of EHDP on urinary creatinine
concentration, and calcium and magnesium
creatinine ratios in the sheep and horse
creatinine mM
Control EHDP %change
Sheep 4.94 + 0.68 (4) 5.51 + 0.65 (4)





2.64 + 0.78 (4) ***3.63 + 0.62 (4) +38%
2.26 + 0.32 (7) **3.31 + 0.43 (7) +46%
Molar ratio; [Ca]/[cr]
Control EHDP %change
Sheep 0.26 + 0.11 (4) *0.77 + 0.15 (4) +196%
Horse 2.34 + 0.21 (7) **6.76 + 1.14 (7) +189%
Each value is a mean + standard error (number of observations).
Values obtained during EHDP administration were compared with
controls: *, P<0.03; **, P<0.02; ***, P<0.01. Where significant




The decreased faecal water calcium observed in the horse might have
been due to formation of calcium-EHDP precipitates in the gut.
However this seems unlikely since insufficient drug was
administered to account for an effect of the observed magnitude.
Additionally, the gut concentration of EHDP would be very different
after oral or subcutaneous administration, yet the effect on the
excretion of faecal water calcium was the same in both cases.
The state of calcium in horse faeces does not seem previously to
have been investigated. However, if faeces are normally saturated
with respect to calcium, then a reduction in faecal water might
result in precipitation of calcium salts and a reduction in total
and ultrafiltrable faecal water calcium excretion whilst total was
unchanged. This could also account for the observed correlation
between faecal water and faecal water calcium.
Alternatively, since the calcium in gut water is probably more
readily absorbed than the component associated with the solid
phase, changes in calcium absorption might be more readily
reflected in this fraction. Thus the change in faecal calcium may
be a consequence of increased intestinal calcium absorption,
perhaps associated with the concurrent hypercalciuria. Evidence in
the rat suggests that EHDP (4 mg kg-^-day--'- by subcutaneous
injection) increases intestinal calcium absorption (Gasser et al,
1972). Balance studies are required to confirm this possibility.
The decrease in GFR observed following EHDP administration to
horses has no direct precedent in the literature. Although the
ponies showed no clinical signs of abnormality it is possible that
changed renal function reflected a mildly toxic action on the
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kidney. In the cat oral EHDP at 50 or 500 mg kg-1 produced
inflammation of both interstitial and tubular elements of the
kidney though no effects were seen at lower doses (Jowsey, Holley
and Linman, 1970). No such effects have been reported in other
species except at very high doses (Nixon, Buehler and Newman,
1972). These reports showed an effect on the tubular elements
rather than on the glomerulus.
In the experiments in the sheep complete 24 hour collection of
urine was not possible because of intermittent leakage of urine
past the catheters. These results must therefore be regarded as of
a preliminary nature. However relative changes in excretion may be
detected by expressing the urinary concentration of calcium and
magnesium as creatinine ratios. Creatinine is a product of muscle
metabolism which is produced in proportion to lean body mass. The
daily urinary output is thus approximately constant. In man the
within individual coefficient of variation of 24 hour creatinine
output is 10% (Scott and Hurley, 1968). Though less accurate than
complete 24 hour collections, creatinine ratios provide an
approximate indication of excretion which is independent of urine
volume. Using this method striking similarities in the effect of
EHDP on the percentage increase in urinary calcium excretion were
seen in the two species.
In this study a relatively low dose of EHDP increased urinary
calcium excretion in horses. Since GFR decreased and plasma
ultrafiltrable calcium concentration was unchanged the filtered
load of calcium was probably reduced. Increased calcium excretion
would therefore seem to be due to decreased renal tubular
reabsorption of calcium. The change in urinary [Mg]/[cr] seen in
the horse merely reflected decreased GFR since 24 hour magnesium
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excretion was unchanged. It may be that the change in [Mg]/[cr]
observed in sheep also resulted from decreased GFR.
In the experiments described in Chapter VI it seemed that EHDP
administration resulted in the formation of calcium-EHDP complexes
which were subsequently eliminated by the kidney. The study
described in the present chapter used only 10% of the dose used for
intravenous infusion in sheep, yet calcium excretion increased
without accompanying shifts in plasma calcium fractions.
Calculation shows that, indeed, complexation cannot account for
the magnitude of incremental calcium excretion described in the
present investigation. Thus, the maximum amount of calcium likely
to be excreted in the form of EHDP complexes can be calculated
taking the worst case case where 20% of the administered EHDP is
absorbed (Michael et al, 1972) and then 50% excreted in the urine
(Michael et al, 1972) accompanied by calcium in the ratio 2:1
(Grabenstetter and Cilley, 1971). On this basis, the maximum
increase in 24 hour urinary calcium following the administration of
25 mg kg-!day-! EHDP to a 145 kg pony is 3 mmol 24 hours-!. the
experiments in the horse the increment in urinary calcium excretion
was 34.1 mmol 24 hours-!, ten times the predicted value (P<0.01).
Thus, the increment in urinary calcium cannot be ascribed to
excretion of complexes.
Acidosis depresses renal tubular calcium reabsorption and so
might account for the observed hypercalciuria. In Chapter VI EHDP
was shown to cause a fall in urinary pH, in the present study
acid-base status was not evaluated. Alternatively increased calcium
excretion may have been related to an increase in intestinal
calcium absorption, already suggested as a possible explanation for
the observed changes in faecal water calcium.
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In conclusion, administration of EHDP to horses depresses renal
tubular reabsorption of calcium and thus, despite reduced GFR,
produces hypercalciuria. This action was not merely a result of
filtration of calcium complexes. The excretion of diffusible faecal
calcium was also reduced, in parallel with faecal water.
Observations in the sheep suggest a similar phenomenon. EHDP (4 mg
kg~lday-l) is known to enhance calcium absorption, this phenomenon




EFFECT OF AMMONIUM CHLORIDE INDUCED ACIDOSIS AND
ETHANE-l-HYDROXY-1,i-DIPHOSPHONATE (EHDP) ON
BONE MINERAL IN THE MOUSE
Summary
1. Mice were given ammonium chloride (0.75% w/v), EHDP (0.03% w/v),
or both drugs ad libitum in the drinking water for 290 days. They
were killed, then blood pH and femoral dry weight, defatted weight,
bone fat and content of calcium, magnesium, sodium and potassium
determined.
2. Mice given ammonium chloride developed acidosis. Bone fat and
monovalent cations (per gm of defatted bone) were reduced.
3. The administration of EHDP also resulted in reduced bone
potassium (both as a total and per gm of defatted bone) compared to
the control group. Thus the effects of EHDP and ammonium chloride
on bone mineral were similar.
5. It was concluded that EHDP was unlikely to be of value in
reducing the effect of acidosis on bone.
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Introduction
Goulding and Broom (1979) examined the effect of EHDP on acid base
balance. They found that in nephrectomised rats, but not in intact
animals, EHDP decreased extracellular and intracellular pH. It was
postulated that since EHDP inhibits skeletal mineralisation it may
prevent the buffering of acid loads by bone.
Barzel and Jowsey (1969) administered ammonium chloride to rats
via the drinking water, this induced a significant loss of organic
matrix, bone ash, calcium and phosphorous. Dekanic (1979) found
similar reductions in bone ash following calcium chloride
administration. Though it was not certain how reproducible these
observations might be (Newell et al, 1975), acidosis induced
changes in bone might serve as a long term model for the study of
bone calcium, thus facilitating investigations of the ability of
EHDP to prevent demineralisation.
It was therefore proposed to examine the effects of EHDP on bone
mineral in normal and acidotic mice.
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Methods
Random bred CF1 mice, five months old, were weighed and randomly
allocated to provide four groups of equal size. They were fed on a
standard diet (BP Nutrition No. 1 modified expanded maintenance
diet) containing (w/w) 0.83% calcium, 0.51% phosphorous, and 0.15%
magnesium. Drinking water containing ammonium chloride (0.75%
w/v), EHDP (0.03% w/v) or both drugs was provided ad libitum to
each of three groups. The fourth group which served as the control
received distilled water. The drinking water was provided in
standard plastic water bottles, they were closely checked for leaks
enabling measurement of the water consumption to be made over the
last 70 days of the experiment.
After 290 days the mice were anaesthetised with ether then
exanguinated by incising the axilla through the axillary artery and
vein. The mixed arterio-venous blood which rapidly filled the
incision was drawn into a heparinised syringe. Exposure to air and
subsequent loss of CO2 was minimised by making a deep incision, so
forming a well into which the blood could flow whilst exposing a
small surface area. This procedure usually yielded 0.4-1 ml of
blood. Blood pH was measured as described in the Chapter II, with
the exception that the micro-sampler attachment of the Corning
blood gas analyser was used. This reduced the volume of blood
required to 0.2 ml. Bones were weighed, defatted, weighed again,




Ten deaths occurred during the experiment, all 6 deaths in the
control group occurred on one occasion and were the result of an
air-lock in the water bottle. The cause of the 3 deaths in the
^4C1 group and the 1 death in the EHDP group was thought to be the
same, though this was not certain.
Over the last 70 days of the experiment the water consumption in
the four groups was 2.8 + 0.1 ml mouse-^day-^ (mean + standard
error). The mean weight of the animals was 26.1 gm and so the
calculated daily doses were 15 mmol kg~l ammonium chloride and 30
mg kg-l EHDP.
At both the beginning and end of the experiment, the weights of
the four groups of mice did not differ significantly (table 8.1).
The weight of the control group increased during the course of the
experiment (P<0.05) but none of the other groups showed significant
changes in body weight.
As expected, the administration of ammonium chloride reduced
blood pH compared to either the control (P<0.01) or EHDP treated
groups (P<0.03) (table 8.1). The simultaneous administration of
EHDP and ammonium chloride was also associated with acidosis when
compared with either the control (P<0.002) or EHDP treated mice
(P<0.003). The administration of EHDP had no significant effect on
blood pH in normal mice or mice with ammonium chloride induced
acidosis.
Analysis of variance revealed significant differences in total
bone fat and potassium. It also showed differences in bone sodium
and potassium per gm defatted bone (table 8.3). Treatment with EHDP
reduced total femoral potassium content (P<0.001) (table 8.3)
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compared to the control group. The ammonium chloride and ammonium
chloride plus EHDP mice showed no significant changes from control
in either femoral weight or the total content of any cation. Femur
fat content was reduced by ammonium chloride compared to either the
control (P<0.001) or EHDP (P<0.001) treated groups of animals.
When femoral cation content per gram of defatted bone was
examined (table 8.4) other changes were revealed. Bone potassium
was still significantly reduced by EHDP (P<0.001). Additionally,
ammonium chloride depressed femoral potassium per gm when
administered either with (P<0.001) or without (P<0.01) EHDP.
Ammonium chloride also depressed bone sodium per gm both in the
presence (P<0.001) or absence (P<0.05) of EHDP. Total measured
cations per gram of bone were not significantly altered by any of
the treatments compared to the control.
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Table 8.1
The body weights of mice before and after treatment with EHDP
(0.03% w/v) and ammonium chloride (0.75% w/v), administered
ad libitum In the drinking water for 290 days
Control NH^ci EHDP NH4CI
and EHDP
Initial
body wt. 23.4+1.0 23.5+0.8 21.5+2.1 24.4+1.1
(19) (19) (19) (19)
Final
body wt. 27.7 + 1.7 25.1 + 1.5 *24.0 + 0.6 27.8 + 1.5
8111 (13) (16) (18) (19)
Signif¬
icance of P<0.05 ns ns ns
difference
Figures are means + standard errors (number of observations). The
significance of differences between initial and final weights for
each treatment group is shown in the table. The final weights for
each treatment were also compared with the control group: * P<0.03.
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Table 8.2
The changes in blood pH in groups of mice treated for 290 days
with EHDP (0.03% w/v) and ammonium chloride (0.75% w/v)





Control 7.34 + 0.04 (8)
NH4C1 7.25 + 0.06 (14) PC0.01 P<0.03
EHDP 7.31 + 0.02 (17) ns P<0.03
NH4CI
and EHDP
7.23 + 0.02 (17) PC0.002 ns P<0.003
Figures are means + standard errors (number of observations).
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Analysisof variance ns ns
a>0.88+12PC0.001 249+13ns 6.53+0.31ns 9.39+0. 3ns 1.64+0 13P<0.001
Figuresameans+standarderror .An ly isofvariancewppli dtea hgroupfmeasured variables.Whensignificantdiffer ncesw rthuobservedbetw entr atments,hn-paired- wasappliedtollcombinationsftreatments.Differencesw reobse vedcomparedtrol: P<0.001;andcomparedtEHDPtreat dgroups:,P< .001.
Table8.4
Cationcontent(pergramfdefattedb e)ofhl tursofgroupsfmicet eat d for290dayswithEHDP(0.03%w/v)andammoniumc loride( .75%w/v), administereddlib tumthrinkingwater
NH,ri4^xAnalysisof
andEHDPvariance
Calcium (mmolgm-^) Magnesium (micro-molg ~l) Sodium (micro-molg -1) Potassium (micro-molg ~l) Totalmeasured cations(mmolgm-^ defattedwt)
Control
(13animals) 6.01+0.10 161+3 250+3 49.3+1.4 6.47+0.10
NH,
4CI
(16animals) 5.94+0.08 153+2 *236+6
EHDP




Figuresa emeans+standardrrors.An ly isfv iancew sppli dtoea hgroupfmeasured variables.Wh nsignificantdiffer ceswerethuobs rvedtw entreatments,hun-pairedt- st wasappliedtollcombinationsftreatment .Differe ceswerobservedc mparedocontrols:*, P<0.05;**,P<0.005,* *,P< . 01;andcomparedthEHDPtre tedgroup:,P< .001.
Discussion
In these studies acidosis did not significantly alter total femoral
content of any of the measured cations whilst EHDP lowered total
femoral potassium content. However the value of total cation
content as a means for comparison was questionable because of the
relatively large variation in body weights between the groups of
animals at the end of the experiment. This was reflected by similar
variability of dry and defatted femur weights. Although not
statistically significant, such variability may bias the data. In
order to overcome this problem the results were also expressed as
cations per gram of defatted bone. The coefficient of variation for
many of the measured variables was greatly reduced by examining the
data in this way.
In the present work, despite a reduction in blood pH, ammonium
chloride had no effect on total femoral calcium content. In
contrast, studies in rats demonstrated significant reductions
(Barzel and Jowsey, 1969). Despite the higher ammonium chloride
concentration used by Barzel et al (1969), as mice drink
considerably more water (240 ml kg-^) than rats (80 ml kg-^)
(Bruce, 1950) the ingested dose was probably greater in the present
study.
It is not clear why bone calcium content was unaffected, it may
be that the mouse has a greater ability than the rat to compensate
for an acid load by mechanisms such as the production of urinary
ammonium (Janicki and Argyris, 1969). However the relatively large
fall in blood pH is evidence against this possibility and suggests
rather that mice femora are, perhaps, relatively resistant to
dissolution by acidosis.
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As in the present study, Barzel et al (1969) did not find that
ammonium chloride altered total bone sodium or potassium. However,
they did not examine sodium or potassium per gm of bone. Burnell
(1971) examined changes in bone mineral in dogs by relating the
content of various ions to calcium. Thus he found significant
reductions in bone sodium and carbonate to calcium ratios in dogs
after only 10 days of ammonium chloride treatment. Though potassium
was not examined, depression of sodium content was similar to the
present study.
The cause of the large reduction in total femoral fat content
following ammonium chloride administration is uncertain. Barzel et
al (1969) found reductions in the organic phase of bone, but did
not examine changes in bone fat content.
The studies clearly demonstrated that EHDP depresses femoral
potassium content. It is not surprising that EHDP (30 mg kg-lday~l)
altered the composition of bone, in view of the increased amount of
non-mineralised osteoid tissue seen in man following prolonged
administration at doses greater than 20 mg kg~lday~l (Jowsey et al,
1971; Russell and Fleisch, 1975). Short term experiments in
animals also demonstrated increased non-mineralised osteoid tissue
(King, Francis and Michael, 1971; Rosenblum, 1974). Determination
of whole bone mineral content is clearly very difficult in
experimental studies in man. The only comparable study In animals
is that of Rosenblum (1974) who did not examine bone monovalent
cations and failed to find any change in bone calcium and
phosphorous content following 28 days of EHDP treatment in rabbits.
There is thus little published evidence which assists discussion
of the observed effects.
It is likely that acidosis would modify the pharmacology of
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EHDP. The pKs of three of the equivalence points of EHDP are 11.5,
7.3 and 3.0 (Grabenstetter, Quimby and Flautt, 1967). Since the pK
of one of the hydroxyl groups is so close to 7.4, blood pH changes
of the order seen here (0.1 pH units) would be expected
significantly to alter the ionization and hence the absorption and
excretion of EHDP. Since EHDP complexes are more dissociated at low
pH and since EHDP probably acts, at least in part, by physically
binding onto bone, lowered extracellular pH might also be expected
to reduce the efficacy of EHDP.
However the changes in bone potassium following EHDP were no
different during simultaneous administration of ammonium chloride,
despite demonstrable acidosis. In fact EHDP and ammonium chloride
had very similar effects. The greater depression of femoral sodium,
(per gm of defatted bone) in the ammonium chloride and EHDP treated
group, as compared with the animals treated with EHDP or ammonium
chloride alone perhaps indicates additive effects. Certainly, EHDP
does not moderate the detected bone changes induced by acidosis. If
bone acid-base buffering is chiefly achieved by loss of carbonate
and bicarbonate, together with their associated monovalent cations
(Burnell, 1971), then these results are at variance with the
suggestion that EHDP reduces the ability of bone to buffer an acid
load (Goulding and Broom, 1979). Other diphosphonates, such as
dichloromethylene diphosphonate, which act more specifically on





In the preparation of this thesis a considerable effort was devoted
to the development and validation of methods of measuring calcium
and magnesium fractions in plasma. The importance of these
fractions has been amply discussed and their lability demonstrated
by the results described in Chapter III which clearly indicates the
importance of validating such methods.
The method of preparing plasma ultrafiltrates seemed to be
susceptible to temperature and Donnan shifts. Small shifts in pCC^
and pH occurred during the procedure, though with care these
changes could be reduced so as to have a minimal effect on
ultrafiltrable calcium and magnesium concentrations. Similarly,
ionized calcium was found to be affected by heparin concentration.
Careful control ensured that heparin concentration had a constant
but very small effect on ionized calcium.
Unfortunately it was not possible to develop a suitable method
of measuring plasma ionized magnesium. The study of Heaton (1967)
has hitherto been widely accepted as providing acceptable reference
values for ionized magnesium. The studies described in this thesis
clearly indicate that this is not the case. In so far as Heaton
(1967) investigated his method, the present studies agree with his
findings. However, more detailed investigation demonstrated that
the method does not distinguish adequately between ionized and
chelated magnesium.
None of the published methods seemed to offer alternatives
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suitable for routine determinations. For example, spectrophoto¬
metry methods are relatively cumbersome and, more seriously,
involve dilution and buffering of plasma ultrafiltrates. This is
likely to lead to considerable errors. Other ion exchange methods
(Frizel et al, 1967), like that of Heaton (1967), may also register
a proportion of complexed cations as free ions.
In this thesis, intravenous infusions of EDTA in sheep had the
primary effects expected of a complexing agent: decreased ionized
plasma calcium, and increased urinary calcium excretion. The
increase in complexed plasma calcium concentration was similar in
magnitude to the EDTA concentration. Similarly the increments in
urinary calcium and EDTA were equimolar.
EHDP infusion had similar effects on calcium kinetics: increased
urinary calcium excretion and decreased ionized plasma calcium.
These observations suggested complex formation was occurring in
vivo, as demonstrated in vitro. However two differences were noted
between EDTA and EHDP. Firstly, whereas with EDTA the increments in
plasma and urinary calcium were due to changes in the
ultrafiltrable fraction, with EHDP increases in chelated calcium in
plasma and urine were due to increases in the non-ultrafiltrable
fraction. Thus it seemed that EHDP, unlike EDTA, was forming
complexes of relatively large molecular weight. Secondly, EHDP
quite clearly complexed significant amounts of magnesium in vitro
and in vivo, as evidenced by changes in non-ultrafiltrable plasma
and urinary magnesium. Prior evidence for magnesium binding could
not be found in the literature.
Since the decrease in ultrafiltrable calcium and magnesium was
the same in plasma and saline solutions containing EHDP, the
non-ultrafiltrable nature of calcium and magnesium in plasma could
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not be related to protein binding of EHDP-cation complexes. It
probably, therefore, resulted from the formation of large
aggregates.
Methods of determining ultrafiltrable calcium and magnesium use
relatively crude filters. However attempts to produce filters which
are comparable to the glomerular filter are fraught with
difficulties. Normally calcium and magnesium in plasma are bound
primarily by plasma proteins and ligands of low molecular weights
(such as citrate and phosphate). Thus, providing the membrane
retains protein yet filters small molecules freely, the measured
ultrafiltrable calcium and magnesium will reflect the true
glomerular calcium and magnesium concentrations. However once
substances of intermediate molecular weight are introduced errors
will occur. The behaviour of the glomerulus with respect to a
variety of substances of varying molecular weight has been
investigated. Giebisch et al (1954) summarised data from a variety
of sources; the relationship between molecular weight and filtered
fraction is shown in figure 9.1.
It seems that the renal clearance of partially filtrable
substances of intermediate molecular weight cannot be adequately
characterised using artificial membranes. Thus the measured
ultrafiltrable calcium and magnesium in the presence of EHDP does
not pertain to the situation in vivo. However, in vitro studies
(Wiers, 1971) suggest that the size of EHDP complexes is such that
they are likely to be only partially filtrable by the glomerular
filter (as defined by the review of Giebisch et al, 1954). The low
renal clearance of 99m_technetium-EHDP ^as been demonstrated
(Hughes et al, 1977). The results of the studies reported in
Chapter VI also suggest low clearance, especially when compared
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Figure 9.1 The ratio of renal clearance/GFR as a function of
molecular weight for a variety of substances (dextrans,
haemoglobin, myoglobin, gelatin, polyethylene glycols, grass
polysaccharides, ovalbumin, ovomucoid, B-lactoglobulin and
lysozyme. Adapted from Giebisch, Lauson and Pitts, 1954).
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with the results of EDTA infusion.
Prior to the studies reported here, no evidence could be found
relating to the ionization of calcium borogluconate. In this work
the non-ionized nature of the solution has been clearly
demonstrated. The infusions of calcium borogluconate were less
readily comparable with those of EDTA or EHDP since the calcium
salt was used. As a result, different changes in blood and urine
levels of calcium and magnesium were seen. Thus, although urinary
calcium excretion increased, any effects due to ligand binding were
obscured by the concurrent hypercalcaemia. For the same reason,
calcium borogluconate infusion, unlike EDTA and EHDP, induced
pronounced increases in all three fractions of plasma calcium. Much
of the increment in plasma calcium was due to an increase in
ultrafiltrable, non-ionized calcium. Thus the complexes were
relatively small compared to those formed by EHDP. Administration
of sodium borogluconate depressed total plasma calcium, EHDP
infusion had the opposite effect. This difference was probably due
to the lower rate of excretion of EHDP as a result of its poor
clearance.
In the treatment of hypocalcaemia, the disadvantages of anions
that complex calcium are clear. Much of the rise in blood calcium
will be ineffectual and ligands which are readily filtered will
enhance the renal excretion of calcium. The use of anions which,
unlike borogluconate, are not filtered appreciably by the
glomerulus would help to retain calcium in the circulation. Such
substances could prove valuable in the treatment of clinical
hypocalcaemia providing the equilibrium constants were such that
calcium was readily released at low plasma ionized calcium
concentration and physiological pH. Blood and Henderson (1974)
190
mention the use of calcium carboxymethyl-dextran. If calcium is
significantly bound by this anion, then it might prove of value.
The ability of endogenous ligands to buffer changes in ionized
calcium following addition of calcium chloride or EDTA to blood was
clearly demonstrated in the evaluation of the Nova-2 calcium
electrode described in Chapter III: only 50% of added or removed
calcium came from the ionized fraction. In a similar way exogenous
ligands, such as borogluconate, might regulate ionized calcium by
complexing calcium and releasing it in inverse proportion to the
plasma ionized calcium concentration. Hydrogen ion buffers are most
effective when the pH of the solution is close to the pK of the
buffer. Similarly, significant benefits with calcium ion buffers
will only be gained when the pCa of the solution is close to the
PKq3 of the buffer. It would also be necessary for the binding
constant to be appropriate; a ligand such as EDTA would clearly be
useless in vivo. During therapeutic infusions of calcium salts,
anions with such properties would prevent excessive rises in plasma
ionized calcium which might otherwise occur with a subsequent risk
of acute myocardial toxicity. Indeed, the studies reported in
Chapter V indicated that when small amounts of calcium
borogluconate were added to plasma, considerably more of the
calcium was ionized than when large amounts were added. This may
represent a significant advantage of calcium borogluconate. The
metabolism of such anions would also affect their value.
These experiments suggest that the action of borogluconate on
calcium kinetics deserves further attention. Although the
advantages and clinical efficacy of calcium borogluconate are not
in dispute, comparative evidence obtained using a variety of with
calcium salts might prove useful. Since 25-30% of treated cases of
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hypocalcaemia relapse (Blood, Henderson and Radostits, 1979), salts
giving improved retention of calcium may offer a significant
advantage in the treatment of hypocalcaemia.
EHDP is rather different from EDTA and borogluconate in that it
clearly has other actions in addition to its ability to alter the
kinetics of calcium and/or magnesium merely by complexation. Thus,
the evidence presented in Chapter VII demonstrated a hypercalciuric
action which, on a stoichiometric basis, could not be accounted for
by complexation. The mode of action of this effect was uncertain
though it may have resulted from enhanced calcium absorption from
the gut.
The major interest in diphosphonates stems from their ability to
decrease the rate of bone turnover. This property could be valuable
in the treatment of many conditions in man and animals. It is
particularly interesting that in the treatment of Paget's disease
(a proliferative bone disease in man associated with increased bone
turnover), remission from disease persists long after the cessation
of treatment. However, although in certain circumstances EHDP
reduces demineralisation (Michael et al, 1971; Lindenhayn et al,
1982), the production of beneficial rather than deleterious effects
clinically, requires careful control of dosage (Rashid, Khairi and
Johnston, 1977).
The future probably lies with other diphosphonates which have a
lesser tendency to cause loss of bone substance. Dichloro-methylene
diphosphonate is one such drug (Gasser et al, 1972), but the most
promising agent at present seems to be 3-amino-l-hydroxy-
propylidene-1,1-diphosphonate (ADP) (Lemkes, Reitsma, Frijilink,
Verlinden-Ooms and Bijvoet, 1977). This drug reduces both
mineralisation and resorption but seems to have a lesser tendency
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to cause de-mineralisation than EHDP. Preliminary studies suggest
that it may prove useful in man (Frijlink, Bijvoet, Velde and
Heynen, 1979).
In this thesis the actions of some drugs which complex calcium
and magnesium have been studied. Their ability to alter partition
of calcium and magnesium between plasma compartments and, as a
result of reduced bio-availability, enhance excretion has been
clearly demonstrated. In addition some more novel actions have been
studied, such as alterations in bone turnover. The latter actions
are less clearly the result of complexation per se, and may result
from more specific pharmacological actions of the drugs.
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Appendix
A comparison between the renal clearance of endogenous
creatinine and inulin in the sheep
Summary
1. Intravenous infusions of inulin were made in four sheep. Urine
was collected for periods of one hour and blood at the beginning
and end of each period. Simultaneous renal clearances of inulin
(Pi
in) and endogenous creatinine (Clecr) were determined during
periods of stable plasma inulin concentration.
2 Cl
ecr was found to be a reasonable method of measuring GFR in
the normal range. However the calculated regression of Clecr on
PI
in differed slightly from the expected line: at high clearances
PI
ecr was slightly greater than Cl^n, at low clearances the reverse
was true. When glomerular filtration rate (GFR) was in the range
14-48 ml min~l, encompassing the majority of observations made, the
two clearances did not differ significantly.
3. It is suggested that the small differences between creatinine
and inulin clearance were due to lack of specificity of the method
used for creatinine determination. The use of Cl
ecr introduces
errors at high or low GFR, but these are insignificant compared to
the normal variability of clearance methods.
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Introduction
Inulin has been found to be a more suitable marker than any other
substance studied for the measurement of GFR. Inulin is neither
secreted nor reabsorbed by the renal tubule (Levinsky and Levy,
1973). Creatinine is also a useful indicator of GFR in the dog
cat, seal and rabbit, however it is secreted by the proximal renal
tubule in man, primates, dogfish, teleosts and chickens (Smith,
1951) and so cannot be used in these species. Two perfunctory
comparisons of creatinine and inulin clearance in sheep have been
published (Shannon,1937; Schmidt-Nielsen, Osaki, Murdaugh and
O'Dell, 1958).
Creatinine clearance is measured either during creatinine
infusion (exogenous creatinine clearance; CI ) or by utilising
endogenous creatinine (Clgcr). on a herbivorous diet endogenous
creatinine is derived almost entirely from the breakdown of muscle
phosphocreatines and creatine, the amount produced is therefore
closely related to lean body mass. For long term experiments
endogenous Clecr is the most practicable method of assessing GFR.
The chromogens in plasma which are measured as creatinine
comprise the "true" and "pseudo" creatinine fractions. The latter
component includes many different substances. Lauson (1951) showed
that non creatinine chromogens in plasma accounted for 25-75% of
the Jaffe positive substances-'- in plasma. The presence of "pseudo"
creatinines forms the major drawback to the use of endogenous
creatinine clearance since it is important that only substances
■*"The Jaffe reaction is the alkaline picrate reaction used for the
determination of creatinine, it measures both "true" and "pseudo"
creatinine, unless used in conjunction with an adsorption
technique.
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which are filtered without secretion or reabsorption are measured.
This problem can be overcome either by infusing creatinine so as to
raise the plasma creatinine sufficiently that "pseudo" creatinine
concentration becomes negligible, or by using a method of
creatinine estimation which eliminates the "pseudo" creatinines.
Narayanan and Appleton (1972) found that methods of measuring
"true" creatinine, including the one used in this study, were not
entirely specific for creatinine. However providing the method used
measures substances which are excreted without reabsorption or
secretion, it will be suitable for the determination of GFR. Thus,
despite evidence that a method is not specific, reliance may be
placed on an examination of the relationship between either CI or
n
ecr and Clin in evaluation of its suitability.
Knudsen (1959) studied creatinine clearance in the horse and
found that both Clgcr ancj cicr were closely related to inulin
clearance. However, the values of Cl^ were 20% higher than the
simultaneously measured Cl.J in •
Shannon (1937) and Schmidt-Nielsen et al (1958) are the only
investigators to have made simultaneous determinations of
creatinine clearance and Cl^n> Shannon (1937) measured Clcr in one
sheep, Schmidt-Nielsen et al (1958) measured Clecr in two sfteep
during a large number of clearance periods. No significant
differences were observed between creatinine and inulin clearances
in either of these investigations.
Since so little work had been done to verify the validity of
C"*"ecr as an estimate of GFR in the sheep it was proposed to compare
the renal clearances of inulin and endogenous creatinine.




Sheep (21-43 kg weight) were catheterised for urine and blood
collection, and for intravenous infusions as described in Chapter
II. Before the start of an infusion samples of blood and urine were
taken as inulin blanks. Inulin was then infused at a rate of 1 mg
kg~lmin--'- following a priming dose of 17 mg kg--*-. Infusion was
started at least one hour before clearances were measured, thus
clearances were only determined during periods of stable plasma
inulin concentration. Four sheep were used in this experiment, two
sheep were used on two separate occasion thus providing a total of
six infusions. Clearances were calculated from hourly urine
collections, and the mean of the concentrations of creatinine or
inulin in blood samples taken at the beginning and end of each
clearance period.
Results
The gradient of the regression of Cl^ on cl_.n differed from 1.00
(P<0.005; figure la). The intercept differed from 0.00 (P<0.02).
The ratio Clecr./Cl£n was correlated with the plasma concentrations
of both creatinine (r=0.79, P<0.001) and inulin (r=0.77, P<0.001).
No significant correlations were observed between urine volume and
^ecr (t=0.32), or urine volume and Cl^n (r=0.28). Over the range
^in 14-48 ml min ^ > ^1 and Cl-^n were not significantly
different. The within infusion coefficient of variation for all
inulin clearance periods was 14.5 + 3.6% (mean + SEM).
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Figure La Comparison of simultaneous measurements of the renal
clearances of inulin and endogenous creatinine in four sheep. The
dashed line shows the expected relationship if the two clearances




Over the range of clearances studied Clin an(j Clecr were very
similar. However at high clearances Clecr over-estimated Clin.
Assuming that Clln actually measures GFR, this finding indicates
secretion of creatinine by the renal tubule. Creatinine is known
to be secreted by the proximal renal tubule in several species
(Smith, 1951) .
Similarly, at low Cl^n> Clecr under-estimated Clin, suggesting
reabsorption of creatinine. Reabsorption from the lower urinary
tract occurs during exogenous creatinine infusion in dogs (Levinsky
and Berliner, 1959) and at low urinary flow in man (Chesley, 1938).
However since the studies reported herein did not demonstrate a
significant correlation between Clecr/Clin and urinary volume, it
is unlikely that significant reabsorption of creatinine occurred
from the lower urinary tract. In addition, significant
reabsorption of creatinine within the nephron has only been
demonstrated during exogenous creatinine infusion (Ladd, Liddle and
Gagnon, 1956) and so is unlikely to account for these observations.
Alternatively, the findings may be a result of failure of the
method to measure solely "true" creatinine. This seems the most
likely explanation since it is known that adsorption of creatinine
by Lloyd's reagent does not eliminate all "pseudo" creatinines in
human urine (Narayanan et al 1972).
Despite the variation in Clecr/Ciinj the clearances of the two
substances were strongly correlated. Errors introduced by this
method are therefore probably not serious, especially in the
detection of relative changes in GFR. Additionally, over the range
of Cl^ 14-48 ml min-"^ including most of the observations, the
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clearances of the two substances were not significantly different.
The maximum deviation of the Clecr versus Clin regression was 17%,
scarcely greater than the observed within infusion coefficient of
variation of Clin Q4.5 + 3.6%).
In conclusion, "true" creatinine apparently undergoes secretion
and possibly reabsortion by the renal tubule of sheep. This error
is probably due to non-specificity of the method with regard to a
number of different constituents of plasma and does not constitute
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